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Abstract
The prohormone proglucagon encodes for multiple peptide hormones, including
glucagon, glucagon-like peptide-1 (GLP-1), and GLP-2, produced through tissue-specific
processing by prohormone convertase (PC) 1/3 and PC2. In alpha cells, PC2 yields
glucagon, the major counter-regulatory hormone to insulin, which together, control
glucose homeostasis. In contrast, GLP-1 and GLP2 are mainly produced in intestinal Lcells by PC1/3. GLP-1 stimulates insulin secretion following a meal, and therefore has
opposing function to glucagon regulating glucose homeostasis; in contrast, GLP-2
enhances gut nutrient absorption. Efficient sorting of proglucagon to secretory granules is
required for nutrient-regulated secretion. The aim of this thesis is to discover the
molecular mechanisms by which proglucagon is targeted to secretory granules, which
ensures that proglucagon is correctly processed to mature hormones, and is necessary for
prompt physiologic response to nutrient status. This thesis identifies several sorting
signals contained within the mature hormone domains of proglucagon that encodes its
targeting information. Using quantitative immunofluorescence microscopy and colocalization analyses, the molecular mechanism that sorts proglucagon to granules is
directed by the domains of glucagon and GLP-1. Despite these two hormones sharing a
large degree of structural homology, it is their particular alpha-helix structures that enable
the sorting of proglucagon. Further, the evidence suggests that proglucagon is first sorted
to granules prior to being processed to active hormones. In alpha cells, carboxypeptidase
E is required for the sorting of glucagon to granules. Together, each neuropeptide or
peptide hormone carries with it a unique sorting “signature” to efficiently reach its
destination, and allows alpha and L-cells to tightly regulate nutrient homeostasis.

Keywords
proglucagon, glucagon, GLP-1, peptide hormone, carboxypeptidase E, prohormone
processing, protein trafficking, protein sorting, confocal microscopy, quantitative colocalization
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Chapter 1
1.1 Introduction
Proper regulation of energy metabolism and glucose homeostasis are crucial for the
survival of any organism. Collectively, glucose homeostasis is exquisitely regulated by
the counter-regulatory actions of insulin and glucagon, the major hormones secreted from
pancreatic islet beta and α cells, respectively. Blood glucose is the primary trigger for
secretion of glucagon and insulin in the maintenance of euglycemia and the defence
against deleterious excursions of glycemia. Insulin and glucagon target the liver, skeletal
muscle and peripheral tissues to regulate glucose homeostasis. In order for these islet
cells to be responsive to blood glucose, islet cells must first package these hormones in
specialized organelles, called secretory granules. Granule storage is a prerequisite for the
conversion from inactive, precursor prohormones to active hormones, and for
maintaining concentrated stores of hormone such that physiologic triggers promptly
counteract changes in nutrient status. The mechanism of packaging insulin in granules is
understood. However, the underlying mechanism of glucagon sorting is not, and it is the
aim of this thesis is to investigate this mechanism.

1.2 Structure, Function and Distribution of Proglucagon
and the Proglucagon-Derived Peptides
Proglucagon is encoded by the glucagon gene (GCG), and expressed in both pancreatic α
cells, enteroendocrine intestinal L-cells, and select neurons in in the hypothalamus and
brainstem. Post-translational tissue-specific processing of proglucagon is achieved by
cleavage at dibasic amino acid sequences separating hormone domains, and a single
mono-basic site to produce active GLP-1 (7-37) (in L-cells only), by the differential
expression and action of prohormone convertases (PCs) (Figure 1). In pancreatic α cells,
where PC2 is expressed, proglucagon is processed to the major product glucagon (Figure
1). In contrast, PC1/3 expression in enteroendocrine L-cells and neurons produces the
major products GLP-1 and GLP-2, and minor products oxyntomodulin and glicentin
(Figure 1). Further details of the processing will be discussed in the section “Processing
of Proglucagon.” Once secreted into circulation, the proglucagon-derived peptides
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(PGDPs) transduce their actions through a family of related receptors.

Figure 1. Post-translational processing of proglucagon to its derived peptides. A
schematic representation of proglucagon in which each domain has been colour-coded,
and the amino acid positions of key processing events have been identified. The amino
acid numbering is relative to the first N-terminal amino acid of proglucagon (lacking the
signal peptide). The major hormone products produced from tissue-specific processing by
their respective prohormone convertase (PC) are shown at bottom. In pancreatic islet α
cells, the major products are glucagon and major proglucagon fragment (MPGF). In
enteroendocrine L cells and in the brain, the major products are GLP-1 (1-37), GLP-1 (737), GLP-2, oxyntomodulin and glicentin.
Glucagon, GLP-1 and GLP-2 all mediate their effects through cognate G-protein-coupled
receptors (1), known as the vasoactive intestinal peptide/glucagon/secretin receptor
family. Mammalians have well-conserved proglucagon and cognate GPCR sequences,
suggesting their physiological importance in early evolutionary nutrient metabolism and
regulation (2, 3). This receptor family activates adenylate cyclase/cyclic adenosine
monophosphate/protein kinase A, and may also couple to phospholipase C and storeoperated Ca2+ signalling (4–7). The proglucagon-derived peptides have a degree of crossreactivity for other PGDP receptors. Most importantly, glucagon and oxyntomodulin are
very weak agonists of GLP-1R by about 100-fold, while GLP-1 is a weak agonist of
GCG-R, approximately 10-fold weaker than glucagon (8–12). Though their sequences
share homology, the PGDPs exert distinct biological effects in the regulation and counter-
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regulation glucose homeostasis.

1.2.1 Glucagon
Glucagon is the primary hormone product of α cells, the major counter-regulatory
hormone to insulin, maintaining euglycemia and glucose homeostasis. The prevailing
belief is that glucose is secreted in response to a hypoglycemia (i.e., a fasted state or in
exercise), by primarily acting upon liver hepatocytes to increase glucose output through
increased glycogenolysis and gluconeogensis (13). Normally, fine control over glucose
control is achieved by the coordinated and pulsatile secretion of glucagon or insulin (14).
The importance of glucagon in this balance is seen when exogenous glucagon
administration potently stimulates large and transient increases in blood glucose in
animals and humans (15–17). Mouse models in which proglucagon is globally deleted
(GCGgfp/gfp) (18), or glucagon signalling is abrogated either globally (GCG-R null) (19,
20) or only within liver hepatocytes (21) causes the development of a slight fasting
hypoglycemia, improved glucose tolerance and normal insulin tolerance. Post-natal
GCGgfp/gfp mice are severely hypoglycemic, and the normalization of glucose
homoeostasis developed in adulthood is an adaptation due to dampened insulin secretion
and down-regulated hepatocyte signalling mechanisms to compensate for the loss of
glucagon (22). Taken together, glucagon is an important regulator of hepatic glucose
output in conditions of hypoglycemia.
In the relative or absolute absence of insulin, glucagon secretion becomes dysregulated.
While a healthy individual resists hyperglycemic episodes, increased glucagon output can
be considered a general defence to prolonged and severe hypoglycemic episodes. In both
T1DM (23) and severe T2DM (e.g., approaching insulin-deficiency) (24), glucagon
response to hypoglycemia is lost, resulting in more severe and recurrent hypoglycemia.
T2DM is further characterized by hyperglucagonemia and increased basal hepatic
glucose output. Fasting hyperglycemia in T2DM is further exacerbated by the
inappropriate and paradoxical hypersecretion of glucagon in a hyperglycemic state (25,
26), leading to prolonged hyperglycemia. Dysregulation of glucagon secretion is central
to the pathogenesis of T2DM hyperglycemia (27) although the exact mechanism
underlying this dysregulation is debated, involving a mixture of abnormal intrinsic
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signalling of the α cell and abnormal autonomic or paracrine control. Since regulated
exocytosis of glucagon involves membrane depolarization and elevated cytosolic
calcium, it is not difficult to imagine that a change in electrical excitability of the α cell
may contribute to this pathogenesis (24). As T2DM progresses, impairment of K-ATP
channel regulation results in the relative decrease in glucagon response. This mechanism
will be discussed in further detail in the section regarding mechanisms of glucagon
secretion.

1.2.2 GLP-1
Glucose homeostasis is also regulated by GLP-1, which exerts insulinotropic effects in a
glucose-dependent manner, and opposing those of glucagon. GLP-1 and GLP-2 are cosecreted from the enteroendocrine L-cells, located mainly along the distal ileum and
colon (28, 29), in a bi-phasic pattern of secretion and in response to nutrient ingestion
(30–32). GLP-1 makes an essential contribution to the control of glucose homeostasis by
direct stimulation of insulin secretion, as shown using both GLP-1R antagonists in
humans (33), and using GLP-1R deficient mice (34). In contrast, GLP-1 indirectly
inhibits glucagon secretion (35), in healthy humans at sub-insulinotropic doses (36) and
is maintained in T2DM (37). However, In T2DM, both the early and late phase of GLP-1
secretion is reduced (31). Evidence from mice (38) and humans (39) suggests that
glucagon suppression acts through paracrine modulation of α cells via local secretion of
insulin. GLP-1 also decreases gastric motility in healthy lean and obese humans with
T2DM (40–42), and decreases gastric emptying and appetite (43, 44). As T2DM is
accompanied by hyperglucagonemia, this may be explained by the loss of GLP-1
secretion. It would also suggest that a healthy individual maintains tight coordination
between the glucoregulatory GLP-1 and counter-regulatory glucagon.

1.2.3 GLP-2
GLP-2 is recognized as an intestinotrophic factor influencing multiple functions of the GI
tract. Unlike GLP-1, GLP-2 does not stimulate insulin secretion (45, 46), but it does
stimulate glucagon secretion (47). GLP-2 increases nutrient absorption from the gut,
maintains the integrity of the intestinal epithelium (29, 48), and increase mesenteric blood
flow in humans (49). This is especially important in intestinal malabsorptive disorders,
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such as short bowel syndrome or distal bowel resections, whereby GLP-2 administration
promotes intestinal growth and adaptation in humans (50, 51). Therefore GLP-2
indirectly contributes to post-prandial nutrient absorption and nutrient homeostasis. In
T2DM, the stimulation of glucagon secretion (45) further contributes to prolonged
hyperglycemia. With respect to the islet, GLP-2 protects against metabolic stress (e.g.,
from high-fat diet), and is essential to the adaptation of α and beta cells to obesity
induced in mouse models of obesity and GLP-2R knockout (52). In this study, the obese
and GLP-2R deficient mice had a disproportionate loss of beta cells and increased
number of α cells, leading to ambient hyperglycemia and elevated glucagon levels.
Pathological expansion of α cells is known to involve the up-regulation of proinflammatory cytokine IL-6 (53). IL-6 is known to mobilize serum FFA levels in mice
(54) which causes oxidative stress and is toxic to beta cells (55). Such a mechanism may
be operating in the GLP-2R knockout mice. Additionally, elevated IL-6 shifts the α cell
phenotype toward expression of PC1/3, therefore producing intra-islet GLP-1 (56), and
later co-secretion of glucagon and GLP-1. In mice, this links the action of GLP-2 to
controlling systemic inflammation and cross-talk between islet cell types with the gut, in
order to preserve normal glucoregulatory responses.
The diverse actions of glucagon, GLP-1 and GLP-2 operate in balance to maintain
nutrient homeostasis. In a fasted state (Figure 2), glucagon is the safe-guard to
hypoglycemia by stimulating increased glucose output from the liver to maintain
euglycemia. Simultaneously, fasted blood glucose levels are below the stimulatory
threshold needed for insulin secretion, and the lack of ingested nutrients will not
stimulate secretion of GLP-1 and GLP-2. Beginning shortly after meal ingestion (~15
min), GLP-1 and GLP-2 are secreted in the first phase (Figure 2), initiating the ileal
brake, modulating gut motility and increasing intestinal nutrient absorption. Therefore,
GLP-1 and GLP-2 are together control the “optimal” rate of nutrient absorption.
Absorbed glucose directly stimulates insulin secretion, further increasing insulin
secretion by the action of GLP-1. Together, insulin, GLP-1 and GLP-2 act to suppress
glucagon secretion and therefore prevent its anorectic effects in the absorptive, fed state.
Perturbations of intestinal absorption or secretion, or insult to islets (e.g., by oxidative-
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stress) disrupt their balance.

Figure 2. Overview of key metabolic actions of insulin, glucagon and GLP-1 on glucose
homeostasis. Hypoglycemia triggers α cells to secrete glucagon, which potentiates
hepatic gluconeogenesis and glycogenolysis. After a meal, ingested nutrients potentiate
GLP-1 and GLP-2 secretion from L-cells. GLP-1 regulates glucose homeostasis by
increasing insulin secretion in a glucose-dependent manner.

1.2.4 Oxyntomodulin and Glicentin
Oxyntomodulin (OXM) contains the glucagon sequence that is C-terminally extended by
IP-1. Oxyntomodulin modulates appetite and body weight, as well as gastric acid
secretion. Oxyntomodulin was discovered in 1981 (57, 58) for its hyperglycemic and
glycogenolytic hepatic effects, mediated through the glucagon receptor (59, 60). In
randomized clinical trials in humans, it increased energy expenditure and satiety, while
decreasing food intake (61, 62), consistent with effects seen from co-administration of
sub-physiologic doses of both glucagon and GLP-1 in humans (36). OXM has weak
affinity to both Gcg-R and GLP-1R, when compared to glucagon and GLP-1 (9, 11). For
instance, it is (~20-fold) more potent than glucagon to stimulate gastric acid secretion
(61). Despite signalling through both the glucagon and GLP-1 receptors, it is believed
that OXM is a GLP-1R-biased ligand, showing a preference toward phosphorylation of
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extracellular-signal-related kinases (ERK)1/2 and less stimulation of in vitro cAMP
assays through differential recruitment of G-α subunits when compared to GLP-1 (63).
This bias is consistent with the recent findings that OXM elevates the intrinsic heart rate
in mice through the GCG-R and not GLP-1R (10, 64). These properties make it attractive
as a new class of dual-agonist for anti-obesity and anti-diabetic therapy as the potential
hypoglycemic effects are tempered by the GLP-1R activation. Similarly, glicentin is
OXM that is N-terminally extended by GRPP. It has even less well understood
pharmacological effects despite also being co-secreted from intestinal L-cells. In humans,
glicentin opposes those effects of OXM on gastric acid secretion (65); it has similar
inhibitory effects on gut motility (66), and delays post-prandial gastric emptying (67). At
present, it is believed that the molecular mechanisms of OXM and glicentin signalling are
likely to be similar. The remaining PGDPs (IP-1, IP-2 and GRPP) do not appear to exert
any interesting effects.
The prohormone proglucagon encodes several structurally related peptides, that have
wide-ranging and contrasting physiologic effects. The α and L-cells that express
proglucagon are able to liberate only the relevant constituent hormone(s) needed to
respond to nutrient status. Tissue-specific processing is known to be caused by the
specific cleavage by expression of either PC1/3 or PC2. In order to prepare adequate
concentrations of active hormones within these cells, proglucagon is sorted into secretory
granules, where conversion to glucagon or the glucagon-like peptides occurs along the
late secretory pathway. Nutrient status potently stimulates secretion of the proglucagonderived peptides so they may exert tight control over glucose metabolism and nutrient
homeostasis. However, the molecular mechanism by which proglucagon is sorted from
the trans-Golgi network (TGN) into granules is not understood. This thesis aims to
uncover this sorting mechanism for proglucagon within α- and L-cells.

1.3 Mechanisms of Regulated Exocytosis
1.3.1 Secretory Pathway
Cells use multiple pathways to ensure exocytosis of various proteins. Beginning with the
early secretory proteins, the nascent peptide chain is synthesized into the ER (68), and
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packaged for delivery to the Golgi from so-called “exit sites,” loaded into vesicles
defined by coat-protein (COP)-II (69). These COP-II vesicles undergo homotypic fusion
in mammals, forming the ER-Golgi Intermediate Complex (ERGIC) that subsequently
becomes/transits en bloc to the cis-Golgi (70). The Golgi is typically regarded as having a
tripartite compartmental organization – consisting of cis, medial and trans cisternae –
along with the Golgi-associated TGN. As cargo transits the stack, it may acquire posttranslational modifications (e.g., sulfation, maturation of N-glycosides, addition of Oglycosides). The mammalian Golgi are morphologically similar, in which several Golgi
stacks are joined laterally into an elongated Golgi ribbon (71), and sometimes the
neighbouring cisternae within stacks can be joined by a tubular-mesh connections rather
than existing as disconnected structures (72, 73). Neuroendocrine cells have been a recent
focus to detail the 3D Golgi morphology (74). The beta cell in particular exhibits this
more complex mesh-like topology (75). The exact details of how secretory proteins
transit the Golgi stack are still a matter of debate.
There are two dominant models for Golgi traffic: vesicular trafficking between stable
compartments, and cisternal progression/maturation. The stable compartments hypothesis
describes the Golgi cisternae as biochemically distinct compartments, in which proteins
progress sequentially through each cisternae, exposed to the unique enzymes and
conditions of each cisterna, by means of anterograde carrier vesicles (76–78). These
carrier vesicles are thought to be defined by coat protein (COP)-I (79, 80). The finding
that purified COP-I vesicles contained Golgi glycosylation enzymes (81, 82), weaken this
model because it implicates COP-I vesicles in both retrograde and anterograde cargo flow
(83, 84). The limitations of this model compelled people to favour cisternal maturation as
an alternate framework. The cisternal progression/maturation model offers a more fluid
description of Golgi dynamics. The cis-cisternae is formed directly from the ERGIC
complex, progressively maturing through the Golgi stack to the trans-most cisterna, and
is ultimately “shed” at the TGN as secretory cargoes are carried along post-Golgi routes.
As a cisterna matures, the resident enzymes are recycled to earlier positions to maintain
their polarized distribution (83–86), though some groups have found a lack of some Golgi
resident recycling in COP-I vesicles (86, 87). A fundamental question is whether COP-I
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vesicles carry (anterograde) secretory cargo. A recent super-resolution fluorescence
microscopy study showed that fused cells can exchange both resident proteins and
secretory cargo over long distances in COP-I vesicles, suggesting bidirectional
transportation (72, 85, 88). The cisternal maturation model is extended by considering the
Ras-related protein subfamily of G-proteins, Rab proteins. The Rab network is a set of
~70 proteins spread over the various membrane-bound compartments of the cell,
including the Golgi cisternae, which may provide a mechanism for both maintaining
cisternal identity and signals maturation (81, 82). By analogy, Rab proteins mark distinct
membranes to help define organelles and vesicles. At present, the cisternal maturation
model is most consistent with the literature and is considered the most appropriate model.
Once cargo arrives at the TGN for sorting, neurons and (neuro)endocrine cells possess a
regulated secretory pathway for transport of specialized neuropeptide and hormone cargo.
Exit from the Golgi along the regulated secretory pathway requires formation of secretory
granules that undergo several steps in order to form, mature and become competent for
exocytosis. Hormones must first be sequestered into an area of the TGN that begins to
protrude (extrude) from the membrane, called the granule precursor or nascent granule.
Scission of the two membranes forms a nascent secretory granule, and often occurs
simultaneously with cargo loading (89, 90). The granule undergoes several maturation
steps, including 1) the removal of extraneous cargo proteins and membrane lipids, 2)
trafficking toward the plasma membrane, 3) acidification of the lumen, 4) docking at the
plasma membrane, before finally being rendered mature granules. These steps are partly
dependent on each other and partly concurrent with each other; the maturation steps
happen with some overlap between consecutive steps as will be discussed later with final
maturation steps. Consider that a beta cell can only immediately release ~20-30 granules
(i.e., readily releasable pool) (91), and that secretory granules are reduced in number (92)
and secretion competency (93) following the development of T2DM. Each of these (more
proximal) maturation steps are therefore very sensitive to interference, to the point that
even slight perturbations could severely negatively impact the ability of the
(neuro)endocrine tissue to adequately concentrate hormones into and maintain a pool of
granules.
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Newly forming granules are limited not only by the cargo to be packaged, but also by the
specific lipid membrane components. The membrane of the TGN is enriched in
phosphatidylinositol-4-phosphate (PI4P), derived from phosphatidylinositol. PI4P is a
signalling lipid on the cytosolic leaflet of the TGN membrane that controls Golgi-toplasma membrane traffic (94, 95). In part, PI4P is implicated in the regulation of granule
biogenesis and exocytosis in chromaffin cells (96, 97), and insulin secretion from beta
cells (98, 99). The precise membrane composition dictates the biophysical properties of
the budding and mature granule, and also provide for spatial coordination of cargo
sorting. Lipids rafts play a central role in the formation of secretory granules, of which
cholesterol is a key component. Mature granule membranes contain cholesterol in the
range of 33-65 mol % (100, 101). Cholesterol depletion by methyl-beta-cyclodextrin
(MBCD) causes multiple defects on insulin and glucagon secretion, while insulin
granules appeared morphologically smaller with less-dense cores (102), without apparent
effect on cholesterol desorption from the plasma membrane (103). Cholesterol depletion
caused the mis-sorting of POMC to the constitutive secretion pathway by preventing the
granule targeting of carboxypeptidase E (CPE) in AtT-20 cells (101), similar to findings
of diminished glucose-stimulated insulin secretion from MIN6 cells (104). Several of the
key processing enzymes associate with cholesterol-sphingomyelin-rich lipid rafts,
including PC1/3 (105, 106), PC2 (107, 108), CPE (101, 109) and secretogranins (100,
110). The other main component of lipid rafts are sphingolipids, including
phosphatidylethanolamine (PE). Reduction of sphingosine kinase Sphk1 in INS-1 cells,
which prevents the biosynthesis of downstream sphingolipids (including PE), abolished
glucose-stimulated insulin secretion by 50-90% (111). Not only is cholesterol a necessary
component of both constitutive and regulated secretory pathways (101, 112),
sphingolipids are also critical to their formation. Additionally, they both provide
membrane flexibility due to liquid-ordered phase separation in membranes (113–115).
The flexibility of the membrane is essential for granule biogenesis, a process of budding
or extrusion from the TGN, ending with scission of the two compartments. Cholesterol
(115) and other lipids like diacylglycerol (DAG) and phosphatidylethanolamine (PE) lend
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spontaneous negative curvature to the budding granule, enabling the formation of the
characteristic neck (rather than a tubular protrusion) for membrane scission (116). The
next most abundant lipid in granule membranes is PE, at ~18-20 mol % (101, 110),
suggesting that the granule membrane is specifically optimized for its formation. DAG
has a cone-shape in an acidic environment (e.g., in the TGN) that lends itself well to the
extreme negative curvature (117) and are implicated in the formation of vesicular carriers
(115). Together, it is believed that these lipids promote the negative curvature of the neck
to aid in granule biogenesis, and a scission complex has been implicated to be recruited to
the granule neck in DAG-dependent and protein kinase D-mediated manner (118–120).
Positive membrane curvature in the secretory pathway can be sensed or even induced by
Bin/amphiphysin/Rvs (BAR) domain-containing proteins; the banana-shaped BAR
domain, formed by a coiled-coil structure, has a convex side that associates with and can
induce positive membrane curvature (121, 122), and are specifically recruited for the
deformation of the TGN membrane (123). Three BAR domain-containing proteins,
arfaptin-1, arfaptin-2 and PICK1, are implicated in the formation of secretory granules.
PICK-1 regulates granule formation in chromaffin (124) and beta cells, such that
impaired PICK-1 function results in reduced insulin secretion, glucose intolerance in
mice, and is implicated as one cause for T2DM in humans (125, 126). Arfaptin-1 and
arfaptin-2 are recruited to domains of the TGN marked by Arf-like 1 (Arl-1) (123) in
endocrine cells, or Arf1 in non-endocrine cells (127). Arfaptins interact with DAG lipids
in the budding granule (89) (presumably at the neck), to promote the formation of
vesicular and tubular structures (123). Arfaptin-1 in particular mediates the fission
process of granules in beta cells (89), either by recruiting a fission complex, or itself
effecting the fission (128). While it is likely these same principles from beta cells that
apply to α cells, granule biogenesis has yet to be studied in α cells.
Since several neuroendocrine and endocrine tissues produce secretory granules, it is
expected that they would have different characteristics (e.g., size, contents, secretory
response). For instance, secretory granules are quite variable in total number and size.
Estimates of granule numbers range from a few hundred in lactotrophs (129), ~20,000 in
bovine chromaffin cells (130), to ~7,000 in mouse α cells (131), and ~6,000 in beta cells

12
(132). Similarly, the mean granule diameter varies considerably, and thus its neuropeptide
cargoes from ~250 nm in diameter in PC12 (133), 275 nm in mouse α cells (131), to ~350
nm in chromaffin cells (130), with ~600-800 nm being the largest granules belonging to
pancreatic acinar zymogen (134). The reason for this variation in size is not well
understood, but at least in lactotrophs, granule size correlates with increased probability
of complete fusion events and full exocytosis of all cargoes (135).
Concomitant with the maturation of immature granules, the granule lumen is acidified.
Vacuolar-type H+-ATPase (V-ATPase) pumps in the Golgi and granules (136) gradually
acidify from pH ~6.3-6.0 in ISGs to pH 5.0-5.5 in mature granules (137–139). Critically,
the production of mature endocrine hormones requires the acidification of the granule
lumen (139–141), which can then activate PC1/3 and PC2 which are optimally active in
the range of pH 5.5-6 (142, 143), coinciding with the conditions of the mature granule
lumen. Inhibition of acidification prevents exocytic fusion, and in particular glucagon and
insulin secretion (144, 145). The V-ATPase also directly interacts with the small Ca2+binding protein, calmodulin, to mediate the calcium-dependent exocytosis of insulin from
beta cells (146, 147), GLP-1 from GLUTag cells (148), and presumably glucagon
secretion (149, 150).
The process of transporting a maturing secretory granule toward the plasma membrane
involves four discrete mechanistic steps: membrane approach/delivery, docking, priming
and fusion. The extrusion process of granule formation is still debated, though there is
good evidence to implicate the BAR domain-containing proteins in chromaffin cells
(124), possibly by acting as a “proof-reading switch” to sense when the granule is “full.”
The kinetic energy of extrusion is controversial and may result either from membrane
scission alone, or from the combination of scission and extrusion due to the action of
myosin Va motor (151). On the other hand, granule size is more likely to be determined
during the membrane-remodelling phase of maturation, for which myosin Va interacts
with a key regulator of granule maturation, Rab3D (152–154). Once ISGs are formed,
they are immediately transported over long distances (i.e., several µm) toward the plasma
membrane, directed along microtubules (155, 156) by the conventional microtubule-
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based motor, kinesin (157, 158), until reaching the actin-rich cortex. In the cortical
region, the granules are carried the last few hundred nm by myosin Va in neuroendocrine
cells (e.g, chromaffin cells (159), PC12 (160)) and also in beta cell lines (161–163).
Interference with cortical trafficking either by siRNA-mediated knockdown of myosin Va
or a dominant-negative of myosin Va-tail protein impairs insulin secretion (162). Since
delivery to the cortex takes ~3-5 sec, it is thought it precedes maturation due to
membrane remodelling and cargo maturation which take take 2-4 hours. However, newly
formed ISGs become competent for secretion in as little as 30 minutes (164), consistent
with the timing of VAMP4 removal from immature granules in AtT20 cells (165), and the
recycling of furin from PC12 granules (166).
The last step in this process before exocytosis is membrane fusion. The basic mechanism
of fusion is mediated by a variety of soluble N-ethylmaleimide-sensitive factor
attachment protein (SNAP) receptor (SNARE) protein complexes. Generally, fusion
occurs when a “donor” or “vesicular” membrane, contains a single SNARE (denoted vSNARE), forms four helix bundle with two additional SNARE proteins on the “target” or
“recipient” membrane (denoted as t-SNARE). Each protein contains one or two SNARE
motifs of ~60-70 amino acids in size, comprised of a repeating heptad of hydrophobic
residues, with a central amino acid being either arginine (v/R-SNARE) or glutamine (t/QSNARE) (167). The specificity of these interactions is encoded by and within the
SNARE motif itself (167, 168). SNARE fusion generally requires the assembly of one RSNARE (usually from the vesicle) and three Q-SNAREs (usually from the “target”
membrane) (156, 160, 169–171). The minimal fusion process is thought to occur in two
steps: the initial formation of a heterodimeric Qa/Qbc complex of plasma membrane
syntaxin-1 (as Qa) and SNAP-25 (as Qbc), followed by the insertion of vesicular RSNARE (synaptobrevin-2/VAMP-2) joining the two membranes in “trans” orientation,
and then “zippering” up to form a “cis” oriented complex and achieving fusion. Though
this complex is sufficient for spontaneous fusion in reconstituted liposomes, it proceeds
with considerably slower kinetics (t 1/2 ~ 10 min) compared to the rapid exocytosis seen in
neuronal synapses (t1/2 ~ few hundreds of μsec) (160, 161, 172). In vivo, several accessory
proteins are important for the regulation of modulation fusion kinetics, responsible for the
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divergence between synaptic vesicles and secretory granule exocytosis kinetics, reviewed
in (155). Synaptotagmins are a critical accessory protein family because of their calciumsensitivity (173). Therefore, layered into the SNARE mechanism is tissue-specific
modulation for a broader complexity of regulating exocytosis.

1.4 Mechanisms of regulated secretion
1.4.1 Mechanisms of glucagon secretion from α cells
Glucagon secretion can be caused by cellular, hormonal and autonomic triggers (Figure
3). These are commonly referred to as secretagogues. The hypoglycemic status (e.g.,
during fasting or exercise) of the individual is arguably the most important physiologic
secretion stimulus. Glucose-regulated glucagon secretion follows a U-shaped doseresponse, with maximal inhibition occurring at 6-7 mM glucose, in α cell lines, isolated
mouse islets (26, 174), as well as in humans (175, 176), below the glycemic threshold (7
mM) for insulin secretion (26). Chronic insult of hyperglycemia to αTC1-6 cells results in
up-regulation of exocytotic machinery and enhanced basal glucagon secretion (177). By
autocrine feedback, glucagon can upregulate its own biosynthesis (178), perhaps as a
rapid mechanisms to replace the newly depleted granule pool. α cells directly sense
glycemia via the glucose sensor, glucokinase (177). Glucose metabolism is linked to
glucagon secretion, such that increases in the cellular ATP/ADP ratio, inhibiting the KATP channel, subsequently inhibiting glucagon secretion (179), otherwise the α cell is
rendered functionally “blind” to external glycemic levels. However, the precise
mechanism underlying glucose-regulated glucagon secretion remains controversial (180).
Amino acids and lipids can also stimulate glucagon secretion. It is well established that
L-arginine is a potent glucagon secretagogue both in vitro and in vivo (181–183), even
overcoming the inhibition present at >5 mM glucose. Leucine in particular can be both
stimulatory at normal physiologic levels, or inhibitor at elevated serum leucine levels
(184). Mixed meals (especially high-fat meals), will also stimulate, rather than suppress,
glucagon secretion in healthy adults (174, 175). Nutrient ingestion and composition are
important physiological triggers for maintenance of glucose homeostasis.
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Figure 3. Mechanisms of glucagon secretion from α cells. A simplified schematic of key
mechanisms involved in regulated secretion of glucagon. Stimulation by amino acids or
decreased glucose triggers membrane depolarization, elevates intracellular calcium, and
initiates glucagon exocytosis. Several paracrine modulators (e.g., insulin, somatostatin,
GABA) can dampen or increase secretion rates, generally by coupling of GPCR to
elevation of intracellular calcium.

Similar to other electrically excitable cells (e.g., chromaffin cells, beta cells), glucagon
exocytosis is triggered by fired action potentials, triggering Ca 2+ ion influx through
voltage-gated calcium channels, and the resulting increase in intracellular Ca 2+ causes
membrane fusion and secretion of glucagon. A principle component to regulating action
potential firing is the K-ATP channel (131, 185). The past 15 years have seen several
investigations into the mechanisms of action potential general and electrical excitability
of α cells. Most clearly underlying glucagon secretion are the voltage-gated calcium
channels (176), and ATP-dependent K-ATP channels (for a thorough review of α cell
electrophysiology, see (180, 186)). Closure of K-ATP channels (e.g., by tolbutamide)
results in α cell depolarization and glucagon secretion both in vitro and from intact islets
in rodents and humans (187), while membrane hyperpolarization (e.g., by diazoxide)
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inhibits glucagon secretion in rodents and humans. The exact mechanism underlying KATP channel activity is still debated, however, since α cells are spontaneously active at
low glucose, and become “silent” as glucose is elevated, a recent hypothesis suggested
that the membrane voltage is maintained near the threshold of depolarization (180).
Under normal conditions, excursions to high glucose should inhibit glucagon secretion,
and hypoglycemic excursions should stimulate secretion. Ashcroft and Rorsman posit
that under pathologic conditions of T2DM and some forms of T1DM, this sensitivity is
reversed leading to paradoxical α cell behaviour. Whatever the importance of K-ATP
channels on α cell behaviour, there are also K-ATP channel-independent mechanisms of
stimulating glucagon secretion.
Several paracrine factors have been proposed to play a role in glucagon secretion,
including insulin, somatostatin, GIP, GLP-1 and GABA. Of these, α cells respond most
robustly to insulin and somatostatin. Insulin is a paracrine inhibitor of glucagon secretion,
as can be expected from counter-regulatory hormones, and was found to be an accurate
reciprocal relationship in T1DM humans with intravenous infusions of insulin (188).
Under extreme hypoglycemia (1 mM glucose), insulin completely inhibits glucagon
secretion from human islets (176); perfused rat pancreata and isolated islets (189); and
mouse islets (190). Transgenic mice with a specific α-cell deletion of the insulin receptor
displayed glucose intolerance, enhanced glucagon secretion under hypoglycemic clamp,
and gradual increase in beta cell mass (191), confirming the importance of direct insulin
action on α cell glucagon response.
Somatostatin is also a critical paracrine modulator of glucagon secretion. The main
isoform of the somatostatin receptor, SST-R2, is functional in human and mouse α cells
(192), that when activated, hyperpolarizes the α cell downstream of intracellular Ca 2+
influx, though prevents exocytosis though an incompletely-defined mechanism. Mice
lacking SST-R2 (193) displayed normal basal glucagon and insulin secretion. However,
glucagon secretion was two-fold greater upon depolarizing stimuli, and exogenous
somatostatin failed to suppress glucagon secretion. Somatostatin is a potent inhibitor of
glucagon secretion in fed states. Easing this “brake” contributes significantly to non-
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fasting

hyperglucagonemia

and

hyperglycemia

(194–196),

consistent

with

pathophysiology of T2DM.
The incretins are interesting for their divergent effects on glucagon secretion. GLP-1
indirectly exerts an inhibitory effect (197–199) on glucagon by stimulating somatostatin
secretion (194, 200, 201). On the other hand, GIP stimulates glucagon secretion in
normoglycemic humans (202). The GLP-1R is virtually absent when detected by PCR or
immunocytochemical techniques in normal rodent and human islets (203). In contrast to
GLP-1, a direct effect of GIP on α cells from perfused rat pancreas was shown to
stimulate glucagon secretion in conditions of hypoglycemia (201). From this, it is likely
that GIP is a direct enhancer, and GLP-1 an indirect inhibitor, of glucagon secretion.
The metabolic glutamate/GABA-glutamine pathway is functionally linked to glucagon
secretion. α cells pump glutamate into secretory granules via vesicular glutamate
transporters (VGLUT) 1/2, co-secreted with glucagon (204, 205). In contrast, GABA and
glycine are pumped into α cell synaptic-like microvesicles (SLMVs) by vesicular
inhibitory amino acid transporter (VIAAT) (206, 207). The activity of VGLUT is downregulated while VIAAT is up-regulated in response to high glucose, and vice versa (208),
allowing the ambient glucose level to determine a fine balance between stimulatory and
inhibitory neurotransmitters loading into granules and SLMVs. Uptake of glutamine
serves as a substrate for production of glutamate and GABA, and the mechanism of
uptake may mirror the case of neurons. Specifically, glutamine may be co-transported
with sodium ions by diamineacyltransferase 2 (SAT2), producing a depolarizing
electrogenic ion current, believed to stimulate glucagon secretion (209, 210). This is
consistent with the generation of intracellular Ca 2+ oscillations (211), which does
stimulate glucagon secretion. In contrast, beta cells load both glutamate and GABA into
SLMVs (212, 213), which can be secreted independently of glucose (214). At the same
time, glutamate uptake depolarizes α cells and stimulates glucagon secretion, providing
an autocrine and paracrine feedback mechanism (214). α cell VGLUT activity may also
work in association with the vacuolar H+-ATPase, which coordinates an increasingly
acidified granule lumen, similar to their operation in beta cells (204, 206, 207). Ambient

18
blood glucose levels can direct islet cells to load both granules and SLMVs with either
excitatory

and

inhibitory

neurotransmitters,

potentially

coupled

with

granule

acidification, to amplify or dampen glucagon and insulin secretion.

1.4.2 Mechanisms of GLP-1 and GLP-2 secretion from L-cells
The “incretin effect” is so-called for amplifying insulin secretion following ingested
nutrients when compared to intravenous administration (32). The incretin hormones,
glucose-dependent insulinotropic factor (GIP; previously called gastric inhibitory
peptide) and GLP-1, are mainly derived from the gut. GIP is mainly secreted by K cells
in the upper small intestine. In contrast, GLP-1 is secreted from L-cells in the lower small
intestine and colon, also able to directly sense nutrients in the lumenal environment (215,
216). Both cell types are expressed in similar (diffuse) quantity throughout the entire gut
(217), making it challenging to study directly. Because of their ability to increase
glucose- and nutrient-stimulated insulin secretion, this anti-diabetic property – and in
particular due to GLP-1 – remains actively pursued for T2DM therapy. Two biologically
active GLP-1 (7-37) and GLP-1 (7-36 amide) peptides equally stimulate insulin secretion
in humans (218, 219), though the physiological significance of two forms is not clear.
The biological relevance to stimulating insulin secretion remains a key gut hormone in
the maintenance of nutrient homeostasis.
The mechanisms of GLP-1 secretion from L-cells are less understood by comparison to
insulin and glucagon. As a note, wherever GLP-1 secretion is discussed, the same
mechanism is also assumed for GLP-2, as both hormones are secreted in equimolar
concentrations, which has not been examined separately. The most reliable in vitro
models remain GLUTag cells, derived from a mouse intestinal tumour expressing
proglucagon-SV40 large T- antigen (220). More recently, a transgenic mouse line
expressing Venus (a YFP) under the promoter of proglucagon (221) has enabled more
efficient and specific primary L-cell studies, a necessary advantage for such diffuse
enteroendocrine cells (28, 217). The post-prandial profile of GLP-1 secretion is biphasic,
with the first peak at 15-30 minutes and the second at 1-2 h (222). Intestinal nutrients
appear to be the major physiologic stimuli of L-cells, especially by sugars, fatty acids and
amino acids and these mechanisms will be discussed below.
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As with (neuro)endocrine cells in general, secretagogue-mediated exocytosis is coupled
to electrical depolarization of the cell membrane (Figure 4), in which calcium uptake is
coupled to exocytosis. Chemosensation of sweet molecules in the gut (e.g., glucose,
fructose, sucrose, artificial sweeteners), activate through the coupled G protein-coupled
receptor, TAS1R2-TASR3, and can be imported into the cell by facultative GLUT
glucose transporters (223), and the Na+-glucose co-transporter, SGLT1, typical of
intestinal brush-border transporters. The taste receptors are stimulated by simple sugars
and common sweeteners, and couple to the G-protein α-gustducin, that upon activation,
elevates intra-cellular calcium and triggers secretion. Mice with deletion of α-gustducin
(-/-), TAS1R2 (-/-) or TAS1R3 (-/-) have nearly abolished glucose-stimulated GLP-1
secretion (224, 225). The electrogenic current of Na+ by SGLT1 is the most important
glucose transport system, directly depolarizing the L-cell, thus triggering secretion (221,
226, 227). This is the key difference to the Ca2+-dependent action potentials in α and beta
cells (228, 229). GLP-1 secretion can also be stimulated by sensation of free fatty acids
and amino acids. In GLUTag cells, GPRC6A is the main amino acid sensing mechanism
(230), primarily by basic amino acids. Although L-cell function was not assessed,
deletion of the receptor pre-disposed mice to obesity, insulin resistance and glucose
homeostasis dysregulation (231). On the other hand, fatty acids are sensed by FFAR1 (or
GPR40) (232) and GPR120 (233). In humans, GLP-1 secretion is stimulated by oral
administration of lipid (234). Though it is unclear which fatty acid receptor is more
important, mice lacking FFAR1 had reduced response to FFA-stimulated GLP-1 secretion
and serum insulin (235). Together, the fatty acid receptors also couple to α-gustducin to
stimulate GLP-1 secretion (236).
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Figure 4. Mechanisms of GLP-1 secretion from L-cells. A simplified schematic of key
mechanisms involved in regulated secretion of GLP-1 (adapted from (237)). Intestinal
lumen nutrient sensation by GPCRs, facultative glucose transport (GLUT) and
electrogenic Na+-glucose co-transporters (SGLT) are shown. GPCR activation or inward
sodium current can trigger membrane depolarization, elevation of intracellular calcium,
and GLP-1 secretion. Thus, several mechanisms couple nutrient stimulation to incretin
hormone exocytosis.

Only one report to date has characterized major SNARE machinery involved in GLP-1
exocytosis. GLP-1 secretion requires the interaction among VAMP2, syntaxin-1a and
SNAP25 in GLUTag cells (238), consistent with their expression in L-cells and with
exocytosis of both insulin and glucagon. There are several similarities between the
stimulus-secretion coupling and exocytosis mechanisms among endocrine cells, and it
suggests that the hormone secretion mechanisms are broadly similar among endocrine
cells. Tissue-specific differences between L- and α-cells are manifest in proglucagon
processing and possibly sorting mechanisms.
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1.5 Processing of Proglucagon
Mammalian proglucagon is synthesized as a 180 amino acid precursor (239–241), whose
domains are organized as in Figure 1. Proglucagon encodes for a plurality of peptides
that are processed in a tissue-specific manner through the action of PC1/3 and PC2. The
end result of differential expression of these PCs in α-cells, L-cells or neurons produces
the characteristic pattern of proglucagon-derived peptides. Proglucagon is not posttranslationally modified (such as glycosylated) with the exception of processing to its
constituent hormones (242, 243), and C-terminal amidation that occurs to GLP-1
(discussed below).

1.5.1 Glucagon production in pancreatic α cells
The processing of proglucagon in α cells begins with cleavage at the inter-domain dibasic
site, Lys70Arg71, liberating glicentin and the major proglucagon-derived fragment
(MPGF) (Figure 1). Glicentin is further processed to glucagon, (along with the flanking
GRPP and IP-1) (244). Proglucagon processing is accomplished by PC2, shown to be
necessary and sufficient for processing to the α cell profile in αTC1-6 cells (245), and is
sufficient for α-cell-like processing in AtT-20 cells (246). PC2 activity depends on a cofactor, neuroendocrine peptide 7B2, both stabilizing PC2 in its active conformation and
inhibiting enzymatic activity until delivery to granules (247, 248). 7B2 also prevents PC2
from aggregating into inactive oligomers (249). PC2 is enzymatically active within
mature secretory granules (137, 142). By using a pulse-chase paradigm, the time
dynamics of proglucagon processing in αTC1-6 cells confirmed the sequential cleavage
beginning at the inter-domain site, Lys70Arg71, producing glicentin and MPGF after 3045 minutes chase (245, 250). These chase times are consistent with a conversion of
proglucagon beginning in the TGN or immature granules. This leaves open the possibility
that some amount of proglucagon is initially processed to glicentin and MPGF in the
TGN or immature granules. One possible endoprotease that could substitute would be
furin, found in all cell types, and active in the TGN and is removed from immature
granules. This is suggested by the findings of proglucagon processing in several nonendocrine cell lines which only express furin (245, 246, 251–253), and is consistent with
the expectation that PC2 would be inhibited by 7B2 in these early compartments of the
secretory pathway. Notably, the remaining processing of glicentin is carried out in mature
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granules at dibasic sites recognized by PC2 to remove GRPP, and in particular, the PC2specific site to remove IP-1 (Figure 1).
Mouse models confirmed the role of 7B2-activated PC2 on α cell production of glucagon.
PC2 knockout mice abolished glucagon production and severely impaired α cell
proglucagon processing (254, 255), consistent with an α cell line derived from these PC2
null islets (256). These mice lacked detectable serum glucagon, had improved glucose
tolerance, consistent with a lack of active glucagon. Interestingly, these α cell granules
became irregular in shape and electron-translucent, suggesting PC2 expression was not
necessary for granule targeting of proglucagon. Proglucagon processing was significantly
decreased either upon depletion of 7B2 in an α cell line, or in 7B2-knockout mice (257),
similar to the PC2-knockout phenotype. Altogether, PC2 is essential to produce glucagon.
There is recent controversy surrounding the production of bioactive GLP-1 within
pancreatic α cells. Whether GLP-1 is produced at all in a healthy pancreas or terminally
differentiated α cells (as described above), the relative expression is far lower than than
of the the gut, its principle site of production. PC2 cannot cleave the Arg77 to yield active
GLP-1, and therefore if it is to be produced, it must encounter PC1/3 (discussed below).
Notably, this is not the case in one recent report (258). α cell differentiation is controlled
by a sequence of multiple transcription factors (reviewed in (259)) such that mature α
cells repress expression of PC1/3 and thus incapable of producing bioactive GLP-1. In
the face of insult or injury to the islet, α cells are known to adapt their phenotype and can
even revert to a precursor α cell, allowing them some functional plasticity in response to
metabolic insults. Severe beta cell chemical ablation in mice is so severe as to cause beta
cells to trans-differentiate into α cells through an insulin +/glucagon+ intermediate cell
(260), implying a transient ability to produce bioactive GLP-1 by PC1/3 expression. The
α cells isolated from PC2-knockout islets expressed PC1/3 and produced GLP-1 (256),
whose α cells were hyperplastic in the originating mice (254). Mature GLP-1 could be
detected in such hyperplastic α cells resulting from the loss of glucagon signalling (by
global GCG-R knock-out) (19), implying the expression of PC1/3. A time-course analysis
of PC1/3 and GLP-1 production within α cells using diabetic (db/db) mice as a model of
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T2DM, and NOD mice as a model of T1DM show that PC1/3 (and GLP-1 production) is
promininently upregulated in T2DM (261). Obesity and T2DM systematically elevate
pro-inflammatory interleukin-6, promoting α cell hyperplasia (53) and production of
mature GLP-1 and PC1/3 in α cells (56). Therefore multiple models of metabolic
disorders (e.g., diabetes, obesity) or chemical insults to the islet can profoundly alter the
α cell phenotype and begin producing detectable quantities of mature GLP-1. However,
the gut remains the major site of GLP-1 production in healthy individuals and animals.

1.5.2 GLP-1 and GLP-2 production in intestinal L-cells
The most important products of intestinal L-cells are the mature GLP-1, GLP-2, and also
glicentin and oxyntomodulin (262, 263), which are increasingly being appreciated as
important hormones for nutrient homeostasis. The processing profile of proglucagon
within the GLUTag cell line and native L-cells (253, 264) is coordinated by PC1/3
(Figure 1). Just like pancreatic α cells, L-cells also process proglucagon at the interdomain site, Lys70Arg71, after ~20-30 min chase (250). Glicentin is processed to
oxyntomodulin after 30 minutes (250), in a molar ratio of about 3:1 of
glicentin:oxyntomodulin (264). PC1/3 further processes MPGF to predominantly produce
GLP-1 (7-37) by cleavage either at Arg109Arg110 or the internal Arg77 within GLP-1, as
well as GLP-2 (250–252). Viral over-expression of PC1/3 into PC2-null αTC1-6 cells is
sufficient to produce bioactive GLP-1 (265), suggesting that the simple change of
convertase could shift the equilibrium toward GLP-1 production. Knockout of PC1/3 in
mice blocks production of GLP-1 and GLP-2 (266, 267). Therefore, PC1/3 is necessary
and sufficient for proglucagon processing in intestinal L-cells. Considering the cellular
location of this processing, such rapid chase times suggest that initial cleavage occurs in
the TGN by furin or PC1/3, or within immature granules (142). Recently, a hypermorphic
PC1/3 mutant (S357G-PC1/3) showed increased specificity to the two dibasic sites
flanking glucagon, liberating ~20% more glucagon than wild-type PC1/3, but did not
alter its basal secretion based on conditioned media samples (268). Since this
hypermorph is active at neutral pH, proglucagon is more likely to be rapidly processed
prior to arriving at the ISG, and it would suggest this initial processing occurs prior to the
sorting of glucagon to granules in GH4C1 cells.
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GLP-1 and GLP-2 differ in the extent of their processing in vivo. GLP-1 and GLP-2 are
co-secreted in equimolar amounts from the same granules (263, 269). The natural form of
GLP-1 extracted from human intestine showed a further processing of the (inactive)
GLP-1 (1-37) by cleavage at the monobasic Arg77 to yield bioactive GLP-1 (7-37) (262,
263). As in cell models, there is natural variation in the ratio of glycine-extended GLP-1
(7-37) and amidated GLP-1 (7-36)-amide both along the length of the intestines and
between mammals (263, 269–271). Mono- and dibasic C-terminal amino acids are
removed by carboxypeptidase E (CPE) (272). After carboxypeptidase activity, GLP-1
amidation is accomplished by peptidylglycine α-amidating mono-oxygenase (PAM) (273,
274). In contrast to GLP-1, removal of the C-terminal basic residues from GLP-2 is its
final modification. The focus of recent GLP-1 research has shifted towards identifying
enteroendocrine L-cells along the entire gut and its multiple physiologic roles.

1.5.3 Proglucagon processing in the central nervous system
The pattern of GLP-1 and GLP-2 production in the CNS is similar to that of the intestines
(275), and so it is presumed that PC1/3 is the responsible convertase. Indeed, the role of
PC1/3 has been extrapolated from the numerous studies of proglucagon processing using
neural-derived and endocrine cell lines. However, this assumption has not been tested in
vivo, partly owing to a much smaller abundance in the brain, compared to the pancreas
and gut. The predominant areas of proglucagon expression in the brain are a subset of
neurons in the solitary tract nucleus (276). Several sensitive peptidomics studies of the
crude lysates of the brainstem (and other brain regions) in normal and transgenic mouse
models such as knockouts of PC2 or PC1/3 (277, 278) or CPE mutant obese mice (279,
280) failed to detect proglucagon-derived peptides, presumably due to extremely low
expression in these regions (personal communication with Dr. L. D. Fricker). Thus the
actions of PC1/3 (or PC2) in the brain have only be inferred from correlation of their
expression with proglucagon-expressing neurons, and this avenue of investigation
remains inconclusive.
Two alternative views are parsimonious with proglucagon expression and processing in
the brain. Proglucagon is certainly expressed by subsets of neurons in the brainstem and
hypothalamus. By comparison with POMC- and NPY-expressing cortical neurons,
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proteolytic processing to NPY, ACTH, beta-endorphine and α-MSH are significantly
dependent on the action of cathepsin L (281, 282). An emerging idea is the expression of
proglucagon, and secretion of GLP-1, by activated glia in the brain. A previous report
identified proglucagon+ cells in the cerebral cortex and hippocampus that are thought to
be glial cells in mice, and also detected GLP-1 secretion from the mouse glial cell line,
BV-2 (283). An alternative endopeptidase, yapsin-1 (284) behaves similarly to PC2, with
specificity to dibasic sites, and in vitro, can liberate glucagon. The mechanism of
processing in glial cells remains unknown. PC1/3 is the traditional prohormone
convertase for processing, though yapsin-1 and cathepsin L are recently proposed
candidates. The idea that proglucagon could be expressed in two distinct regions in the
brain also invites further investigation into potentially novel mechanisms of its
processing in the brain.

1.5.4 The ultra-structural localization of the proglucagon-derived
peptides within granules
There has been much interest in the ultra-structural characterization of α cells and
localizing glucagon within the late secretory pathway. Previous findings by Orci and
colleagues (285) distinctly co-localized glucagon and glicentin within the same granule in
which glucagon was diffusely located within the electron dense core while glicentin is
segregated to the electron-lucent halo. In those granules studied, there were equal
proportions of glucagon+ granules and glicentin+ granules (which was likely GRPP),
suggesting that glicentin enters mature granules where it then undergoes processing by
PC2. Using anti-sera directed against mid-sequence GLP-1 or GLP-2 in α cells revealed
that the staining pattern is restricted to the electron-dense core (286), consistent with the
identification of MPGF in α cell granules. Similarly, glicentin, GLP-1 and GLP-2
appeared to co-localize in serial thin-section immunoelectron images of human L-cells
(286). Here, GLP-1 is diffusely localized within the dense core, while GLP-2 was
localized to the halo, suggesting that MPGF has undergone processing in an immature
granule to allow for their topological segregation. Interestingly, there have not yet been
molecular dynamic studies to determine diffusion rates within granules. None of the
ultra-structural studies have shown glucagon, or any of the other PGDPs, to adopt higherorder or crystalline structures, suggesting that proglucagon is less prone to aggregation in
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the secretory pathway. Previous data from our lab has also ruled out an ability for
proglucagon to bind to reconstituted liposomes. This makes the existence of a receptor an
attractive hypothesis for proglucagon sorting. Immunoelectron analysis of granule
contents does not reveal the degree of co-storage of the various PGDPs within granules.
To address the outstanding question of whether proglucagon processing precedes its
initial sorting, and therefore MPGF and glicentin may enter the same or different granule
populations, live cell fluorescence imaging or proteomic approaches are necessary to
determine the proportion of the various PGDPs within immature granules. It remains
unanswered from immunoelectron surveys whether glicentin and MPGF are always
found in immature granules, or if they may be diverted to different granule subpopulations.
Processing is only one critical component to the production and secretion of hormones as
they must end up in secretory granules for proper physiologic response to stimuli.
Critically, sorting form the TGN toward mature granules necessarily parallels the
processing events to yield the PGDPs. As proglucagon and its derived peptides transit the
regulated secretory pathway, they will encounter the necessary low-pH and high calcium
environments necessary for PC1/3 or PC2 activity, they will be concentrated, and this
compartmentalization is required for nutrient stimulated secretion of glucagon, GLP-1
and GLP-2. To date, the molecular mechanism that determines how proglucagon is sorted
to granules remains unknown. However, several clues from the study of other
neuropeptides and hormones suggest that structures within proglucagon may act as a
sorting signal, guiding its route toward granules.

1.6 Mechanisms of Sorting
In characterizing the route prohormones take along the regulated secretory pathway, an
essential bottleneck that must be overcome, is the efficient sorting and condensation into
secretory granules. Two models were proposed to explain this step (285). Sorting can
occur either through a cargo-receptor interaction that is mediated by a sorting signal, or,
cargo proteins reversibly self-aggregate prior to entry in nascent granules. Subsequent
research of intracellular trafficking research has focused on identification of sorting
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signals and their receptors, and characterizing cargo aggregates in the secretory pathway
(reviewed in (287)). This section focuses on what is known about the specific structural
motifs, or sorting signals, of peptide hormones and neuropeptides.

1.6.1 Aggregation of hormones
Condensation of granule cargo by aggregation was first described by Palade (288). The
hypothesis is that cargo proteins have a weak affinity to aggregate under the ionic
conditions of the secretory pathway, and that in doing so, provides an thermodynamically
efficient mechanism condensation, which then enter granules as electron-dense
aggregates. Two “classic” examples of aggregation are put forth as evidence for
aggregation of cargo hormones. First, pro-atrial natriuretic peptide (pro-ANP) is secreted
from secretory granules of atrial cardiomyocytes in response to increased blood volume.
Sorting to granules in either AtT-20 or PC12 cells seems to require calcium-mediated
aggregation via diacidic residues in its pro-domain (77). Mutation of Glu23,Glu24 in the
sorting domain (pro-ANP 11-30) increases solubility of aggregates in vitro, and results in
constitutive secretion from AtT-20 cells. Second, the somatotropin family which includes
growth hormone (GH), prolactin and placental lactogen. These structurally related
hormones are characterized by a four α-helix bundle, they do not undergo processing by
prohormone convertases, and are stabilized by intra-molecular disulphide bonds (289).
Prolactin and GH form aggregates in the Golgi that traffic as electron-dense cores
through the regulated pathway (288). However, aggregation is not a one-size-fits-all
mechanism for the regulated secretory pathway. The ability for cargo proteins to
aggregate (either in a high calcium or low pH environment) varies substantially, and
aggregation is better observed as a function of the protein rather than the secretory
pathway. Human prolactin could not aggregate in 10 mM Ca2+ in vitro at any acidic pH,
conditions that match the granule environment, negating the idea that sorting relies on
this mechanism (290). Sorting-signal tagged human serum albumin traffics efficiently to
granules in AtT-20 while undergoing no (or negligible) aggregation in AtT20 cells (291).
While short charged segments of amino acids mediate aggregation of pro-tachykinin to
sort into granules (292). Alternatively, inducing aggregation in the secretory pathway can
actually reduce sorting efficiency and secretion (293, 294). Regardless of the influence of
aggregation at the TGN, ample empirical evidence shows that prohormones and
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neuropeptides mostly rely upon specific domains or structures that facilitate their correct
targeting and secretion.

1.6.2 Dibasic sorting signals
Dibasic sites are well-known because of their endoproteolysis by prohormone
convertases to yield mature hormones from their precursors. That these sites undergo
cleavage along the regulated secretory pathway makes them attractive sorting signals.
The representative example of dibasic sites influencing sorting is pro-renin (295), which
contains two dibasic sites in its pro-domain that are essential for both its processing and
regulated secretion. Similarly, pro-neurotensin/neuronedin N and pro-thyrotropinreleasing hormone (pro-TRH) both require processing at multiple dibasic sites to gain
entry to granules (296–299). Dibasic signals are identified for pro-NPY (300), pro-gastrin
(301), and pro-VGF (non-acronymic) (302).

1.6.3 Diacidic sorting signals
The first identified sorting signal was a di-acidic motif from pro-opiomelanocortin
(POMC) (303, 304), and is also found in pro-insulin (305), pro-brain-derived
neurotrophic factor (pro-BDNF) (306) and pro-enkephalin (307). For POMC, the key
acidic residues for receptor interaction are Asp9,Glu14, stabilized by Leu11,Leu18, that
must be constrained in an amphipathic disulphide loop conformation (303, 304). For proinsulin the disulphide bonds constrain Glu-A17,Glu-B13 and Leu-A16,Leu-B17
necessary for receptor binding (304, 305). Therefore, this constrained di-acidic amino
acid motif is a well-conserved sorting signal.

1.6.4 Amphipathic α-helices
The somatostain family includes somatostatin (SST) and cortistatin (CORT). Prosomatostatin is sorted to granules via an N-terminal amphipathic α-helix in the prodomain (308, 309). Cortistatin also contains a homologous pro-domain α-helix (309), of
unknown functional significance. A final example is found in pro-cocaine and
amphetamine regulated transcript (pro-CART) (310). The amphipathic nature of these
helices, in which a large hydrophobic patch surrounded by charged residues can direct
granule sorting (311), possibly by hydrophobic association with membrane lipids or intermolecular aggregation. Although not a hormone, PC1/3 is also targeted to granules via an
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amphipathic helix (PC1/3 738-753) that can be partly attributed to both calciumdependent aggregation of these helix domains, and membrane association (106).

1.6.5 Disulphide loops
Pro-vasopressin and pro-oxytocin are highly conserved peptides that sort to secretory
granules using both oligomerization as well as multiple intra-molecular disfulide loops
(312). Entry into the regulated pathway first requires cleavage of the pro-domain from the
hormone (313). Once processed, these pro-domain/hormone heterodimers can aggregate
via intra- or inter-molecular disulphide loops and the conformation of the hormone
domain is crucial for sorting using both AtT20 and Neuro-2a cells (312, 314). In contrast,
pro-somatostatin contains a mostly disordered pro-domain and two dibasic cleavage sites
to generate the mature hormones, SST-14 and SST-28, characterized by a C-terminal
disulphide loop. It was recently suggested that the nature of this loop can dynamically
form fibrils and directly affect exocytosis, and possibly even sorting efficiency (315).
Therefore, further nuances to the sorting mechanism remain to be identified.

1.6.6 Glycoproteins with sorting signals
The gonadotropins including follicle stimulating hormones (FSH) and luteinizing
hormone (LH) are distinguished in that they are heterodimeric glycopeptides, consisting
of an common α, and unique beta chain. Thus, the beta chain determines the identity of
the hormone, its biological specificity, and the mechanism of intracellular trafficking
(316). Despite being secreted from gonadotropes, FSH and LH are secreted differently:
constitutive secretion of FSH and regulated secretion of LH (317). The information
encoded for regulated secretion is encoded by the C-terminal heptapeptide of the LH-beta
subunit, not found in the FSH-beta subunit (318, 319). The exact mechanism is not clear,
and the data do not rule out a role for either increasing folding efficiency in the ER by the
presence of the heptapeptide this leading to regulated secretion (320) or whether the
hydrophobic nature is required aggregation, or interaction with a yet unidentified sorting
receptor (321).

1.6.7 Compounding sorting signals may increase returns
Sending hormones to granules is often not accomplished via one signal alone. Instead,
multiple sorting signals may synergistically combine to increase storage efficiency (302,
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322). The advantages of this process are clear. Prohormones that are differentially
processed in multiple tissue types (e.g., POMC and proglucagon) may use tissue-specific
receptors, thus allowing independent routes for prohormone processing and secretion.
Increasing sorting efficiency is paramount to efficient production of bioactive peptides.
What is clear is that there is not a single universal sorting signal. So far, the molecular
range of identified signals can be as small as two dibasic amino acids or large loop-based
structures. Aggregation may play a role in these processes, though its extent appears to be
highly variable, and in many examples, is unnecessary for sorting. Still, all of these
modalities may combine in any particular prohormone in order to modulate the efficiency
of their sorting. Generally, sorting signals tend to be contained in the pro-domain, and not
in the hormone domains. In order to complete the mechanism, protein binding partners,
so-called sorting receptors, recognize these motifs to facilitate granule entry.

1.6.8 Sorting Receptors
Just as there is a variety of sorting signals, these signals are recognized by a smaller
subset of receptors. The search for a universal sorting receptor is elusive, and in reality,
multiple (neuro)endocrine mechanisms exist to serve the diversity of (neuro)endocrine
peptides. The operational definition of a sorting receptor must meet several criteria: 1)
receptors and their cargoes should co-target to the same granules; 2) receptors should
bind to their ligands in a pH- or cation-dependent manner to show specificity for binding
in the TGN or immature granules; and 3) a loss of the interaction or receptor should
severely affect regulated secretion and cause mis-sorting the constitutive pathway. Due to
the need for a receptor to selectively bind cargoes at mildly acidic conditions of granules,
and then release them upon exocytosis when exposed to a neutral pH, these interactions
are likely to be very dynamic, binding with both low affinity and high specificity. Sorting
efficiency can be increased by the partial co-aggregation between receptor and cognate
hormone(s), in a one-to-many relationship along the ionic gradient(s) of the secretory
pathway. In this way, cargo is efficiently concentrated, while not creating additional
demand for activation energy. Two sorting receptors used by endocrine tissues involve
processing enzymes and granins. Together, these few members serve a broad range of
hormones thus identified.
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The first bona fide sorting receptor is carboxypeptidase E (CPE), which is responsible for
trafficking the “POMC” proteins: POMC, pro-insulin, pro-BDNF and pro-enkephalin, as
previously discussed. Inactive pro-CPE is directed to the TGN (57 kDa form) by a Cterminal trans-membrane α-helix in cholesterol-sphingolipid enriched membrane domains
(323), and maturing in granules (324). The ability to bind prohormone cargo relies on
Arg255 and Lys260 (304) that can bind two acidic amino acids ~12-15 Å on the
hormone, stabilized by two hydrophobic residues spaced ~5-7 Å apart. Evidence for CPE
as a sorting receptor is most convincing from depletion studies of transgenic mice. A
strain of mice called CPEfat/fat, harbors a mutant S202P-CPE, that is enzymatically
inactive (325). CPEfat/fat mice constitutively secrete POMC (326) and proinsulin,
becoming obese, diabetic, and the granules of beta cells lack the characteristic electrondense cores (325). Similar results for pro-insulin were observed in CPE knock-out mice
(327).
PC1/3 and peptidylglycine α-amidating monooxygenase (PAM) are the other processing
enzymes that act as sorting receptors and are co-targeted to granules. PC1/3 has an
membrane-associated amphipathic α-helix (105, 106), while PAM is a type 1 membrane
protein (274). The loss of the membrane-associated α-helix in PC1/3 mis-routes pro-renin
for constitutive secretion (105, 328). Within granules, PAM acts on hormone substrates to
produce C-terminal amidation of glycine residues (such as in GLP-1). In secretory
granules of atrial myocytes, PAM is the sorting receptor of pro-ANP (329), despite not
being a substrate of PAM. No reports on whether PAM acts as a sorting receptor within αor L-cells exist, though it seems unlikely, since heterozygous knock-out PAM+/- mice
have normal basal blood glucose and glucose tolerance at 2 months of age, and only
develop mild obesity by 10 months, likely a non-specific complication of the model (329,
330). Therefore the possibility remains that PC1/3 may sort proglucagon in L-cells.
The granins are a complex family of proteins, co-operatively sorting cargo hormones and
are major components of the granule matrix. Chromogranin A and B (CgA and CgB),
coupled to secretorgranins II and III (SgII and SgIII) are most important for sorting. CgA
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is the most abundant constituent in chromaffin and all pancreatic islet cells (331, 332),
while beta and α cells also contain SgII and SgIII (333). At the TGN, it is believed that
the granins nucleate partial aggregation at the mildly acidic pH and the calcium
environment of the TGN (334–337). Importantly, the granins selectively aggregate with
neuropeptides and hormones, excluding constitutively secreted cargoes (338). CgA and
CgB are soluble proteins that require the aide of an adaptor protein, one of the
secretogranins for granule targeting. The most profound demonstration of CgA (and also
CgB) actions on hormone storage, is that CgA-/- mice have severely impaired
catecholamine storage in adrenal chromaffin cells (339, 340), and is moderately impaired
in CgB-/- mice (330, 341). The effects on other (neuro)endocrine tissues are rather mild
(even unaffected) likely due to compensation by upregulation of other granins (342).
Over-expression of CgA can enhance sorting of GH and NPY to granules (343), and CgB
can direct POMC to granules and for increased secretion of ACTH (344). The
secretogranins, SgII and SgIII, are adaptors of chromogranins (110, 345, 346), by directly
associating with lipid rafts of granule membranes. The granin mechanism can explain the
increased stoichiometry ratio of cargo to receptor, a common (yet unproven) criticism of
the sorting receptor hypothesis. Co-aggregation of soluble cargo in the TGN by
chromogranins produces a large mass of peptides that can then be targeted to granules by
the

membrane-bound

secretogranins,

efficiently

packing

large

quantities

of

chromogranins and hormones. SgIII does bind the condensed aggregates of granin and
neuropeptides (e.g., adrenomedullin), providing a high-capacity sorting mechanism
(347), and SgII appears to operate in a similar fashion (110). Together, segregation of
regulated cargo is retained in the area of nascent granule formation.
To illustrate an example, consider the sorting of POMC. SgIII binds the cholesterol-rich
membrane at the N-terminus, while either binding CgA or CPE via the C-terminus (100,
346–348). SgIII and CPE are both closely associated in cholesterol-rich membrane
domains, and can individually bind to POMC (349, 350). As a nascent granule forms,
CgA is carried to granules by SgIII, while POMC is carried by CPE (and also CgA),
where they will encounter each other in the lipid raft-enriched membrane. SgIII is also
required to properly sort CgA in AtT-20 cells (110), but can only bind to either CgA or
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CPE at one time (349). Therefore, at the nascent granule membrane, POMC can be
handed off to CgA which has a high binding capacity due to aggregation, while SgIII
laterally binds to either CgA (to retain POMC) or CPE (to facilitate a transfer to the
SgIII-CgA complex) (349, 350). This “hand off” mechanism describes two actions
happening in parallel, from the independent delivery of POMC via CPE and CgA/SgIII,
to the transfer to CgA/SgIII complexes. This view is compatible with a condensing ISG
actively retaining hormones in the maturing granule.

1.7 Rationale and Specific Aims
In the case of proglucagon, it is organized into several constituent hormone sequences.
Each of these sequences contains at least one putative sorting signal, in addition to
several dibasic sites that flank each major hormone domain. At present, neither the
existence of sorting signals, nor the existence of sorting receptors involved in
proglucagon trafficking, have been investigated. Based on the discussion of signals and
receptors above, it is likely that such a mechanism should exists, especially considering
the need for α- and L-cells to produce distinct subsets of proglucagon-derived hormones.
I hypothesize that specific sorting signals within the hormone domains of proglucagon
determine its intracellular trafficking through specific interaction of a receptor to
facilitate efficient storage within granules and processing to mature hormones.
Aim 1: To identify sorting receptors and sorting signals that mediate the sorting of
proglucagon to secretory granules.
A) I will identify candidate sorting signals using the predicted 2D and 3D structure of
proglucagon, and determine whether these structures are necessary for sorting by using
site-directed mutagenesis to specifically disrupt each structure.
B) I will determine whether a known prohormone sorting receptor, carboxypeptidase E, is
necessary for sorting proglucagon to granules by quantifying intracellular trafficking in
the absence or presence of transfected CPE. The mechanism will be confirmed by using
siRNA-mediated depletion of CPE from an α and L cell line, and measuring the degree of
regulated secretion by RIA.
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Aim 2: To characterize the molecular properties of sorting signals within the peptide
domains of proglucagon.
A) I will determine which hormone domains contain sorting information by making
specific genetic constructs and following intracellular trafficking and measuring regulated
secretion.
B) To determine the biochemical nature of the sorting signal using site-directed
mutagenesis.
C) I will determine the temporal sequence of proglucagon processing and sorting.
Aim 3: To develop and validate a quantitative co-localization algorithm to determine
in which sub-cellular compartment a protein of interest is targeted.
I will validate the utility of several common quantitative immunofluorescence colocalization techniques by conducting computer simulation experiments. I will create a
work-flow

for

conducting

quantitative

co-localization

analyses

for

future

immunofluorescence studies, then compare this method with more complex colocalization analytic methods.
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2.1 Introduction
Ingested nutrients stimulate the secretion of glucoregulatory hormones from both the
pancreas and the gut to exert control over glucose homeostasis. Proglucagon is a
polypeptide prohormone expressed in pancreatic α cells, intestinal L cells, and a select
subset of neurons in the brainstem. It is processed in a tissue-specific manner to produce
distinct sets of constituent hormones. Expression of prohormone convertase (PC)-2 in α
cells produces glucagon, the major pancreatic hormone product (1, 2). Glucagon is
secreted in response to hypoglycemia and is the major counter-regulatory hormone to
insulin, activating hepatic glycogenolysis and gluconeogenesis to maintain euglycemia
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(3). In contrast, PC1/3 in intestinal L cells and neurons produces oxyntomodulin, GLP-1
and GLP-2 (4–7). These nutrients are secreted in response to nutrient ingestion, and each
has a distinct effect to control glucose homeostasis within a nominal range (8). GLP-1 is
enhances post-prandial insulin secretion, whereas GLP-2 is an intestinotropic hormone
that increases intestinal blood flow and nutrient assimilation (9). Oxyntomodulin is an
anorectic hormone, decreasing food intake and increasing satiety and energy expenditure
(10). Therefore, nutrient status potently stimulates secretion of the proglucagon-derived
peptides so they may exert tight control over glucose metabolism and nutrient
homeostasis.
In order for endocrine and neuroendocrine tissues to robustly respond to changes in
nutrient status, neuropeptides and hormones are directed along the regulated secretory
pathway. This biosynthetic pathway is distinct from unregulated, constitutive secretion,
and maintains specialized storage organelles called secretory granules. Two hypotheses
have been proposed for the targeting of hormones to granules. In the “sorting-byretention” model, hormones condense into large aggregates in the trans-Golgi network
(TGN) that are retained in nascent secretory granules, while the maturing granule
selectively removes other proteins. Alternatively, prohormones in the “sorting-for-entry”
model specifically bind to either membrane-bound sorting receptors or membrane lipids,
by a structural sorting signal. Once prohormones enter immature granules, they will
undergo endoproteolysis to yield bioactive hormones, which are then condensed and
stored in the granules as an electron-dense core, characteristic of their appearance by
electron microscopy. Secretion can then be stimulated in a Ca2+-dependent manner by an
appropriate secretagogue (e.g., nutrient ingestion). Based on the “sorting-for-entry”
model, we can begin to explore the molecular mechanism of the sorting signals of
proglucagon.
The known sorting signals of prohormones range in their molecular complexity. These
include 1) dibasic amino acid sequences, found in pro-neuropeptide Y (11); 2)
amphipathic α-helices (12) such as those in pro-somatostatin (13), pro-CART (14), VGF
(non-acronymic) (15), pro-renin (16), pro-gastrin (17), and pro-neurotensin (18); and 3)
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acidic residues found on disulphide loops found within POMC (19) and proinsulin (20).
An α-helix predominates the structures of glucagon (21) and GLP-1 (22) based on their
known X-ray crystal structures, and GLP-2 (23) by the NMR solution structure,
suggesting that proglucagon contains significant helical content within its hormoneencoding domains. Proglucagon also contains five proteolytic dibasic sites located at
hormone domain junctions (Figure 1). The α-helix of glucagon contains an embedded
dibasic site, a motif that targets VGF to granules (15). Lastly, different sorting motifs may
synergistically enhance granule targeting (24). Therefore proglucagon trafficking may
rely on information encoded in several putative sorting signals, located in the α-helices of
mature glucagon and glucagon-like peptide domains, and multiple dibasic cleavage sites.

Figure 1. Post-translational processing of proglucagon to its derived peptides. A
schematic representation of proglucagon in which each domain has been colour-coded,
and the amino acid positions of key processing events have been identified. The amino
acid numbering is relative to the first N-terminal amino acid of proglucagon (lacking the
signal peptide). The major hormone products produced from tissue-specific processing by
their respective prohormone convertase (PC) are shown at bottom. In pancreatic islet α
cells, the major products are glucagon and major proglucagon fragment (MPGF). In
enteroendocrine L cells and in the brain, the major products are GLP-1 (1-37), GLP-1 (737), GLP-2, oxyntomodulin and glicentin.
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In order for hormones to be targeted to granules, a sorting receptor must recognize and
bind the sorting motif. Carboxypeptidase E (CPE) is a granule-resident enzyme that
cleaves C-terminal basic amino acids. It is known to be a sorting receptor for both proopiomelanocortin (POMC) and pro-insulin by interaction of two acidic residues of the
sorting signal, with complementary basic residues on the receptor surface (19, 20, 25).
Individually, PC1/3, PC2 and CPE are co-targeted to granules with hormones. PC1/3 cotargets pro-renin to granules in order to produce renin in AtT-20 cells (26). Deletion of
the C-terminal tail of PC1/3 that tethers to lipid rafts of granule membrane mis-routes
pro-renin for constitutive secretion (27, 28). However, no such evidence exists to suggest
that PC2 directly impairs granule targeting, though this hypothesis was not specifically
investigated. Even in α cells isolated from PC2 null islets (2) and a derivative α cell line
(29) show no defect of regulated secretion (aside from the obvious defect in processing).
A strain of mice called CPEfat/fat, harbors a mutant S202P-CPE, that is enzymatically
inactive (30). CPEfat/fat mice constitutively secrete POMC (25) and proinsulin, becoming
diabetic, and the granules of beta cells lack the characteristic electron-dense cores (30).
Similar results for pro-insulin were observed in CPE knock-out mice (31). Because these
enzymes are co-targeted to granules with their substrate hormones, and CPE has been
shown to specifically interact with the POMC sorting motif, the possibility exists that
CPE, PC1/3 and PC2 are candidate receptors for proglucagon sorting.
In the present study, we investigated the requirement of CPE as a sorting receptor for
proglucagon. We hypothesized that in the absence of CPE, sorting of proglucagon to
granules would be greatly diminished. Furthermore, we also investigated whether PC1/3
or PC2 co-expression would have an effect on sorting of proglucagon. We found that
CPE alone plays a role in trafficking proglucagon to granules and that this may be
specific to α cells. We also investigated the hypothesis that proglucagon contains sorting
signals by focusing on the glucagon α-helix and its embedded dibasic site. By finding that
granule targeting was impaired by specific mutation of these two structures, we provide
the first characterization of sorting signals contained within the glucagon α-helix of
proglucagon.
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2.2 Methods
2.2.1 Cell Culture, plasmids and transfection
Wild-type Neuro 2a (N2a wt) cells and Neuro 2a cells stably transfected with mouse CPE
(N2a-CPE, clone 17) were obtained from Dr. Y. P. Loh (Bethesda, MD, USA). Cells were
maintained in DMEM containing 10% FBS and stable transfectants were maintained in
media containing 400 µg/ml G418. N2a wt cells were also stably transfected with the
enzymatically inactive form of CPE, E300Q (32) using Lipofectamine 2000 (Life
Technologies). Stable transfectants were selected in 800 µg/ml G418, pooled and
maintained in 400 µg/ml G418. To examine the role of CPE in sorting proglucagon, N2a
wt, N2a-CPE and N2a-E300Q cells were transfected with hamster pre-proglucagon (in
pcDNA 3.1; a kind gift from Dr. D. F. Steiner, Chicago, IL, USA). To examine the roles
of other prohormone convertases, both N2a wt and N2a-CPE cells were transiently
transfected with plasmids encoding mouse PC1/3 and PC2 (kind gifts from Dr. N. G.
Seidah, Montréal, QC, Canada). To determine whether proglucagon co-localizes to
granules of N2a-wt cells, we constructed a proglucagon-EGFP plasmid. Pre-proglucagon
cDNA was PCR amplified to add the KpnI (proG-EGFP forward primer, 5’-GGT ACC
ATG AAG AAC ATT TAC ATT GTG G-3') and BamHI (proG-EGFP reverse primer, 5'GGA TCC GCT TTC TTG TCA GTG ATT TTG GT-3') restriction sites (underlined) in
frame with EGFP (bolded nucleotides). Using PCR amplification and restriction digest,
pre-proglucagon was cloned into the pEGFP-N1 backbone (Clontech Labs, Takara Bio)
to add a C-terminal EGFP tag. To determine possible sorting signals, the sequence of
proglucagon was mutated independently at three sites: at the processing site, R70K71; at
the dibasic site within glucagon, R17R18; and at two leucines that were postulated to
flank the helix structure within glucagon, L14 and L26. The processing site mutant,
K71Q, was a kind gift from Dr. D. F. Steiner (Chicago, IL, USA). We generated the
mutation at the dibasic site, R18Q (forward primer sequence 5'-AAA TAC CTG GAC
TCC CGC CAA GCC CAA GAT-3'), and the double leucine-to-proline mutation was
done in two steps; L14P was made using forward primer 1, 5'-TAC AGC AAA TAC
CCG GAC TCC CGC CGA GCC-3'; and L26P was subsequently generated using
forward primer 2, 5'-CAA GAT TTT GTG CAG TGG CCG ATG AAC ACC-3'. Bold
sequences in primers indicate site of mutation. All site-directed mutagenesis reactions
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were carried out using the QuikChange™ II Site-Directed Mutagenesis Kit (Agilent
Technologies, Santa Clara, CA, USA) and results were confirmed by sequencing at the
London Regional Genomics Facility, University of Western Ontario.

2.2.2 Depletion of Carboxypeptidase E by siRNA Knockdown
Specific knock-down of CPE in either alphaTC1-6 or GLUTag cells was achieved by
synthesizing siRNA using the Silencer siRNA Construction Kit™ (Life Technologies,
Carlsbad, CA, USA). The kit included a negative control, Ambion Silencer Negative
Control #1, a sequence with no known targets in the mouse genome. Initial targets were
selected from the mouse CPE mRNA sequence (GenBank™ accession #NM_013128.1)
as generated by Ambion's online algorithm, and subsequently screened using a BLAST
search to identify seven candidate sequences with no homology to known mouse
mRNAs. All seven candidate siRNA sequences were synthesized, screened in both cell
lines and validated for the extent of CPE depletion by western blot using the CPE 4-5
antibody that detects the N-terminal domain of CPE (a gift from Dr. Y. P. Loh, Bethesda,
MD, USA) (Figure 7A). A single target was chosen, CPE73, spanning nucleotides 14081428 (sense strand: 5'-C CCT GCT GTT GGG GTG GAC TT), for its significant and
reproducible ability to decrease CPE levels in both cell lines (Figure 7A). CPE73 was
used in subsequent depletion experiments, in which 200 nM concentrated CPE73 or
control siRNA were transfected using Oligofectamine (Life Technologies) as per
manufacturers instructions for 72 h prior to secretion experiments or fixation for
immunofluorescence microscopy.

2.2.3 Western Blot
For western blot analysis, all cells were grown in six-well plates, lysed and protein
extracted. Protein concentration was quantified by densitometry and 20 µg of total
protein was separated on 12% SDS-PAGE gels as previously described (33). Proteins
were transferred onto nitrocellulose membranes and probed using specific antisera
against CPE (CPE 4-5), or against PC1/3 or PC2 (kind gifts from Dr. N. G. Seidah,
Montréal, QC, Canada). Bands were visualized using Super Signal West Pico
chemiluminescent substrate (Thermo-Fisher Scientific, Toronto, ON, Canada) and bands
were quantified by densitometry as described (33). Secreted CPE was detected by media
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collection and lyophilized. The concentrated residue was resuspended in sample buffer
and loaded entirely into one well. As a result of concentration, these samples migrated
more slowly through the gel and had a greater apparent molecular weight (Mr) of 60 kDa.

2.2.4 Secretion Experiments
AlphaTC1–6 cells (a kind gift from Dr. C. B. Verchere, Vancouver, BC, Canada) were
maintained in DMEM containing 15% horse serum and 2.5% FBS. GLUTag cells (a kind
gift from Dr. D. J. Drucker, Toronto, ON, Canada) were grown in low-glucose DMEM
containing 10% FBS. For stimulated secretion experiments, αTC1–6 cells were seeded in
24-well plates in replicates of six and pre-incubated in Hank's buffered salt solution
(HBSS; 138 mM NaCl, 5.33 KCl, 4.00 NaHCO 3, 1.26 CaCl2, 0.50 MgCl2, 0.44 KH2PO4,
0.41 MgSO4, 0.30 Na2HPO4) containing 25 mM glucose for 1 h. Cells were then
incubated in HBSS containing 1 mM glucose and 10 µm each of forskolin and 3isobutyl-1-methylxanthine (IBMX) for 1 h. GLUTag cells were incubated in low-glucose
(5.5 mM) DMEM +0.5% FBS without (basal) or with (stimulated) 10 µm each of
forskolin and IBMX for 2 h. After all secretion experiments, media were collected and
trifluoroacetic acid (TFA) was added to 0.1%. Cells were rinsed twice in HBSS, and
scraped in 1 mL homogenisation buffer (1 M HCl, 1 M formic acid, 1% (v/v) TFA, 1%
(w/v) NaCl). The cells were sonicated in one 12 s burst, centrifuged and the supernatant
was collected, and both media and cell extracts were passed through a Sep-Pak C18
reverse-phase cartridge to elute proglucagon-derived peptides as previously described (4,
5). Glucagon and GLP-1 content were assessed by RIA using the glucagon and GLP-1
RIA kits (Linco/EMD Millipore, Bedford, MA, USA). The antibody provided in the
glucagon RIA kit specifically detects the C-terminal end of glucagon and does not crossreact with any other proglucagon-derived peptides.

2.2.5 Immunofluorescence and image acquisition
For immunofluorescence, cells were grown on glass coverslips, as described (33). The
primary

antibodies

used

were

directed

against

glucagon

(rabbit;

1:1000;

Bachem/Peninsula Laboratories, Torrance, CA, USA), and either the Golgi marker p115
(mouse; 1:50; Transduction Laboratories, San Jose, CA, USA), or the secretory granule
marker chromogranin A (rabbit; CgA; 1:50; Abcam). Additionally, primary antibodies
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against insulin (guinea pig; 1:1000), GFP (rabbit; 1:250; A. v. peptide, Clontech
Laboratories, Takara Bio, Mountain View, CA, USA), or transcription factor PDX-1
(rabbit; 1:50) were used in the validation of the Pearson's correlation coefficient image
analysis (described below). Coverslips were blocked in 10% goat serum and 1% bovine
serum albumin in PBS. The anti-glucagon antibody was raised against the entire sequence
of glucagon, and thus recognises unprocessed proglucagon, glicentin, oxyntomodulin and
glucagon. To examine CPE immunoreactivity, slides were incubated with the CPE 7–6
antibody (raised in rabbit; kind gift from Dr. Y. P. Loh, Bethesda, MD, USA), which
recognises the C-terminus of CPE. Alexa 488-IgG (Invitrogen) was used to visualise the
glucagon or CPE antibody, and Alexa 594-IgG for the p115 or CgA antibody.
Cells were visualized using an Olympus IX81 widefield fluorescence microscope and
images were acquired using In Vivo software. Ten optical sections were acquired at 0.2
µm steps to cover the z-axis field of the cells, using a 60x oil immersion objective lens.
Image stacks were then processed by the blind (3D) deconvolution algorithm provided in
Image-Pro Plus software (Media Cybernetics Inc., Rockville, MD, USA).

2.2.6 Image analysis using Pearson's Correlation Coefficient
Image analyses were conducted using FIJI (FIJI is just ImageJ) (version 1.46h) (34), a
distribution of ImageJ (NIH, Bethesda, MD, USA). Co-localization analyses were
conducted using the Co-localization 2 plugin in FIJI. During the course of image
analysis, it became apparent that there were bugs in the quantification of co-localization.
I fixed the bugs and contributed the code to the FIJI/ImageJ project. Details of the bug
fixes can be found in Appendix 1. Regions of interest were drawn around single- or
multi-cell bodies from pseudo-coloured red and green fluorescent images to exclude as
much background as possible. The segmented region was defined by a binary mask and
applied to both image sets. Using raw, unprocessed images presents the possibility that
any identified co-localizaion could instead be a false-positive. To ensure false-positives
were not included in subsequent analyses, each red/green image pair was first screened
using the Coste's significance threshold test (35). Costes' algorithm scrambled one image
to test for spurious co-localization and simultaneously determines a threshold intensity
for each colour, above which pixels are considered to be statistically correlated. Paired
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red and green pixels were then used to quantify co-localization using the Pearson's
correlation coefficient (PCC) (r), according to:

Here, the i-th and j-th pixels represent the respective regions of interest, Sc1 and Sc2, of
co-localized pixel intensities in each colour channel, and all signal intensities, regardless
of co-localization, are denoted by S1 and S2 or their averages, S1av and S2av. Importantly,
the numerator is dependent on an unbiased estimation of co-localized pixels as chosen by
the Costes' algorithm, while the denominator uses all pixels within respective regions of
interest to establish a signal-to-background ratio. This measurement also has the desirable
properties of being invariant to the region of interest shape, and each pair of images is
normalized to their own mean fluorescence intensities. Calculated correlation coefficients
were treated as a single experimental dataset and differences were tested using a onefactor ANOVA omnibus test, and Tukey's HSD post-hoc test using a significance
threshold of α = 0.05. Group sample sizes (n) varied between 10-25, with adequate power
to detect the effect sizes shown here. The Pearson's correlation coefficient method was
validated in INS-1 832/13 cells using markers known for a low degree of co-localization
(insulin and PDX-1) and a high degree of co-localization (insulin and CgA).

2.2.7 De novo Protein Modeling
At present no crystal or solution structure of the full proglucagon molecule exists. To
determine whether such a model may provide mechanistic insight to the sorting of
proglucagon, the full-length proglucagon polypeptide sequence was submitted to the
Robetta 3D modelling web server for de novo 3D protein structure prediction (36).
Robetta uses the Ginzu model (37)

to find match sub-domains against known

homologous structures that have been deposited in the Protein Data Bank
(http://www.rcsb.org/pdb/). Proglucagon was parsed into two sub-domains, each modeled
using the incretin hormone, glucose-dependent insulinotropic peptide (GIP; PDB:2B4N
and PDB:2OBU). The N-terminal domain (proglucagon 1-77; PDB:2B4N) had a
position-specific iterative BLAST (PSI-BLAST) (38) confidence score of 5.40; the Cterminal domain (proglucagon 78-158) (PDB:2OBU) had a HH-Search (39) confidence

62
of 2.33. The Robetta server assembled both sub-domain models for final folding and
side-chain packing, to produce five full-chain 3D structures.

2.3 Results
2.3.1 Pearson's correlation coefficient accurately reflects degree
of co-localization
If proglucagon sorting to granules is sensitive to changes in CPE expression, we should
be able to detect a change in sub-cellular distribution at steady state using quantitative colocalization. We used Pearson's correlation coefficient (PCC) to quantify the degree of
co-localization. The degree of co-localization correlates with sorting efficiency to
granules, and therefore we used co-localization as a measure of sorting efficiency of
proglucagon. The PCC measurement has previously been used to describe the colocalization of the neuropeptide secretogranin II to granules in both PC12 and chromaffin
cells (40). Further, the PCC is thought to be an accurate method of co-localization
because it correlates normalized fluorescence intensities on a pixel-by-pixel basis (41).
(A more detailed discussion on the quantitative techniques used in co-localization and
common misunderstandings of PCC are addressed in Chapter 4.) Here we describe the
qualitative degree of co-localization alongside quantitative measurements of Pearson's
correlation coefficient. Because the explanation of qualitative images is subjective by
nature, Zinchuk and colleagues have proposed a method to translate qualitative
descriptions to quantitative ranges1 of co-localization parameters (42). Using these
mappings adds consistent quantitative meanings to these subjective qualifiers. Before
using the PCC to measure proglucagon sorting efficiency, we first validated the method
by measuring two proteins that are known to have either a low or high degree of colocalization with each other.
To verify the degree of co-localization between two sets of proteins in their native cells,
we used the insulin-producing rat INS-1 832/13 beta cell line. These cells efficiently store
a large amount of insulin in secretory granules, which is co-stored with a granule matrix
1

As described by Zinchuk, the “fuzzy” ranges for Pearson's correlation coefficient (auto-thrshold) map
as follows. Very weak: -1.0 ~ -0.27; Weak: -0.26 ~ 0.09; Moderate: 0.10 ~ 0.48; Strong: 0.49 ~ 0.84
and Very strong: 0.85 ~ 1.0.
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protein, chromogranin A (CgA). Therefore we expect a high degree of steady-state colocalization between insulin and CgA in the Golgi and granules. Both insulin and CgA
immunoreactivity were detected in a para-nuclear structure, consistent with the Golgi,
and in punctate structures along the cell processes, consistent with secretory granules
(Figure 2A). PCC analysis on these images showed a very strong co-localization (Figure
2B), as expected. In contrast, the beta-cell specific pdx-1 transcription factor is active in
the nucleus, and should have a low degree of co-localization with insulin. The subcellular distribution of insulin immunoreactivity was the same, while nearly all pdx-1 was
localized to the nucleus (Figure 2A). As expected, insulin and pdx-1 were not colocalized with each other, but the PCC analysis showed that it was just barely
“moderately” co-localized by using the numeric mappings (PCC = 0.49, on the border
between weak and moderate co-localization) (Figure 2A). Correspondingly, there is very
low overlap after inspection of the pdx-1 immunofluorescence signal (Figure 2B).
Insulin was very significantly co-localized to granules (p<0.001) than it was with pdx-1
in the nucleus. This high degree of insulin and CgA co-localization by Pearson's has also
recently been demonstrated in rat insulinoma INS-1 cells (43). Therefore we confirm the
specificity of Pearson's correlation coefficient to measure co-localization.
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Figure 2. Validation of Pearson's correlation coefficient. (A) INS-1 832/13 cells were
immunodetected using antibodies against insulin (green) and pdx-1 (red) or
chromogranin A (CgA, red). Insulin and CgA are located in the Golgi and secretory
granules (punctate signal located in cell processes), while pdx-1 was localized to the
nucleus. Representative images are shown. (B) Mean PCC of pdx-1 and insulin (light
grey bar) and CgA and insulin (dark grey bar). As expected, there is weak correlation
between insulin and pdx-1, and very strong co-localization between CgA and insulin. *
p<0.01. Values are mean ± SEM (n=10).
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2.3.2 Proglucagon is sorted to granules in the presence of
Carboxypeptidase E
We next investigated the role of CPE on the sorting efficiency of proglucagon. CPE
immunoreactivity was not detected by western blot in wild-type N2a cells (N2a-wt), and
could only be detected after stable transfection of CPE (N2a-CPE) (Figure 3A). In the
absence of CPE (N2a-wt cells), proglucagon immunoreactivity was mostly localized to
the cis/medial-Golgi, as indicated by p115 co-immunostaining (Figure 3B), and there
was a strong co-localization between proglucagon and p115 by PCC analysis (Figure
3C). In contrast, in N2a-CPE cells which over-express CPE, proglucagon
immunostaining shifted toward being stored in punctate structures in the cell processes at
steady state, consistent with storage in granules (Figure 3B). PCC analysis showed
moderate co-localization in the presence of CPE through a significant decrease in colocalization (p<0.01) (Figure 3C). Therefore, the presence of CPE efficiently increased
proglucagon sorting to granules, as reflected by a loss of co-localization with the early
Golgi marker, p115, and punctate appearance of proglucagon in granules.
In order to validate that proglucagon is co-localized to granules, we transfected N2a-CPE
with proglucagon-EGFP (enhanced green fluorescent protein). Cells were coimmunostained for EGFP to detect proglucagon, and CgA to detect granules (as in INS-1
cells) (Figure 4). As expected, proglucagon immunoreactivity very strongly co-localized
(r = 0.84 ± 0.01) with CgA-positive punctate structures in the cell processes (Figure 4).
Therefore, N2a-CPE cells efficiently sort proglucagon to granules.
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Figure 3. CPE plays a role in the sorting of proglucagon. (A) Western blot analysis of
cell extracts from Neuro2A cells lacking CPE expression, and after transfection of wt or
E300Q mutant CPE. (B) Full-length proglucagon was transfected into N2a cells, either
alone (– CPE), or co-transfected with CPE or E300Q mutant CPE. Cells were immuno-
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stained using antibodies against glucagon (green) and the Golgi protein p115 (red).
Representative images are shown. Scale bar represents 10 µm. (C) FIJI/ImageJ software
was used to determine the fluorescence intensity co-variance (PCC) of proglucagon and
p115. Proglucagon showed a significant decrease in mean correlation with p115 when coexpressed with CPE, and a significant increase when co-expressed with the E300Q
mutant CPE. Values are means ± S.E.M. (n=10–25). *p<0.01 vs – CPE; # p<0.01 vs both
cells with and without CPE.

Figure 4. Proglucagon is sorted to secretory granules in N2a cells expressing CPE. N2a
cells were transfected with CPE and proglucagon-EGFP, and immunostained using
antibodies directed against EGFP (green) and CgA (red), a granule resident protein. Mean
Pearson's correlation coefficient was significant (PCC=0.84 ± 0.01, n=6) and showed
very strong co-localization.

2.3.3 Proglucagon sorting depends upon properly sorted CPE
In an effort to resolve whether the effect of CPE on proglucagon sorting was influenced
by its enzymatic activity or its ability to sort to granules, we made stable transfectants of
N2a-wt cells with the inactive Glu300Gln mutant of CPE (Figure 3A). If CPE acted as a
sorting receptor for proglucagon, we hypothesized that proglucagon sorting efficiency
should correlate with CPE trafficking. In E300Q CPE cells (N2a-E300Q), proglucagon
immunoreactivity was localized to the Golgi, as in the cells lacking CPE (Figure 3B).
Co-localization of proglucagon with p115 was very strong (Figure 3C), as reflected by a
significantly increased PCC (p<0.01) when compared to that of N2a-wt, indicating a
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greater abundance of proglucagon in the Golgi. Furthermore, co-localization analysis of
proglucagon with p115 in N2a-wt cells was significantly greater than in N2a-CPE
(p<0.01) (Figure 3C), suggesting that the presence of CPE significantly enhanced sorting
efficiency of proglucagon. This was interesting because it suggested that the E300Q
mutation impaired the post-Golgi sorting of proglucagon. In support of this hypothesis,
E300Q-CPE was robustly detected in the Golgi (Figure 5A) and could not be detected in
media (Figure 5B). On the other hand, CPE was detected along the tips of cell processes
(Figure 5A) could be detected in media (Figure 5B), consistent with storage in granules.
This suggests that E300Q CPE exit from the Golgi was also impaired, and is not properly
sorted in N2a cells.

Figure 5. The E300Q mutant CPE is not sorted efficiently to secretory granules. (A) In
cells expressing wild-type CPE, punctate staining along the tips of the cell processes
indicates presence in secretory granules. In cells expressing E300Q, CPE
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immunofluorescence largely coincides with that of p115. (B) Wild-type CPE is secreted
from N2a cells where a portion is cleaved from the granule membrane resulting in a
smaller, soluble form of secreted CPE. The E300Q mutant CPE is not present in the
media, further indicating that is it not transiting through the secretory pathway in N2a
cells. The apparent increase in molecular weight of the secreted form is due increased salt
content of the lyophilized sample resulting in slower migration through the gel, as stated
in Methods.

2.3.4 The effect of PC1/3 and PC2 on proglucagon sorting
Since proglucagon is co-targeted to granules with either PC1/3 (in L cells) or PC2 (in α
cells), we also tested the hypothesis that PC1/3 or PC2 were sufficient for proglucagon
sorting. We were also interested in whether the co-expression of CPE with either PC1/3
or PC2 could enhance CPE-mediated proglucagon sorting. N2a-wt cells were a
convenient system for this experiment because they lack endogenous PC1/3 and PC2
(Figure 6A). We transfected N2a-wt cells with either PC1/3 or PC2 alone, or in
combination with wild-type CPE. When PC1/3 was transfected alone, it was detected as a
single 84 kDa pro-form, while co-expression with CPE resulted in both an 84 kDa form
and an active 66 kDa form (Figure 6A). The expression pattern of PC2 remained
unchanged (Figure 6A). Proglucagon immunoreactivity was mostly localized to the
Golgi when expressed either with PC1/3 or PC2 alone (Figure 6B), and the Pearson's
analysis showed that there were no significant differences from the N2a-wt cells lacking
CPE (Figure 6C). The co-localization of proglucagon and p115 was unaffected by PC2,
with or without CPE (Figure 6B,C). Proglucaogn was localized in the Golgi similarly to
the absence of CPE (Figure 6B), and Pearson's analysis showed similarly poor colocalization (Figure 6C). Addition of CPE mostly restored proglucagon sorting, as small
amounts were seen in granules (Figure 6B) and Pearson's analysis showed improved colocalization (p<0.05) compared to PC1/3 alone, though it was not restored to the same
level as CPE alone. These results are consistent with CPE enhancing proglucagon sorting
alone.
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Figure 6. The presence of PC1/3 or PC2 does not enhance sorting of proglucagon. (A)
Western blot analysis of PC1/3 (upper panels) and PC2 (lower panels) expression after
before and after transfection into N2a cells. Wild-type N2a cells have no detectable
expression of either PC. In cells lacking CPE, PC1/3 immunoreactivity is present as a
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single 84 kDa band, while in the presence of CPE, it is mostly present as a 66 kDa band.
PC2 is present as a 66 kDa band with or without CPE. (B) Full-length wild-type
proglucagon was transfected into N2a cells, either with PC1/3 or PC2 alone or in
combination with CPE. Cells were processed using antibodies against glucagon (green)
and the Golgi protein p115 (red). Representative images are shown. Scale bar represents
10 µm. (C) Mean correlation of proglucagon and p115 fluorescence in cells expressing
PC1/3 or PC2, alone or in combination with CPE, was not significantly different from
cells not expressing CPE. Values are means ± S.E.M. (n=10–25). *p<0.01 compared with
– CPE, # p<0.01 compared with + PC1/3 alone.

2.3.5 CPE affects proglucagon sorting in α cells, but not L cells
To determine if the effect of CPE of proglucagon sorting is relevant to α or L cell
physiology, we conducted knockdown studies using alphaTC1-6 cells, an α cell line
derived from mouse glucagonoma, and GLUTag cells, a mouse L cell line derived from
mouse enteroendocrine tumours. Out of a screen for CPE-specific siRNAs, we selected
CPE73 for its reliable and reproducible ability to deplete CPE (see Methods; Figure 7A).
To confirm whether CPE had a physiologic effect, we conducted secretion assays on
alphaTC1-6 cells for glucagon, and GLUTag cells for mature GLP-1. Using CPE-73
siRNA, we significantly reduced CPE expression by 61±3% in alphaTC1-6 cells (n=3,
p<0.05) (Figure 7B) and by 74±7% in GLUTag cells (n=3, p<0.05) (Figure 8A).
Knockdown of CPE in alphaTC1-6 significantly increased basal glucagon release (n=6,
p<0.05) with a corresponding decrease in cell content of glucagon (n=6, p<0.05) (Figure
7C,D). The transfection efficiency of alphaTC1-6 cells, as assessed by EGFP
transfection, was 36.6 ± 3.7% (calculated from 10 images, each with ~50 cells).
However, stimulated secretion by forskolin/IBMX was lost with reduced CPE (n=6,
p<0.01) (Figure 7C,D). In contrast, no differences in regulated secretion of GLP-1 were
detected in GLUTag cells using forskolin/IBMX stimulation (n=6, p<0.001) (Figure 8B).
CPE appears to specifically affect glucagon secretion from α cells, while L cells remain
unaffected.
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Figure 7. CPE depletion affects regulated secretion of glucagon from alphaTC1–6 cells.
(A) Screen of siRNA directed against CPE. Seven siRNA were synthesized against nonhomologous targets of mouse CPE, transfected into both cell lines, and screened for the
extent of depletion by western blot using the N-terminally directed CPE4-5 antibody. A
siRNA directed against GAPDH and a mock transfection without siRNA were used as
controls. Equal protein lysates were separated on SDS-PAGE as determined by BCA
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assay. The greatest degree of depletion was achieved using siRNA-73, and so this was
used for subsequent experiments. (B) Western blot analysis shows siRNA-mediated
knockdown of CPE expression in alphaTC1–6 cells. (C and D) AlphaTC1–6 cells were
treated with transfection agent alone (mock), or 200 nM of control siRNA or siRNA-73
against CPE. (C) There was a significant increase in secretion in response to 10 mM
forskolin/IBMX treatment in mock- and control- transfected cells. In cells transfected
with siRNA CPE, basal secretion was significantly higher than in control cells, and there
was no response to stimulation with forskolin/IBMX. * p<0.001 compared with control
transfected basal secretion. Values are means ± S.E.M. (n=6). (D) Glucagon cell content
decreased in cells transfected with siRNA-73 compared with control siRNA. * p<0.05, **
p<0.01 compared with control siRNA values. Results are representative of four
independent experiments.

Figure 8. CPE depletion has no effect on regulated secretion of GLP-1 from GLUTag
cells. (A) Western blot analysis shows siRNA-mediated knockdown of CPE expression in
GLUTag cells. (B) GLUTag cells were treated with transfection agent alone (mock) or
200 nM of either control siRNA or siRNA-73 against CPE. There was robust stimulated
secretion in response to 10 mM forskolin/IBMX treatment in all groups. Values are
means ± S.E.M. (n=6). *** p<0.001 compared with basal secretion. Results are
representative of four independent experiments.
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2.3.6 Proglucagon contains a sorting signal within the glucagon
sequence
Sequence analysis of proglucagon revealed that glucagon contains a substantial α-helical
structure, which contains two embedded basic arginines (R18R19). If these structures act
as sorting signals, then sorting should be impaired by their specific mutation. We
generated independent mutations to disrupt either the dibasic site by an arginine to
glutamine mutation (R18Q), or the α-helix by dual leucine-to-proline kinks (L14P,L26P),
and expressed these mutant proglucagons in the presence of CPE. Each mutant was more
abundant in the Golgi (Figure 9A). Compared to wild-type proglucagon, both the
L14P,L26P mutant (p<0.01) and R18Q dibasic mutant (p<0.05) were strongly and more
significantly co-localized with p115, and similar to each other in their degree of colocalization (Figure 9B). These data suggest that the specific α-helix of glucagon
encodes the information for proper sorting of proglucagon.

2.3.7 Initial processing of proglucagon at K70R71 enhances
sorting to granules
The precise order of when proglucagon undergoes cleavage at the K70R71 site and initial
sorting to granules is not known. It is possible that this cleavage event makes the sorting
signal accessible for more efficient sorting, or that sorting occurs first, and proglucagon is
subsequently processed. While PC1/3 and PC2 are the physiologically important
convertases in the production of proglucagon-derived peptides, neither are expressed in
Neuro2a cells and therefore would not cleave at this site. A related enzyme, furin, is
expressed in all cells (44), and has been shown to process proglucagon at the K70R71
inter-domain site (45). As furin is trafficked from the TGN to immature granules within
the secretory pathway, cleavage of proglucagon by furin in these compartments may
facilitate entry to granules. To examine this hypothesis, we blocked furin-mediated
cleavage by mutation of the K70R71 site to R71Q. The R71Q mutant was mainly
localized in the Golgi (Figure 9A), and Pearson's analysis showed that co-localization
with p115 (Figure 9B) was significantly greater (p<0.05) than that of wild-type
proglucagon (Figure 9B). This suggests that processing of proglucagon at the K70R71
enhances sorting efficiency, and supports the view that the initial processing event occurs
before the sorting event.
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Figure 9. Identification of putative sorting signals in proglucagon. N2a cells expressing
CPE were transfected with wt proglucagon, or the following mutants: K70R71Q, which
disrupts a furin cleavage site; R18Q, which disrupts a dibasic site within glucagon; or
L14P/L26P, which reduces the α-helical content of glucagon. (A) wild-type proglucagon
shows strong immunoreactivity in the tips of the cell processes, and very weak signal in
the Golgi. By contrast, there is strong Golgi signal that co-localized with p115 in cells
expressing the K70R71Q mutant proglucagon, as well as signal in the cell processes.
Representative images are shown. Scale bar represents 10 µm. The R18Q and L14P/L26P
mutants show some Golgi co-localization and post-Golgi signal. (B) Mean correlation of
proglucagon and p115 fluorescence in cells expressing wt proglucagon (wt) or indicated
mutants. All mutant constructs showed significantly higher mean correlation with p115
compared with wt proglucagon, indicating some disruption in sorting. * p<0.05, **
p<0.01 compared with wild-type.

2.3.8 Modelling the 3D structure of proglucagon
We sought to produce a 3D conformational structure of proglucagon in order to see if any
new information could be provided regarding the mechanism of contained sorting signals.
We submitted the full proglucagon sequence for de novo structure prediction to the
Robetta software suite (Seattle, WA, USA; http://robetta.bakerlab.org/), and five
structures were predicted. The model with the greatest confidence score is shown in
Figure 10. Though the five structures contain very different spatial conformations, each
predicted structure contains significant α-helical content, three of which are found within
the sequences of glucagon (proglucagon 33-61), GLP-1 (proglucagon 72-108), and GLP2 (proglucagon 126-158), and the K70R71 inter-domain site are indicated in Figure 10.
Since these helices appear to be randomly oriented within a disordered structure, joined
by two flexible hinges of IP-1 and IP-2, this is consistent with a previous partial model of
proglucagon (45). This model is unlike the previously reported structure (45) in which
glucagon, GLP-1 and GLP-2 are depicted as rigid α-helices arranged in a trimeric
structure. Furthermore, our protein modelling data predict that the α-helices of GLP-1
and GLP-2 may also serve as sorting signals. If CPE directly binds to proglucagon, our
model the canonical “POMC signal” is formed from the flexibility of the molecule, or it
may be that proglucagon contains a novel class of sorting signal that interacts with CPE.
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Figure 10. Structural model prediction of proglucagon. The Robetta modelling web
server was used to generate a de novo 3D protein structure prediction for entire sequence
of proglucagon. The results are presented in cartoon format, with N- and C-terminal
indicated, and the inter-domain cleavage site K70R71 labeled. The sequence of glucagon
is coloured green, GLP-1 (1–37) yellow and GLP-2 red. The structure is largely
disordered, with α-helices of glucagon, GLP-1 and GLP-2 oriented randomly within the
structure. The K70R71 cleavage site appears to be located in an unstructured region,
which may provide flexibility and accessibility to furin.

2.4 Discussion
This is the first report to investigate the mechanisms of the sorting of proglucagon to the
secretory granules of the regulated secretory pathway. Proglucagon processing largely
occurs in granules, where, distinct sets of constituent hormones in both α and L cells are
produced by tissue-specific PC enzymes. The mechanisms of granule exocytosis that
result in the nutrient-regulated secretion of glucagon and GLP-1 have also been
investigated. The question that remains is, what are the mechanisms underlying how
proglucagon is sorted to granules so that it may be processed and secreted. Proglucagon
must eventually enter granules, where the mildly acidic and millimolar calcium
environment of the granule lumen are required for optimally active prohormone
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convertases to produce glucagon, GLP-1 and GLP-2. Furthermore, efficient storage in
granules is necessary for α and L cells to remain sensitive to nutrient status and thus
trigger a robust secretory response. The initial sequence of whether sorting precedes
processing (or vice versa), are not known. As proglucagon is co-targeted to granules with
its processing enzymes, we investigated whether these enzymes play a role in the
underlying mechanism. Here we have identified sorting signals that directly affect the
efficiency of sorting to granules. We have also identified a role for CPE as a sorting
receptor to mediate proglucagon sorting to granules in an α cells and not L cells.
For this study, we chose the model Neuro-2a mouse neuroblastoma cell line because it
correctly targets hormones to the regulated secretory pathway (46), and because we
obtained a clone that lacked endogenous CPE (47), that made for an excellent control to
examine the role of CPE as a sorting receptor. Conveniently, the Neuro-2a wild-type cells
also lack detectable endogenous PC1/3 and PC2, which would prevent endogenous
processing of proglucagon and allow their individual roles to be examined in the sorting
of proglucagon. In order to quantify the degree of sorting, we chose to examine colocalization by calculating Pearson's correlation coefficient. The use of Pearson's
correlation coefficient (PCC) is readily applicable to this task (48) and is thought to be an
accurate quantitative parameter for diffraction-limited microscopy (41). It has been used
to characterize the sorting of neuropeptide SgII in PC12 cells (40). From its mathematical
formulation, Pearson's is robust to varying protein densities and uniform noise. A
common alternative parameter, Mander's coefficient, was created in order to solve a
perceived sensitivity problem (41), and ironically, is far too sensitive in practice as to
approach near perfect co-localization where non-exists (49). Other methods of colocalization (e.g., overlap coefficient) discard meaningful fluorescence signal, or are not
specific. A greater degree of correlation results in a more positive PCC value and two
proteins are said to be co-localized. This should not be confused with measurements of
the fraction of proteins which are co-localized, which is only accurately measured by subdiffraction limiting techniques (e.g., super-resolution). When used with background
subtraction, and compared to appropriate biological controls, as used in this report,
Pearson's correlation is a useful quantitative technique. We measured co-localization
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between proglucagon and p115, a marker of the cis- and medial-Golgi, by
immunofluorescence microscopy. We used p115 instead of a granule marker, because in
these cells, CgA gave a strong Golgi signal which masked changes to proglucagon
localization. The Pearson's method successfully discriminated between insulin and pdx-1,
proteins known to be co-localized or segregated, and confirmed that proglucagon was colocalized in CgA+ compartments in our Neuro-2a cells. Therefore, our co-localization
analyses can accurately distinguish co-localized proteins within a sub-cellular
compartment.
Since it has been shown that CPE acts as a specific sorting receptor for a wide range of
hormones, including POMC (25) and proinsulin (20), this was the most promising
candidate for a sorting receptor for proglucagon. When CPE was absent, the punctate
granular immunofluorescence pattern was reduced, a pattern also seen with POMC in
these N2a-wt cells (47). Since α and L cells both express CPE, we sought to confirm
these results in cells that normally synthesize proglucagon. When the siRNA knockdowns
were conducted, two types of controls were included, a mock transfected control without
siRNA, and a scrambled siRNA non-specific to any known target in the mouse genome.
It was felt that loading controls were not necessary because the mock and siRNA control
transfections are internal controls. In the absence of CPE in alphaTC1-6 cells, regulated
secretion of glucagon was lost. Consistent with our previous findings in which long-term
culture of alphaTC1-6 cells in high glucose (25 mM) upregulated granule exocytotic
machinery, these cells secrete glucagon in the presence of CPE (33). Our results now
suggest that CPE is needed for the sorting of glucagon to granules, and that CPE plays an
α cell specific role for sorting proglucagon to granules, as GLP-1 secretion was
unaffected in the absence of CPE. There is relatively less CPE content in α cells when
compared to L cells (50, 51), so it is theoretically possible that alphaTC1-6 cells were
more sensitive to knockdown studies than were GLUTag cells by the property of
containing less CPE. Following knockdown, GLUTag cells could have retained a
minimum effective threshold of CPE to still allow for the sorting of proglucagon to
granules and would then appear unaffected by knockdown. In both cell types, CPE
removes the C-terminal basic residues from both proglucagon and its intermediates to
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produce mature hormones. This may also suggest that α cells are more sensitive to the
location of CPE activity on PGDPs compared to L cells, and there could exist a CPEindependent mechanism in L cells.
In an effort to test if the enzymatic activity of CPE was required for sorting proglucagon,
we used the E300Q-CPE mutant, which had been previously shown to have an intact Cterminal sorting signal (47, 52) and target to granules of NIT3 cells derived from CPE fat/fat
mouse beta cells (32). However, the enzymatically inactive E300Q-CPE failed to sort
proglucagon to granules. This was interesting because the immunofluorescence staining
of both proglucagon and E300Q-CPE localized to the Golgi, and proglucagon was
strongly blocked from sorting to granules. In our hands, the E300Q-CPE was not secreted
from Neuro-2a cells, while proglucagon strongly co-localized to the Golgi, contradicting
this previous study (32). The strong immunofluorescence signal in the Golgi suggests that
E300Q-CPE is not degraded. Instead, it is possible that the impaired trafficking of
E300Q-CPE is specific to N2a cells. Similar cell-specific findings were found with the
S202P-CPE (fat) mutant, in which a significant fraction escapes proteosomal degradation
and sorts to granules in NIT-3 cells (53), yet appears completely degraded in pituitary
cells (30). Nevertheless, we could not distinguish whether proglucagon sorting is
independent of the CPE enzymatic activity. This situation is similar to the impaired
sorting of PC1/3 that prevented pro-renin from entering granules (16).
CPE is activated in the acidic environment of the granules (pH ~5.5-6.0), and although
the membrane bound form maintains some enzymatic activity, the soluble form of CPE is
the major active form (54–56). Activation of CPE involves a conformational change of its
enzymatic pocket, which can be specifically blocked by catalytic site-directed inhibitors
(e.g., bromoacetyl-D-arginine) (55). The conformational state of CPE is already
established to be a major determinant that determines whether the POMC sorting motif
binds to complementary motifs on CPE-sorted prohormones (57, 58), independent on its
enzymatic activity (55), and consistent with the characterization that the E300Q-CPE
maintained sorting function (32). Therefore, our results suggest the possibility that
proglucagon is sorted by binding to a novel interaction surface of CPE distinct from that
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used by POMC.
We generated several putative 3D structures of proglucagon in order to resolve whether it
is compatible with the known sorting receptor motif of CPE. On the surface of CPE are
two exposed basic residues, Arg255 and Lys260 (58), that can bind two acidic amino
acids ~12-15 Å apart on POMC, proinsulin, pro-enkephalin and pro-BDNF (19, 20, 25,
57, 58), stabilized by two hydrophobic residues spaced ~5-7 Å apart. Our model of
proglucagon reveals that the mature hormone domains contain predominant α-helices,
consistent with the known structures of purified recombinant hormones, yet the 3D
organization of the molecule is largely disordered. Given the flexibility of the molecule, it
is conceivable that a CPE binding motif could be in the disordered GRPP or IP-2, which
contain several acidic amino acids. Alternatively, a coiled-coil conformation comprising
glucagon and GLP-1, is another compatible CPE binding motif. Though hard to predict,
the inherent flexibility of some intrinsically disordered proteins show binding diversity
for multiple, specific ligands (59). Nevertheless, the specific nature of the interacting
domains between proglucagon and CPE still need to be determined as it may represent
novel sorting motif on the surface of CPE.
In addition to prohormone maturation, processing enzymes can influence trafficking of
prohormones to granules. Both PC1/3 and PC2 are targeted to granules with proglucagon,
and it is not yet known whether they are involved in the sorting of proglucagon. PC1/3
has been implicated in sorting of pro-renin (16), so it may aid proglucagon sorting. One
report of a human neuroendocrine cell line (BON-1) found that induction of PC1/3 upregulated expression of both CgA and SgII (60), two granins that function together as
sorting machinery, providing evidence of co-operation among independent sorting
receptors. Neither the pro-form of PC1/3 or the active form had any effect on
proglucagon sorting efficiency beyond the effect seen with CPE. In contrast, there is no
evidence that PC2 plays a role in hormone sorting or secretion, but we decided to
investigate it given that it producing glucagon within granules. In the extreme, PC2
knockout mice are expectedly deficient in glucagon (2, 61). These α cell granules had
abnormal morphology, yet they appear to maintain regulated secretion of proglucagon
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and processing intermediates (2), indicating that sorting of proglucagon was unaffected in
the absence of PC2. Consistent with this report, we found that PC2 had no effect on the
sorting of proglucagon, so it would seem that PC2 has no bearing on proglucagon sorting.
Our data shows that CPE plays a role in sorting proglucagon in Neuro-2a and α cells,
while L cells may possess an alternate sorting mechanism.
Adding to this complexity is the fact that proglucagon undergoes several steps of
processing to yield mature hormones. It is thought that the first step of processing occurs
at the inter-domain Lys70Arg71 cleavage site to yield glicentin and MPGF. These two
peptides are consistently detected when proglucagon is transfected into a non-endocrine
cell line, leading to the hypothesis that this cleavage occurs in the TGN. This processing
event in non-endocrine cells that lack a regulated secretory pathway would be mediated
by furin, since it is expressed in all cell types (4, 45). By pulse-chase studies,
proglucagon is first processed into glicentin and MPGF in α cells and many endocrine
cell lines by ~30 minutes of chase (1, 45, 62). However, this technique lacks sufficient
resolution to identify the compartment in which proglucagon is processed, and therefore
this initial cleavage could occur in the TGN or within immature secretory granules. Both
glicentin and MPGF must then sort into secretory granules, where PC1/3 and PC2 will
produce mature hormone. Therefore, the R71Q mutant used in our study represents an
important block early in the sequence of post-translational processing, which we found
significantly reduced sorting efficiency. This is interesting because it suggests that
processing at this site increases sorting efficiency, and should happen prior to the sorting
event. Another way to address the temporal order of the initial sorting and processing
events would be to identify whether glicentin and MPGF enter the same, or distinct
granule populations. Due to a lack of specific antibodies to monitor every single
proglucagon-derived peptide, and adequate systems to monitor proglucagon processing
and trafficking in vivo, it is unclear which granule populations contain glicentin and
MPGF. As a result, this alternative approach cannot distinguish whether initial processing
precedes sorting, and if so, is this initial processing is required to enhance sorting
efficiency. While there are several examples whereby different hormones enter the same
granule population, whether this is the dominant sorting mode for proglucagon is not
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known. In the case of pro-TRH, processing intermediates are known to enter distinct subpopulations of granules (63). Our results raise the possibility that glicentin and MPGF
contain independent sorting signals since glucagon and GLP-1 are liberated from these
distinct intermediates.
An important finding of this paper is the first documentation of sorting signals contained
within proglucagon. On the basis of sorting signals identified in other prohormones (64),
we focused on two likely signals within proglucagon, 1) the glucagon α-helix, and 2) the
dibasic site within the glucagon α-helix (Arg17Arg18). Since mutations to either structure
similarly reduced the sorting efficiency of proglucagon, it is likely that sorting
information is uniquely encoded by the entire glucagon α-helix. That the two homologous
α-helices in GLP-1 and GLP-2 apparently cannot, or do not, compensate for this
mutation, may be a result of lacking an embedded dibasic site. Note that the information
encoded in the α-helices of GLP-1 and GLP-2 is investigated in greater detail in Chapter
3 (65). Efficient sorting to granules is important to guarantee both proper processing to
mature hormones, and that α and L cells have sufficient stores of active hormones to
remain responsive to changes in nutrient status. Such a robust response is needed if
glycemic control by glucagon and GLP-1 are to be tightly controlled. The nature of the
glucagon sorting signal, and whether GLP-1 and GLP-2 encode similar information is
examined in Chapter 3.
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3.1 Introduction
Proglucagon is an endocrine prohormone that is expressed in pancreatic α cells, intestinal
L cells, and select neurons of the hypothalamus and brainstem. It is the precursor for the
peptide hormones glucagon, glucagon-like peptide (GLP)-1 and GLP-2. Glucagon is the
main

glucose

counter-regulatory

hormone,

principally

stimulating

hepatic

gluconeogenesis and glycogenolysis to maintain euglycemia (1). Conversely, GLP-1 and
GLP-2 are secreted from intestinal L cells in response to nutrient ingestion; GLP-1
stimulates insulin secretion in a glucose-dependent manner, and GLP-2 increases
intestinal blood flow and nutrient absorption (2). Oxyntomodulin, which contains the
sequence of glucagon plus a 6 amino acid C terminal extension (Figure 1) is also

88
postprandially secreted from L cells and acts as a potent appetite suppressant (3).
Therefore, all three hormones exert distinct metabolic actions to maintain nutrient
homeostasis.

Figure 1. Post-translational processing of proglucagon to its derived peptides. A
schematic representation of proglucagon in which each domain has been colour-coded,
and the amino acid positions of key processing events have been identified. The amino
acid numbering is relative to the first N-terminal amino acid of proglucagon (lacking the
signal peptide). The major hormone products produced from tissue-specific processing by
their respective prohormone convertase (PC) are shown at bottom. In pancreatic islet α
cells, the major products are glucagon and major proglucagon fragment (MPGF). In
enteroendocrine L cells and in the brain, the major products are GLP-1 (1-37), GLP-1 (737), GLP-2, oxyntomodulin and glicentin.

The post-translational processing of proglucagon by prohormone convertases (PCs)
follows a strict temporal sequence, in which an initial cleavage at K70R71 yields two
fragments, glicentin and major proglucagon fragment (MPGF) in both α cells and L cells
(Figure 1) (4, 5). Pancreatic α cells produce glucagon through cleavage of glicentin by
PC2 (4, 6), and PC1/3-mediated processing yields glicentin, oxyntomodulin, GLP-1 and
GLP-2 within L cells and neurons (7–9). There is evidence that proglucagon processing
in α cells is altered under conditions of beta cell injury such that bioactive GLP-1 is
produced (10). Each of these peptide hormones must be stored in dense-core secretory
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granules, a compartment unique to endocrine and neuroendocrine cells, for nutrientregulated secretion. It is well documented by pulse-chase and immunoelectron
microscopy studies that the final stages of processing occur in the secretory granules (5,
11, 12), and therefore, the sorting of proglucagon to secretory granules is essential for the
production of its bioactive peptide hormones. However, it is not known if the initial
cleavage of proglucagon to glicentin and MPGF occurs before or after sorting to
granules. One component of a sorting mechanism that appears to be common to a number
of prohormones is a sorting signal that is contained within the prohormone sequence. If
the initial processing of proglucagon precedes sorting to granules, then a sorting signal
must be present in each of glicentin and MPGF, leading to the intriguing possibility that
proglucagon contains at least two sorting signals that are spatially segregated.
Several types of prohormone sorting signals have been described that mediate specific
interactions with membrane-bound sorting receptors or co-target with processing
enzymes. Proinsulin (13, 14) undergoes aggregation mediated by hydrophobic residues. A
disulfide-bonded loop exposes two acidic amino acid residues comprise a sorting signal
within pro-opiomelanocortin (POMC) (15, 16), proinsulin (14), proenkephalin (17) and
pro-brain-derived neurotrophic factor (pro-BDNF) (18), and interacts with the sorting
receptor carboxypeptidase E (CPE). Paired basic amino acids that are cleavage sites for
PCs serve as sorting signals in pro-neuropeptide Y (pro-NPY) (19), pro-renin (20),
progastrin (21), proneurotensin (22) and pro-VGF (non-acronymic) (23), suggesting that
these prohormones are co-targeted with their processing enzymes. Finally, amphipathic αhelix regions/domains are required for the sorting of prosomatostatin (24) and prococaine and amphetamine regulated transcript (pro-CART) (25). Any or all of these
sorting signals may exist within a single prohormone and may synergize to increase
sorting efficiency (23, 26, 27).
Of these various known sorting signals, proglucagon contains two predicted types:
significant α-helical content within glucagon, GLP-1 and GLP-2, as documented by their
known crystal or NMR structures (28–30), and a dibasic amino acid sequence within the
α-helix of glucagon (R17R18; proglucagon 49-50). Interestingly, unlike other
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prohormones, the α-helices lie within ordered hormone-encoding regions, and not in a
prodomain (31). Additionally, these hormone domains are evolutionarily conserved,
particularly regarding their biophysical characteristics (32). We have previously identified
R17R18 and the α-helix within glucagon as putative sorting signals, and our results also
suggested that processing of proglucagon to glicentin and MPGF precedes sorting (33).
Therefore, in the present study, we investigated the possibility that proglucagon contains
multiple sorting signals in the different hormone domains. To this end, we have
extensively characterized the role of each predicted α-helix within proglucagon in sorting
to the regulated secretory pathway in the well characterized neuroendocrine PC12 cell
line. Our study reveals that two non-amphipathic α-helix domains within the sequences
of glucagon and GLP-1 are necessary and sufficient to target proglucagon to granules. We
also combine these results to a model of proglucagon processing and sorting in α- and Lcells.

3.2 Methods
Plasmid construction and reagents
Fusion proteins were constructed using proglucagon-derived peptide sequences attached
to the 3’ end of the cDNA encoding the CH2/CH3 domains of mouse IgG-2b (termed Fc),
preceded by the pro-renin signal peptide, as previously described (Figure 2) (24), (a kind
gift from Dr. T. Reudelhuber, Montreal, QC, Canada). Proglucagon-derived DNA
sequences were amplified from Syrian hamster pre-proglucagon cDNA (a kind gift from
Dr. D. Steiner, Chicago, IL, USA; GenBank TM accession J00059.1). All primers were
purchased from Sigma Aldrich (Oakville, Ontario, Canada), and the specific primers used
in this study for PCR amplification or site-directed mutagenesis can be found in Table 1.
All fusion constructs were constructed in pcDNA3.1 (Life Technologies, Burlington,
Ontario, Canada).
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Table 1. Primer pairs used for cloning and mutagenesis
Fusion Construct

Oligonucleotide Sequence Pair (5' → 3')

Fc (for construction of Fc
alone and Fc-Glucagon)

Forward: 5'-AAGCTTGGCATGGATCAATTC
Reverse: 5'-GGATCCAGGCCTACCCGCAGA

Fc stop mutation

Forward: 5'-GACCATCTCCCGGTCTCCGGGTTAGCCTGGATCC
Reverse: 5'-GGACTAGTGGATCCAGGCTAACCCGGAGACCGGGAG

Fc-Glucagon frame shift

Forward: 5'-CCTGGATCCACTCAGTCCAGTGTGGTGG
Reverse: 5'-CCACCACACTGGACTGAGTGGATCCAGG

Glucagon *

Forward: 5'-GAATTCCATTCACAGGGAACA
Reverse: 5'-GCGGCCGCCTAGGTGTTCATCAG

Leu26Pro-Glucagon
amplification

Forward: 5'-GAATTCCATTCACAGGGAACA
Reverse: 5'-GCGGCCGCCTAGGTGTTCATCGG

Arg18Gln-Glucagon
mutagenesis

Forward: 5'-AAATACCTGGACTCCCGCCAAGCCCAAGATTTTG
Reverse: 5'-CAAAATCTTGGGCTTGGCGGGAGTCCAGGTATTT

Leu14Pro-Glucagon
mutagenesis

Forward: 5'-TACAGCAAATACCCGGGACTCCCGCCGAGCC
Reverse: 5'-GGCTCGGCGGGAGTCCGGGTATTTGCTGTA

Fc (for construction with
GLP-1, GLP-2, Glicentin,
MPGF)

Forward: 5'-GCTAGCATGGATCAATTCCGATGG
Reverse: 5'-AAGCTTACCCGGAGACCGGGAGATGG

GLP-1 (1-37) §

Forward: 5'-GGATCCCACGATGAGTTTGAGAGG
Reverse: 5'-GAATTCTCCTCTGCCTTTCACC

GLP-1 (7-37) §

Forward: 5'-GGATCCCACGCTGAAGGGACC
Reverse: 5'-GAATTCTCCTCTGCCTTTCACC

GLP1 E27 mutagenesis

Forward: 5'-GGCCAGGCTGCAAAGGAGTTCATTGCTTGG
Reverse: 5'-CCAAGCAATGAACTCCTTTGCAGCCTGGCC

GLP-1 Stop codon
mutagenesis

Forward: 5'-GGTGAAAGGCAGAGGATGAGAATTCTGCAGATATCCTTAAG
Reverse: 5'-AAGGATATCTGCAGAATTCTCATCCTCTGCCTTTCACCAGC

GLP-2 §

Forward: 5'-GGATCCCATGCGGACGGCTCCTTC
Reverse: 5'-GAATTCGTCAGTGATTTTGGTTTG

GLP-2 Stop codon
mutagenesis

Forward: 5'-CAAACCAAAATCACTGACTAGGAATTCTGCAGATATCCTTAAGT
Reverse: 5'-AGGATATCTGCAGAATTCCTAGTCAGTGATTTTGGTTTGAATC

Asp3Gln-GLP-2 mutagenesis Forward: 5'-GGATCCCATGCGCAGGGCTCCTTCTCC
Reverse: 5'-GGAGAAGGAGCCCTGCGCATGGGATCC
Asp8Lys,Glu9Lys,Asn11Lys, Forward: 5'-GCTCCTTCTCCAAGAAGATGAAGACGATTCTCAAGAGTCTTGCC
Asp15Lys-GLP-2
Reverse: 5'-GGCAAGACTCTTGAGAATCGTCTTCATCTTCTTGGAGAAGGAGC
mutagenesis
Glicentin §

Forward: 5'-GGATCCCATTCCCTTCAGGACACGGAGG
Reverse: 5'-GAATTCCTAGCGTTTGGCAATGTTGTTCCTGTTC

MPGF §

Forward: 5'-GGATCCCACGATGAGTTTGAGAGGCACGC
Reverse: 5'-GAATTCCTATTTCTTGTCAGTGATTTTGGTTTGAATCA

Oxyntomodulin§

Forward: 5'-CTCGGATCCCATTCACAGGGAACATTCACCAGTGACTACAG
Reverse: 5'-GTGAATGGGATCCGAGCTCGGTACCAAGCTTACCCG

Note: Underlined sequence indicates the restriction sites used for cloning. Bolded sequences indicate sitedirected mutations. A conservative mutation was made within GLP-1 to remove an internal EcoRI
restriction site. Bolded and underlined text indicates a stop codon. Constructs used a flexible linker of
either eight amino acids (denoted by §; sequence: KLGTELGS) or a ten amino acid linker (denoted by *;
sequence: GSTQSSVVEF).
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The cDNA sequence of Fc was selectively amplified using the Fc primers (Table 1) and
ligated to the pcDNA3.1 backbone, between HindIII and BamHI restriction sites. To
construct an Fc expression plasmid, an in-frame stop codon was mutated between the
coding region and the HindIII restriction site, using the Fc stop primers (Table 1).
Mutagenesis reactions were performed using the QuickChange II Site-Directed
Mutagenesis kit (Agilent Technologies, Mississauga, Ontario, Canada) according to the
manufacturer’s protocol.
The Fc-wild-type glucagon fusion construct was generated ('Fc-WT Glucagon'; Figure
2), in which glucagon cDNA was amplified using specific primers for glucagon (Table
1), and ligated between the EcoRI and NotI restriction sites, joined by a 10 amino acid
linker (Table 1). To determine possible sorting signals, the sequence of glucagon was
mutated in two ways (Figure 2): two leucines, L14 and L26, which are postulated to
stabilize the α-helix, were mutated to L14P,L26P ('Fc-LP glucagon') by specific
amplification and mutation using the respective L14P and L26P glucagon primers (Table
1); and the dibasic sequence R18R19 was changed to R18R19Q ('Fc-RQ glucagon') using
the R18Q mutagenesis primers (Table 1).
Subsequent proglucagon-derived peptide constructs used a similar Fc expression system,
in which Fc was ligated into the NheI and HindIII restriction sites. Expression constructs
were generated for the following peptides: GLP-1 (1-37), GLP-1 (7-37), GLP-2,
oxyntomodulin, glicentin and MPGF (referred to as Fc-GLP-1 (1-37), Fc-GLP-1 (7-37),
Fc-GLP-2, Fc-OXM, Fc-Glicentin and Fc-MPGF, respectively; Figure 1 & 2), and
ligated into the BamHI and EcoRI restriction sites. An internal EcoRI cut site was silently
mutated using the GLP-1 E27 primers (Table 1). From Fc-GLP-2, we generated sitedirected point mutations, specifically changing five acidic amino acids to either neutral,
D3Q, or basic, D8K, E9K, N11K, D15K (referred to as Fc-Dipolar GLP-2; Figure 1 & 2,
Table 1). These mutations were chosen in order to mimic the dipolar nature of the
glucagon α-helix, which share less than 40% homology, and also to keep the α-helix
intact. Lastly, each of these constructs was terminated by an in-frame stop codon,
introduced either by site-directed mutagenesis or PCR amplification. All results were
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3.2.1 Cell Culture and transient transfections
Wild-type PC12 cells (a kind gift from from Dr. W. J. Rushlow, University of Western
Ontario, London, Ontario, Canada), were maintained in high-glucose (25 mM) DMEM
(Life Technologies), supplemented with 15% horse serum (Life Technologies) and 2.5%
FBS (Life Technologies). AlphaTC1-6 cells (a kind gift from Dr. C. B. Verchere,
University of British Columbia, Vancouver, British Columbia, Canada) were cultured as
previously described (34). Cells were transfected using Lipofectamine 2000 (Life
Technologies). To prepare cells for microscopy, cells were grown on glass cover-slips
coated with rat-tail type I collagen (100 μg/mL; Sigma) at a density of 4∙105 cells/cm2 the
day prior to transfection. For secretion assays, cells were grown in poly-D-lysine coated
6-well tissue culture dishes (Corning, Mississauga, Ontario, Canada). Cells were allowed
to grow for 48 h following transfection.

3.2.2 Secretion experiments
On the day of the experiment, media were changed to high-glucose DMEM
supplemented with 1% dialyzed FBS. After preincubation, cells were incubated for 3 h in
the same medium (“3 h basal”) followed by 15 min incubations without (“-K”) and with
(“+K”) 55 mM KCl to stimulate granule exocytosis (35). Cells were quickly rinsed in
Hanks' buffered salt solution (HBSS) between incubations. All media (1 mL per sample)
were collected on ice, with fresh protease inhibitor cocktail (Roche, Mississauga,
Ontario, Canada), 2 μg/mL aprotinin, 55 mM Tris, 1 mM EDTA, pH 7.4 for
immunoprecipitation, and cell lysates were collected and protein concentration was
quantified as previously described (34).

3.2.3 Immunoprecipitation, Western blot and secretion index
The media and cell lysates were applied to 50 μL of Protein A-Sepharose (GE Health
Care, Uppsala, Sweden), incubated at 4°C overnight with rotation, after which beads
were recovered, and protein was eluted by heating to 70°C for 10 min. The
immunoprecipitated proteins were separated on 10% NuPAGE pre-cast gels (Life
Technologies) or SDS-PAGE and transferred to nitrocellulose membranes. Fcimmunoreactive bands were visualized by incubating membranes with goat anti-mouse
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IgG HRP-conjugated antibody (1:5000 concentration; Life Technologies) followed by
SuperSignal Chemiluminescent substrate (Thermo-Fisher Scientific, Toronto, Ontario,
Canada). Bands were quantified by densitometry as described previously (26). Secretion
indexes were expressed as a ratio of stimulated to basal secretion, normalized to total
protein (22), and were used for statistical analysis.

3.2.4 Co-immunprecipitation of Chromogranin A complexes
To perform co-immunoprecipitation experiments, the Fc-construct transfected PC12 cells
were lysed in either a neutral or pH 5.5 buffer (20 mM sodium acetate, 0.1 M KCl, 1%
Triton X-100), cell debris was cleared by centrifugation (22,000x g for 10 min at 4°C),
and supernatant was taken for protein quantification. Protein concentration was
quantified using a colorimetric BCA assay (Thermo-Fisher), and results read out on a
multi-well plate reader (Bio-Rad). Immunoprecipitations were done for the Fc epitope
using Sepharose A beads (as described), using a total of 100 ug whole cell lysate, diluted
to a final volume of 1 mL (plus a protease inhibitor cocktail) to facilitate over-night
incubation (16 h, 4°C) on a tube rotator. The following morning, Sepharose beads were
pelleted (5,000x g, 30 sec), washed in the same ice-cold buffer used for
immunoprecipitation. The protein complexes were eluted by heating (70°C, 10 min) and
immediately chilled on ice. Samples were then immuno-blotted for CgA to detect
possible co-immunoprecipated complexes.

3.2.5 Immunofluorescence
Cells were processed for immunofluorescence as previously described (26). Slides were
incubated with antibodies against the secretory granule marker, chromogranin A (CgA)
(1:100; Abcam, Cambridge, MA, USA), or the synaptic-like microvesicle marker,
synaptophysin (1:250; Abcam). AlexaFluor488 IgG (Life Technologies) was used to
visualize the reporter, Fc, and AlexaFluor594 IgG for the CgA or synaptophysin antibody.
Coverslips were mounted using a ProLong Gold Anti-fade mounting medium (Life
Technologies).

3.2.6 Image Acquisition and Analysis
Immunofluorescence images were acquired using a Zeiss LSM 510 Duo Vario confocal
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microscope (Zeiss Canada Inc., Toronto, Ontario, Canada) and a 63x 1.4 NA PlanApochromat oil differential interference contrast objective lens using the Zen 2009
software (Zeiss Canada Inc.). Three cover slips per transfection were imaged for analysis.
Image analysis was conducted using FIJI version 1.46h (36), a distribution of ImageJ
(NIH, Bethesda, MD, USA), using the Co-localization 2 plug-in within FIJI. Regions of
interest were manually drawn around distinct single- or multi-cell bodies, positive for Fc
and either chromogranin A or synaptophysin. Co-localization of these pixels from each
pseudo-coloured image were used to calculate Pearson’s correlation coefficient, as
previously described (33). To generate a 3D rendering of the spatial localization of FcWT glucagon and Fc-Dipolar GLP-2, the Imaris software package (Bitplane AG, Zurich,
Switzerland) was used. The 3D voxel information was used to assign 0.25-0.30 μm
spheres to computed point sources of light in each channel. Only the co-localized spots
are shown, as determined by spatial overlap within a maximum distance of 0.30 μm.
Correlation coefficients from each experiment were treated as one experimental data set
(n=30-35).

3.2.7 Secondary Structure Predictions and Biophysical Property
Calculations
Secondary structure predictions (see Table 2) were carried out with the PSI-PRED
algorithm (version 3.1) (37). Percent helical content was calculated as the ratio of total αhelical residues to the peptide length. The corresponding pI was calculated using the
ExPASy bioinformatics portal (38) and the mean hydrophobic moment was calculated
using the method of Eisenberg et al. (39). Hydrophobic cluster analysis was carried out
by the method of Gaboriaud et al. (40).

3.2.8 Statistical Analyses
Differences were assessed using a one-way ANOVA with Tukey's HSD post-hoc test.
Statistical significance was accepted at the level of p<0.05, and the results are expressed
as the mean ± standard error. Statistical analyses were performed using GraphPad Prism
version 5.02 (GraphPad Software Inc, La Jolla, CA, USA).
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3.3 Results
3.3.1 Rationale for using PC12 as a model of hormone trafficking and
secretion
While in our previous publication we observed abundant localization of proglucagon in
secretory granules in Neuro2a cells (33), these cells did not respond to any secretagogue
(K+, Ba2+, dbcAMP, IBMX alone or in combination) in our hands. Since showing
regulated secretion of our fusion constructs was a necessary part of our study, we sought
another model of a cell type with a regulated secretory pathway. We avoided the use of α
or L cell lines so as not to confound our results with endogenous proglucagon and derived
peptides due to the multi-step nature of proglucagon processing. We chose the PC12
neuroendocrine cell line, because: 1) they have a very well-characterized regulated
secretory pathway; 2) they express CPE, which we have shown to be a sorting receptor
for proglucagon in α cells; and 3) they lack significant PC1/3 and PC2 activity, thus
allowing us to assay individual proglucagon-derived peptides for sorting independently of
processing. PC12 cells were used to characterize the sorting of multiple classes of
neuropeptides and hormones that agree with the mechanism in their native tissues,
including: proinsulin and pro-enkephalin (41), pro-BDNF (18, 42), pro-CART (25), proneurotensin (43) POMC (17), and pro-renin (44). In fact, the regulated secretory pathway
in PC12 cells better characterized than in either of the accepted models of proglucagon
processing, alphaTC1-6 and GLUTag cells, and they have many key proteins in common.
PC12 and alphaTC1-6 cells express chromogranin A, human α cells additionally express
chromogranin B, and secretogranins III (34, 45, 46), while L cells express CgB, and
secretogranins II, III and V (47), thus showing similarities in sorting machinery. The
exocytosis machinery is also similar, with both PC12 and alphaTC1-6 cells expressing
the SNARE proteins syntaxin-1a, VAMP2, SNAP25 (34, 48) and the SNARE-associated
proteins Munc13-1 and Munc18-1 (49, 50), while AP-1 and AP-3 are expressed by PC12
and mouse α cells (51). More recently, it has been shown that the GLUTag L cell model
also expresses SNAP25, VAMP-1, -2 and -3, syntaxin-1a and Munc18-1 (52). The
literature therefore strongly supports the use of the PC12 cell line as a model for the
sorting of proglucagon to the regulated secretory pathway in α and L cells.
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3.3.2 Glucagon contains an α-helix sorting signal
In order to identify sorting signals contained within glucagon, we transfected PC12 cells
with either Fc alone or the Fc-WT Glucagon fusion constructs described in Figure 2A.
Expression of fusion constructs was confirmed by Western blot (Figure 2B). First, we
determined the extent of regulated secretion of fusion proteins from PC12 cells using 55
mM K+ as a secretagogue. The KCl secretagogue causes depolarization of the plasma
membrane, triggering a rapid, calcium-dependent fusion of secretory granules with the
plasma membrane, resulting in exocytosis of granule cargo. A lack of response to
secretagogue stimulation (i.e., secretion index equal to unity) indicates constitutive
secretion, whereas a significantly elevated secretion index indicates the ability of
glucagon to direct Fc into secretory granules of the regulated secretory pathway (53).
Second, we examined the extent to which the Fc fusion proteins were sorted to secretory
granules by quantitative co-localization with the secretory granule marker, chromogranin
A (CgA). Taken together, these experiments specifically determined the nature of sorting
signals within glucagon that direct it to granules.
As expected, the fragment of the mouse IgG heavy chain, Fc, was secreted in a
constitutive manner as shown by the lack of K +-stimulated release, and a secretion index
of 1 (Figure 3A, B). In contrast, fusion of Fc to WT glucagon resulted in regulated
secretion, as indicated by a robust secretory response to 55 mM K + (Figure 3A) and a
secretion index that was significantly elevated (p<0.05) compared to Fc alone (Figure
3B). Therefore, WT glucagon contains a signal that is sufficient to sort Fc to granules. We
then investigated the structural nature of the sorting signal within glucagon by mutating
the α-helix (Fc-LP Glucagon) and the role of the R17R18 motif in sorting (Fc-RQ
Glucagon). The secretion of Fc-LP glucagon secretion did not increase upon secretagogue
stimulation (Figure 3B), and the secretion index was not significantly different from Fc
alone (Figure 3B). In contrast, Fc-RQ glucagon showed similar regulated secretion to
WT glucagon (Figure 3A), and significantly greater secretion index (p<0.05) compared
to Fc alone (Figure 3B). These results suggest that the α-helix within glucagon, and not
the dibasic site, may serve as a sorting signal to direct proglucagon into granules.
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To identify the subcellular distribution of the fusion proteins, we conducted
immunofluorescence confocal microscopy to visualize Fc immunoreactivity and the
extent of co-localization with the secretory granule marker, CgA. Co-localization was
quantified

as

the

fluorescence

intensity

co-variance

between

Fc

and CgA

immunofluorescence, using Pearson’s correlation coefficient (PCC), described previously
in (33). Fc alone had a para-nuclear staining pattern characteristic of Golgi localization
(arrowhead, Figure 3C). The corresponding measured fluorescence correlation of Fc and
CgA (Figure 3D) appears high, but likely reflects the fact that both Fc and CgA are cotrafficked through the Golgi under steady-state conditions, rather than localization of Fc
in granules. In contrast, Fc-WT glucagon expression was localized in CgA-positive
granules along the cell periphery and toward the tips of the cell processes (arrow, Figure
3C), a pattern that indicates localization in secretory granules (33). Pearson’s correlation
of Fc-WT glucagon with CgA was significantly greater than Fc alone (p<0.01; Figure
3D), thus demonstrating the sorting of Fc-WT glucagon to secretory granules. When the
α-helix of glucagon was disrupted in Fc-LP glucagon, Fc immunoreactivity was
predominantly localized to the Golgi, and the corresponding Pearson’s correlation was
not significantly different from Fc alone (Figure 3D). Lastly, Fc-RQ glucagon was
localized within CgA-positive secretory granules in a punctate pattern similar to that of
Fc-WT glucagon (arrow, Figure 3C). Pearson’s correlation of Fc-RQ glucagon with CgA
was significantly greater than Fc alone (p<0.001) (Figure 3D) and not significantly
different from Fc-WT glucagon. Taken together, our results indicate that the α-helix
within glucagon is a necessary and sufficient sorting signal, while the dibasic R17R18
motif is not required for sorting.
In order to show that the sorting of the Fc constructs is not an artifact of the cell type, we
repeated secretion and immunofluorescence experiments using Fc-WT glucagon in
alphaTC1-6 cells, a glucagon-secreting cell line (34). Fc-WT glucagon exhibited a similar
degree of stimulated secretion with 15 mM arginine (SI = 2.3 ± 0.1 vs 1.1 ± 0.2 for Fc
alone, p<0.01) to that seen in PC12 cells stimulated with 55 mM K+. Similar values were
also observed in alphaTC1-6 cells with the localization of Fc-WT glucagon in CgApositive granules (PCC = 0.80 ± 0.03 vs 0.51 ± 0.03 for Fc alone, p<0.001) as in PC12
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cells. As shown in Figure 2B, the level of expression of Fc-WT glucagon in alphaTC1-6
cells was within the range observed for PC12 cells. These results validate the use of PC12
cells and Fc-PGDP constructs to identify sorting signals in proglucagon.

3.3.3 GLP-1, but not GLP-2, efficiently targets Fc to secretory
granules
Since our previous work indicated that the processing of proglucagon to glicentin and
MPGF may precede entry into granules (33), we tested the possibility that proglucagon
may contain sorting signals within its other constituent peptides. Fc fusion proteins of the
glucagon-like peptides, GLP-1 and GLP-2, were constructed and expressed in PC12 cells.
Both GLP-1 (1-37) and GLP-1 (7-37) were included so as to test the role of the Nterminal 6 amino acids of full-length GLP-1. Both the Fc-GLP-1 (1-37) (p<0.001) and
Fc-GLP-1 (7-37) (p<0.001) exhibited robust K+-stimulated secretion compared to the
constitutively secreted Fc reporter (Figure 4A,B). Surprisingly, Fc-GLP-2 did not exhibit
regulated secretion (Fig 4A,B). Immunofluorescence microscopy showed that both forms
of Fc-GLP-1 directed Fc to granules, as evidenced by a punctate fluorescence pattern
along the cell periphery and toward the tips of cell processes (arrow and inset, Figure
4C). There was significant correlation between CgA and Fc fluorescence for Fc-GLP-1
(1-37) (p<0.001) and Fc-GLP-1 (7-37) (p<0.001) (Figure 4D) Fc-GLP-2 showed a
stronger para-nuclear localization, and interestingly, was also present in punctate vesicles
which appeared to be distinct from those that were immuno-positive for CgA (arrowhead
and inset, Figure 4C). There was no significant difference in co-localization with CgA
and Fc compared with Fc alone (Figure 4D), consistent with the lack of K+-stimulated
secretion. Therefore, our data suggest that GLP-1 (7-37) contains sufficient information
for granule sorting. However, GLP-2 is not sorted efficiently into dense-core secretory
granules, and may instead be routed to another vesicle compartment in PC12 cells.
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3.3.4 A dipolar α-helix GLP-2 mutant sorts to secretory granules
Since GLP-2 shares only 38% and 32% homology with glucagon and GLP-1,
respectively, it possible that the sequence context contributes to the differences in the
sorting of glucagon and GLP-1 compared with GLP-2. We therefore introduced point
mutations in GLP-2 that would mimic the charge distribution within the sequence of
glucagon by changing four acidic amino acids in the α-helix to basic lysines (see
Methods, Table 1), termed “Fc-Dipolar GLP-2” (Table 2). In contrast to Fc-GLP-2, FcDipolar GLP-2 showed a robust response to 55 mM K + (Figure 4A), and the secretion
index was similar to that of Fc-WT glucagon and significantly greater than Fc alone
(p<0.05) and Fc-GLP-2 (p<0.05) (Figure 4B). Immunofluorescence microscopy showed
that Fc-Dipolar GLP-2 was localized to CgA-positive granules (Figure 4C). The extent
of co-localization between Fc-Dipolar GLP-2 and CgA was significantly greater than Fc
alone (p<0.001) and WT GLP-2 (p<0.001) (Figure 4D). Therefore, altering the charge
distribution of the a-helix of GLP-2 was sufficient to direct Fc to secretory granules.
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Table 2. Biophysical Properties of Major Proglucagon Derived Peptides.
Fusion
Peptide

Peptide Sequence

1) Mutation
2) pI
3) Mean Hydropohic
Moment

Fc-WT HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
Glucagon
(72% α-helix content)

1) WT
2) 5.76
3) 0.55

Fc-LP HSQGTFTSDYSKYPDSRRAQDFVQWPMNT
Glucagon
(45% α-helix content)

1) L14P, L26P
2) 6.39
3) 0.47

Fc-RQ HSQGTFTSDYSKYLDSRQAQDFVQWLMNT
Glucagon
(72% α-helix content)

1) R18Q
2) 4.43
3) 0.58

Fc-GLP-1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
(7-37)
(68% α-helix content)

1) WT
2) 4.68
3) 0.69

Fc-GLP-2 HADGSFSDEMNTILDSLATRDFINWLIQTKITD

1) WT
2) 4.23
3) 0.66

(67% α-helix content)

Helical
Cluster
Projection
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FcDipolar
GLP-2

HAQGSFSKKMKTILKSLATRDFINWLIQTKITD
(67% α-helix content)

1) D3Q, D8K, E9K,
N11K, D15K
2) 10.46
3) 0.64

Amino acid sequences of the peptides used in this study are shown, with the wild-type or mutant
sequence indicated. Underlined portions of sequence correspond to α-helical content of the
peptides. Stars indicate proline (hydrophobic), diamonds indicate glycine (uncharged,
hydrophobic), open squares indicate threonine (uncharged, polar), and dotted squares indicate
serine (uncharged, polar). Enclosed amino acids represent hydrophobic patches.

3.3.5 Biophysical Properties of Glucagon, GLP-1 and GLP-2 αhelices determine sorting efficiency
Despite the fact that the amino acid sequences of glucagon, GLP-1(7-37) and GLP-2(133) are all highly conserved and contain a predominantly α-helical structure, our results
clearly show that the α-helix alone is not sufficient to target PGDPs to granules. We
determined the biophysical nature of the helices by calculating the hydrophobicity and
charge distribution for the helical portion of each peptide. The hydrophobic clusters
within wild-type glucagon (Table 2 & Figure 3) were disrupted within Fc-LP glucagon
and remained intact in Fc-RQ glucagon, indicating that the leucines are important in the
formation of larger hydrophobic clusters. Therefore, the signal within glucagon must
consist of an intact α-helix. We then conducted hydrophobic cluster analysis of glucagon,
GLP-1 and GLP-2, and did not observe any differences in either size or location of
hydrophobic clusters (Table 2) between these highly-conserved sequences (54). These αhelices are flanked by highly conserved N- and C-terminal tails, indicating that these αhelices are in a similar peptide context. The mean hydrophobic moments for the α-helix
regions of glucagon, GLP-1 and GLP-2 were similar, reflecting the degree of
amphiphilicity of these helices. However, there were significant differences in net charge
of the α-helices. The calculated pIs for the glucagon and GLP-1 α-helices were greater
than that of GLP-2 (Table 2), suggesting the net charge (electrical polarization), rather
than hydrophobicity, is a more important determinant of proglucagon sorting (Table 2).
Lastly, based on the charged amino acid distribution, glucagon and GLP-1 have a net
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polarization along the length of their helices, while GLP-2 has a more uniform negative
charge distribution. By introducing a dipolar mutation to GLP-2, the charge distribution
resembled that of glucagon/GLP-1, thus reconstructing a net polarization within GLP-2.
Our results demonstrate that efficient targeting of glucagon (Figure 3), GLP-1 (Figure 4)
and the GLP-2 dipolar mutant (Figure 4) to granules is determined by dipolar α-helices,
that contain distinct positive and negative patches to polarize the length of the helix are
sufficient to target glucagon and GLP-1 to secretory granules.

3.3.6 MPGF, but not glicentin, sorts to secretory granules
It has been documented that initial processing of proglucagon occurs at K70R71 early in
the secretory pathway (5), possibly in the Golgi, to yield glicentin and MPGF (Figure 1).
In this scenario, the processing of proglucagon to glicentin and MPGF may precede
sorting to granules. We therefore examined the sorting behavior of glicentin and MPGF,
with the hypothesis that processing at K70R71 would occur prior to sorting. Surprizingly,
however, secretion of Fc-Glicentin was not stimulated by 55 mM K + (Figure 5A) and its
secretion index was similar to Fc alone (Figure 5B), indicating that glicentin was not
sorted to the regulated secretory pathway. In contrast, secretion of Fc-MPGF was
significantly stimulated by 55 mM K + (p<0.001) (Figure 5A, B). These results were
corroborated by analyses of subcellular localization. In contrast, Fc-Glicentin showed
very little co-localization with CgA (arrow and inset, Figure 5C). Quantification of
Pearson's correlation coefficients showed Fc-MPGF had a significantly higher value than
Fc-Glicentin (p<0.01) and Fc alone (p<0.01) (Figure 5D). Therefore, our data
demonstrate that MPGF, but not glicentin, is sorted to granules, thus implying that
proglucagon must be sorted to granules prior to being cleaved to glicentin and MPGF.
This is an intriguing finding because both glicentin and MPGF contain sorting signals
(glucagon and GLP-1, respectively), yet they are sorted quite differently. These results
suggest that 1) the sorting signal within the sequence of GLP-1 is sufficient to direct
MPGF to secretory granules, and 2) the sorting signal within glucagon is masked by the
N-terminal GRPP (Figure 1).

3.3.7 Oxyntomodulin sorts to secretory granules
In order to determine if GRPP is masking the sorting signal within glucagon, we
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generated Fc-OXM (Figure 2). Secretion of Fc-OXM was significantly stimulated by 55
mM K+ (p<0.01) (Figure 5A, B), in contrast to Fc-Glicentin. Immunofluorescence
microscopy of Fc-OXM showed co-localization with CgA-positive granules (Figure 5C),
and quantification of Pearson's correlation coefficient showed that Fc-OXM had a
significantly greater value than Fc alone (p<0.01; Figure 5C, D). Therefore, the sorting
signal within glucagon is sufficient to direct oxyntomodulin to granules. These results are
consistent with the hypothesis that GRPP masks the glucagon sorting signal in the context
of glicentin (Figure 1), thus providing a mechanism by which glicentin is not sorted to
granules.

3.3.8 The Dipolar α-helix can bind to chromogranin A in a pH- and
calcium-dependent manner
Since CgA is the most abundant protein constituent of PC12 secretory granules, I tested
whether CgA could specifically bind the dipolar α-helix. To test for a specific reaction in
conditions that mimic the lumen of mature secretory granule, pH 5.5 and 10 mM calcium,
two sets of pull-downs were examined, for a total of four conditions. PC12 cells
transfected with a panel of Fc constructs were immunoprecipitated, using either a neutral
or pH 5.5 sodium acetate buffer, with or without 10 mM added calcium. The only
condition that could pull down CgA by immunoprecipitating for Fc, was the pH 5.5 and
10 mM Ca2+ condition (Figure 6). CgA was not pulled down using untransfected PC12
cell lysate, nor with Fc alone, or Fc-LP glucagon. In contrast, CgA bound most strongly
to Fc-WT glucagon, Fc-GLP-1 (7-37) and Fc-MPGF, with minimal detected binding to
Fc-WT GLP-2 and Fc-Glicentin. These results suggest a specific interaction between
CgA and the dipolar α-helix sorting signal.
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Figure 6. Identification of CgA as a sorting receptor. Immunoprecipitation for an Fcfusion protein, and immunoblot for CgA. Western blot image is from coimmunoprecipitation in a pH 5.5 sodium acetate buffer with 10 mM Ca2+. No coimmunoprecipitated complexes were detected under neutral pH, or without 10 mM Ca 2+
(total of 4 conditions tested). At right is a CgA immunoblot from 10 µg lysate of
untransfected PC12 cells. + symbol indicates relative quantity of immunoprecipitate.

3.4 Discussion
Highly efficient sorting of proglucagon is required for the maturation of the proglucagonderived peptides, and subsequent storage within secretory granules. Proglucagon is a
unique prohormone from the perspective of its structural organization. Several
prohormones, such as pro-thyrotropin-releasing hormone (pro-TRH) and progonadotropin-releasing hormone (pro-GnRH), have structured prodomains, while the
active hormone domain(s) are completely disordered (31). In contrast, proglucagon
exhibits disordered prodomains (GRPP, IP-1 and IP-2), with mostly ordered hormone
domains, as our previous work has shown (33). Additionally, the sequences of glucagon,
GLP-1 and GLP-2 are highly conserved with respect to their charge distribution (32).
With this information in hand, we wished to characterize how proglucagon is targeted for
regulated secretion by identifying the relevant sorting signals encoded within the ordered
hormone domains of proglucagon. We constructed fusion proteins linking each PGDP to
a reporter, Fc. Our results demonstrate that both glucagon and GLP-1 contain dipolar αhelices in which charged residues are distributed around hydrophobic patches, and that
these helices direct sorting to granules. In contrast, GLP-2, which contains an α-helix that
is not polarized, is very inefficiently sorted. Surprisingly, the sorting of glicentin, which
contains the sequence of glucagon and therefore the identified dipolar α-helix, was
inefficient, while MPGF maintained its sorting efficiency. Oxyntomodulin was sorted
efficiently to secretory granules, thus demonstrating that the N-terminal sequence of
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glicentin masked the sorting signal contained within the α-helix of glucagon. We
conclude that proglucagon contains two sufficient sorting signals contained within the
sequences of glucagon and GLP-1, in the form of a dipolar α-helix, and that the α-helix of
glucagon is masked after proglucagon is processed to glicentin.
In our previous studies of proglucagon trafficking using Neuro2a cells, our index of
sorting efficiency was the co-localization between proglucagon and the cis/medial-Golgi
marker, p115 (33). The high correlation value of R18Q-proglucagon led us to conclude
that the dibasic R17R18 sequence within glucagon could contribute to sorting. In the
present study, we calculated co-localization of the Fc constructs with the granule-resident
protein CgA. Here, a high correlation reflected more efficient co-localization in granules,
indicating that the R17R18 sequence may not be a factor in the sorting of proglucagon to
granules, or that it may be cell type-specific. However, it is important to note that the
sorting of the α-helix mutant of glucagon was calculated to be inefficient in both systems,
indicating that the α-helix within glucagon is a primary sorting signal for proglucagon
regardless of the cell type.
Previously identified α-helical sorting signals indicates that their amphipathic nature
directs sorting of prohormones and their processing enzymes to the regulated secretory
pathway. Prohormones containing granule-targeting amphipathic helices include prosomatostatin (24) and pro-CART (25). The sorting signals of the prohormone processing
enzymes PC1/3 (53, 55), PC2 (56), and CPE (57) are also amphipathic α-helices. Our
previous work showed that reducing the α-helical content within glucagon reduced
proglucagon sorting efficiency in Neuro2a cells (33). We now show that proglucagon
contains two sorting signals in the form of non-amphipathic α-helices with a unique
arrangement of hydrophobic patches and charged residues. Dikeakos et al. addressed
sorting determinants by using synthetic α-helices, finding that the tested amphipathic
helices with a charged face, or a non-amphipathic helix with a substantial hydrophobic
patch and segregated charged residues, were efficiently sorted to granules (27). They
inferred two important features of helical sorting signals: segregation of charged residues
from hydrophobic patches is essential; and the degree of hydrophobicity correlates well

111
with sorting efficiency. While synthetic α-helices were sorted with as few as 5 charged
residues (27), our data showed that as few as three charged residues within the sequences
of glucagon and GLP-1 can direct sorting. The pIs of the helices within glucagon and
GLP-1 are more similar than GLP-2 to the granule lumen environment (pH 5.5), possibly
aiding their targeting to granules. Our hydrophobic cluster analyses show a dipolar charge
distribution segregated from hydrophobic patches within glucagon and GLP-1, which
were able to sort to granules. In contrast, the helix within GLP-2 has slightly different
characteristics; while the nature of the hydrophobic patches are identical to those in
glucagon and GLP-1, the charge distribution is not dipolar, consisting of only negatively
charged residues along the helix. This difference resulted in very inefficient sorting,
suggesting that charge distribution is more important than hydrophobicity for the nonamphipathic α-helices of proglucagon. We may now estimate the minimal hydrophobic
domain required for sorting, in which a large, contiguous hydrophobic face (27), can be
reduced to two dis-contiguous patches of 3 to 4 residues on opposing faces of the helix.
This inference is supported by the recent finding that the pro-CART helix contains a
smaller hydrophobic face relative to synthetic helices (25). This underscores the
importance of the α-helix as a platform for sorting signal construction in general, and in
proglucagon, the sorting information is encoded by the dipolar distribution of electric
charge in relation to hydrophobic patches along the helix surface.
The differences in sorting efficiency between glicentin and MPGF suggest a contextdependent regulation of sorting when considering that glicentin does not efficiently sort
to granules, despite containing a sorting signal within the sequence of glucagon. After
proglucagon is initially processed at the inter-domain cleavage site, K70R71, glucagon is
flanked by the sequences of GRPP and IP-1 (Figure 1). We used the PSI-PRED server
(37) to analyze the predicted secondary structure of glicentin, and it revealed that IP-1 is
disordered when not joining glucagon to GLP-1, a characteristic of omega loops (58).
The N-terminal GRPP domain is also highly disordered, and enriched in acidic residues.
Our previous model of proglucagon shows this disordered region masks the basic Nterminal residues of the glucagon helix (33), and the present study confirms this masking
by showing that removal of the GRPP domain results in the targeting of Fc to granules.
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Conformational masking has been demonstrated in moesin, in which an α-helical domain
regulates the degree of unmasking between its N- and C-terminal ligand-binding domains
(59); and in the prohormone protachykinin, in which the negatively charged pro-region
masks the positively charged product, calcitonin gene related peptide (60). We now show
that glicentin experiences a similar conformational masking by GRPP. On the other hand,
MPGF experiences no such masking since IP-2, which links the helices of GLP-1 to
GLP-2, appears to be partially helical (5, 33), thus maintaining the availability of the
GLP-1 helix for efficient targeting to granules.

Figure 7. Schematic representation of proglucagon sorting and processing in α and L
cells. Proglucagon (red bars) is synthesized in the ER and transported through the Golgi
to the trans-Golgi network (TGN). Our data support the hypothesis that proglucagon is
first sorted to immature secretory granules (ISGs) via dipolar a-helices within glucagon
and GLP-1, and then cleaved to glicentin and MPGF (squares), possibly by furin. Within
mature secretory granules (SGs), the prohormone processing enzyme PC2 processes
glicentin to glucagon in α cells, while PC1/3 cleaves glicentin and MPGF to yield
oxyntomodulin, GLP-1 (7-37) and GLP-2 in L cells.
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This asymmetry between glicentin and MPGF trafficking presents interesting
implications for the temporal relationship between proglucagon processing and sorting. It
is well documented that proglucagon processing begins with the early cleavage event at
the interdomain site, K70R71 (5, 9); in alphaTC1-6 cells, glicentin and MPGF were
detected at 30-45 min via a pulse-chase paradigm (4). Our previous work has shown that
mutation of K70R71 reduced the efficiency of proglucagon sorting in Neuro2a cells (33),
and this result led us to conclude that processing may occur before sorting. However, the
present study does not support this conclusion. If proglucagon processing occurs prior to
sorting, our present model would predict that glicentin would be sorted inefficiently,
which would impact the production of glucagon in α cells. Therefore, we now propose
that the K70R71 site simply acts as another sorting signal, and together with the α-helices
of glucagon and GLP-1, targets intact proglucagon to granules, whereupon processing to
glicentin and MPGF occurs, as illustrated in Figure 7. Our model also suggests that the
two α-helical sorting signals are functionally redundant, perhaps reflecting an
evolutionary selection towards a high sorting efficiency for proglucagon. That the
sequences of glucagon and GLP-1 are highly conserved (32) lends evidence to this
reasoning. This is in contrast to pro-TRH, where PC1/3-mediated processing early in the
secretory pathway is required for efficient sorting to distinct sub-populations of granules
(61, 62).
Identification of sorting signals within proglucagon gives rise to the question of potential
binding partners, or sorting receptors. While the results of Chapter 2 indicated a role for
CPE in α cells, I also tested the possibility that CgA could act as a receptor because it is
the most abundant soluble granule protein in both α and PC12 cells. CgA could only be
co-immunoprecipitated using Fc-constructs at mildly acidic and millimolar calcium
conditions that mimic the mature granule chemical environment, and that the interaction
was specific to the dipolar α-helix and the quantity of complex that was pulled down
correlated well with co-localization analyses. Therefore it is promising that CgA may be a
sorting receptor for glucagon in α cells. The absence of the processing enzymes PC1/3
and PC2 from PC12 cells supports our previous findings (33) that neither enzyme plays a
role in the sorting of full-length proglucagon. The amphipathic α-helices identified within
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prohormone processing enzymes, PC1/3 (26, 63), PC2 (56), and CPE (16), are known to
associate with the cholesterol-rich domains of granule membranes. However, we could
not demonstrate binding of purified proglucagon to liposomes (data not shown), and
therefore hypothesize that proglucagon may bind to granule proteins. It is possible that
granins bind prohormones, such as POMC (64). We have some evidence that
proglucagon sorting involves interaction with CPE in α cells (33). Studies investigating
the roles of other granin proteins in sorting proglucagon are currently underway.
In conclusion, we have shown that proglucagon contains two dipolar non-amphipathic αhelices with relatively small hydrophobic faces that act as sorting signals for entry into
secretory granules of endocrine cells. Our data support a mechanism by which
proglucagon is sorted to granules prior to the initial cleavage event that results in the
production of glicentin and MPGF (Figure 7). That these sorting domains lie within the
ordered domains of encoded proglucagon-derived peptides, and not in a disordered
prodomain that characterizes many other prohormones, highlights the unique sorting
“signature” of proglucagon, and further emphasizes the disparate nature of sorting signals
that lie within prohormones and other proteins destined for the secretory granules of the
regulated secretory pathway.
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Chapter 4
Practical Co-localization
Fluorescence Microscopy

Analysis

for

Quantitative

Statement of Author Contribution
This review is wholly the work of Mr. Guizzetti.

4.1 Introduction
In the previous two chapters, I have used quantitative fluorescence microscopy to
objectively examine the sub-cellular trafficking of proglucagon in situ. The conclusions
of these chapters have heavily relied upon co-localization analyses of these images to
draw conclusions about the varying degrees of sorting efficiency along the secretory
pathway. Image quantification allows the researcher to extract quantifiable data,
sometimes from biologically variable samples or using limited image data, that can be
then be used for hypothesis testing to reach accurate and precise conclusions.
Increasingly more cell biology studies are using quantitative fluorescence microscopy
techniques to examine the function and the associations between two labelled molecules
within specific intracellular compartments, most often proteins. Co-localization analysis
remains the most common image analysis tool for confocal immunofluorescence
microscopy in cell biology research. While super-resolution studies are still less common
than those using the more accessible confocal microscope, it is useful to discuss the
practical application and interpretation of co-localization in diffraction-limited image
sets. Despite the literature already devoted to the use of co-localization, there are still new
studies published that claim to analyze co-localization, or fail to make any analysis and
instead switch a qualitative descriptions, and in general, these studies are not rigorous in
their analytic methodology. To complicate matters, researchers will sometimes alternate
between their intended meaning of the word “co-localization.” The usage changes from
qualitative descriptions of overlapping/coincident fluorescence signals, or if calculating a
co-localization, still choose to use statistics that are less than ideal for the application, or
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considered for the structures that need to be resolved for protein localization and
intracellular trafficking.
In order to convert from analog light into a digital image, a fundamental hardware
component is the photomultiplier, converting the incident photons into a digital signal. As
an image is acquired, the laser beam is raster scanned or swept across the sample, and the
emitted light is collected, amplified by the photomultiplier, converted to a digital signal
and is registered as a single pixel. Therefore, each complete image is formed by the
sequential acquisition of each pixel. It is good practice while doing optical imaging to
increase SNR by monitoring the live exposure histogram of an acquired image in realtime. By adjusting emitted light intensity (e.g., by increasing laser power, electronic gain,
pinhole aperture), the PMT will detect more incident photons, translating to a greater
discrete pixel intensity and utilizing as much of the image dynamic range as possible.
This permits more accurate and precise quantification because the collected image data
will better represent the specimen. Care should be taken such that no pixels are oversaturated due to over-exposure, as this will lose higher intensity pixel information.
Conversely, the minimum pixel intensity should be just above the adjusted black value of
the PMT, to ensure the emitted photons are properly represented. The quality of downstream image processing is only as good as the final image produced by the entire digital
microscope system, and digital images are more sensitive to imperfections than compared
to what our eyes perceive.
Image processing are “off-line” techniques used to correct for some deficit in the
collected images. These techniques may improve image SNR by removing background
(segmentation), filtering out noise, or using deconvolution. Some techniques can be to
reduce size or dimensionality of the data, such as drawing regions-of-interest, or making
3D projection images, while others can be to interpolate new information such as 3D
volume rendering and reconstruction. This is not an exhaustive list, but gives the reader
ideas of some image processing techniques. The researcher should be aware that raw
images are data, and must be treated as such. When performing any image processing
technique, it is essential that they be made on duplicates of the original images so that the
raw data can always be accessed, and it necessitates the creation of a digital backup. Any

121
of the techniques performed must also be stated in the publication's methods section for
transparency and reproducibility.
There are also some practical tips to keep in mind in how computers represent the
intensity of each pixel. A pixel is represented by a computer as a number of bits (usually
8-, 12- or 16-bits), called a bit-depth. The bit-depth represents the range of possible
values that a pixel can have. For example, an 8-bit image can take 2 8 possible values (256
shades of grey), and is the dynamic range of all pixel values in image. When working
with digital images, the bit-depth must never be reduced or truncated. Doing so
compresses the dynamic range of the image, and “clips”/truncates the high intensity pixel
data. This high-intensity detail is likely to contain the signal-of-interest, and would
represent a degradation of image and data quality. As a practical example, a 16-bit image
(65,536 levels of grey) contains pixel intensities in the range of 10-40,000, and when
converted to 8-bit, clips all pixels at or above 256 to the same intensity, resulting in a
severe loss of image detail and apparent over-saturation of the clipped 8-bit image.
Similarly, histogram compression results in a altered image contrast between pixels.
Acquired images are often converted to tagged-image file format (TIFF) files for analysis
because all pixel information is maintained in its raw state and does not allow for “lossy”
compression schemes, unlike JPG and other formats, that discard information to produce
a smaller image file. Image processing should be done on the raw image data so that the
researcher is assured the results are representative of the image, and not an artifact of the
image file format. Several commercial and free software packages conduct image
conversion and analysis. The techniques that are applied to one image (of one image
channel) must be applied to all image channels for consistency of data quality. This is
important for conducting co-localization studies, which require two (or more) image
channels.

4.2

Quantitative
localization

Multi-Channel

Image

Analysis

and

Co-

For consistency, it will be useful to first define what is meant by co-localization, and
what it can tell the user regarding their species of interest (usually proteins). Ideally, the
researcher wants an image analysis tool that can determine whether two proteins are
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physically interacting with each other, and would turn to co-localization as a quantitative
measure of interaction. However, diffraction-limited microscopy does not offer sufficient
resolution to quantify such a physical interaction due to the nature of image acquisition.
Instead, suitable microscopy techniques to validate inter-molecular interaction must
utilize the physical phenomenon of Förster resonance energy transfer (FRET) (detecting
interaction with spatial resolution of <10 nm), or bimolecular fluorescence
complementation

(BiFC)

(producing

an

active

fluorophore

upon

protein

complementation) (for reviews see (1, 2)). Additionally, the increasing adoption of superresolution microscopy is better suited for the quantification of the percent of interacting
proteins. The much greater spatial resolution affords the development of new algorithms
and more sophisticated tests of interaction, such as object-based or proximity-based
methods (3–6), or adopting techniques from statistical physics to account for several
proteins of interest, for example (7).
Co-localization can report on the degree of spatial co-distribution. Quantitative colocalization accounts for two components: simple overlap (sometimes called cooccurrence), and the tendency to co-distribute (or co-segregate). Therefore, fluorescence
co-localization is best suited for determining the tendency to associate with the same
cellular or molecular structure, as opposed to measuring the association of freely
diffusing and interacting molecules. Simple overlap alone is insufficient to determine colocalization, and various overlap coefficients have been used as the basis for evaluating
co-localization. Worse yet, “judging by eye,” for the degree of yellow signal when red
and green signals overlap, is highly subjective and offers meaningless interpretation. This
can best be demonstrated by the optical illusion in which the perceived colour contrast of
one colour varies within the context of its background, in other words, seeing colours that
are really not there (e.g., Munker illusion 1) (8). Incorporation of spatial association adds
robustness to the co-localization methods, in that two (or more) bodies that are colocalized should be observed in the same location and should have concordant spatial
locations. In studies of intracellular trafficking of cargo proteins, the most common
approach is to fluorescently label one cellular compartment, such as the cis- or trans1

This optical illusion can be generated using FIJI by going to File > Open Samples > Spirals, and
observing that the blue and green spirals are actually the same colour.
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Golgi (e.g., (9–11)), or specific vesicular compartments, such as secretory granules (e.g.,
(10, 12, 13)), or lysosomal/endosomal compartment (e.g., (14–16)). In the context of
examining protein intracellular trafficking through the secretory pathway, accurate
quantification can be used to examine steady-state distribution of protein localization
when compared to transient co-localization in the Golgi, or it can be used to assess
efficiency of storage within a terminal destination within secretory granules. Live cell
imaging can also extend this analysis to reveal kinetics of movement through distinct
sub-cellular compartments, a question that is increasingly more relevant with confocal
microscopy

(17)

and

super-resolution

imaging

(14). Accurate

co-localization

quantification can lead to new insights for cell biological processes, such as the
preference to secrete insulin from younger granules of pancreatic beta-cells (17).
However, it is not justified by co-localization alone that just because two proteins exist in
the same compartment that they should necessarily be interacting, just as it is
unreasonable to expect that co-localization can always quantify the stoichiometric ratios
of interacting proteins. It is important to understand the capabilities and limitations of
such quantification techniques.
Here I present a framework for conducting a quantitative co-localization study to measure
protein co-localization and intracellular trafficking. To better inform the user on how to
interpret various commonly used correlation parameters, I have generated simulated
image sets containing point source objects, in order to provide a cell-free context for
understanding parameter interpretation and evaluating their performance. The simulated
image sets are also useful to control the statistical distribution of pixel intensity and
spatial location. I will make several assumptions about the reader in order facilitate the
discussion. Firstly, the reader should be familiar with good confocal imaging practices (a
good primer on common pitfalls in confocal microscopy is found at ((18))). Images are
captured in which the “signal” is well above the “background” and “noise” due to cellular
and substrate auto-fluorescence (e.g., ((19, 20))), controlling uneven illumination (e.g.,
(21)), and the fluorophores are sufficiently separated in their excitation/emission spectra
to prevent fluorophore cross-talk and bleed-through. Furthermore, image sets must be
acquired in uncompressed image formats. A good review on the digital aspects of image
files and microscopy can be found by (22).
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Both commercial (e.g., Imaris, Image Pro, Axiovision, Colocalizer Pro) and free software
packages (e.g., FIJI/ImageJ) that measure co-localization include several different
algorithms from which the user is expected to know the correct method to use. Especially
in earlier co-localization studies, researchers often presented several computed
measurements alongside their immunofluorescence images, not deciding on a single
“best” algorithm for their data. Ideally, the choice of co-localization parameter should be
an objective measurement of true co-localization of 2 (or more) labelled molecules. The
co-localization statistics should be 1) sensitive to the effect of one molecule codistributing with the other; 2) insensitive to background noise; 3) insensitive to relative
changes in fluorescence intensity channels (e.g., scale independent); and because no two
cells are alike, 4) the statistics should be insensitive to changes in overall cell
morphology, such that they are shape independent. I will discuss these four points to help
interpret the multitude of co-localization measurements.

4.2.1 Mathematical parameters used for co-localization analyses
This section discusses the parameters used for quantitative co-localization and their
mathematical definitions. The most commonly used parameters for these studies are
Manders' overlap coefficient and Pearson's correlation coefficient, and some less
common correlation parameters (listed in Table 1). If the reader is familiar with the
mathematical definitions of the parameters, they can skip ahead to the next section for a
discussion of the merits of these parameters.
Table 1. Mathematical parameters used for quantitative co-localization analyses.
Coefficient Name

Measured quantity

Equation

Ref.

Overlap

Simple overlap

1

(23)

Manders' overlap (MOC)

Intensity-weighted Overlap

2,3

(23, 24)

Pearson's correlation (PCC)

Correlation between channel
intensity

4,5

(25)

Spearman's rank-correlation
(SRC)

Rank-ordered correlation
between channel intensity

4

(26)

Kendall's tau

Rank-ordered correlation
between channel intensity

6,7

(27, 28)
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reports the degree of similarity between two images conditioned on the assumption that
they are independent. The possible advantage to using Kendall's tau over Spearman's
rank-correlation coefficient is that Kendall's tau correlation can be assumed normal in
real applications under the null hypothesis that all possible rank-ordered pairs occur with
equal likelihood (27). Since Kendall's tau calculation of rank-pairs is exhaustive, the
complete distribution can be quickly calculated (27), using a computer to verify the
Normality assumption, allowing the computation of approximate confidence intervals.
These qualities make it a strong candidate to consider alongside more accepted
parameters of co-localization for co-localization analysis, and should also be applicable
in super-resolution image studies.
The original version of this test are based on interpretation of scatter plots in the intensity
correlation analysis (ICA) (30, 31). The ICA method is based on the underlying
assumption that pixel intensity in one image is symmetrically distributed (not necessarily
from a Normal distribution), such that, for an image which as random (or mixed)
staining, the sum of mean differences is zero ( ∑ Si −Sav ≃ 0 ). By extension, the two
channel version assumes that the joint probability distribution of pixel pairs is also
symmetrically distributed, such that

∑ ( S 1,i−S1, av )⋅( S2,i −S 2,av ) ≃0 .

When individual

pixel intensities are plotted against the product ( S1, i −S 1,av )⋅( S 2,i−S 2,av ) , a scatter plot is
produced, that can be visually examined to judge correlation of immunostaining. A scatter
plot that is biased to the right of vertical line at ( S1,i −S 1, av )⋅( S 2,i−S 2, av )=0 is interpreted
as correlation, while a scatter plot mainly along this vertical line represents independent
staining, and a bias to the left represents segregation. However, because this
interpretation is subjective, a it required the computation of Li's intensity correlation
quotient (ICQ), in order to allow for a hypothesis testing using the sign-test.

ICQ=

∑ [ ( S 1,i−S 2,av )⋅( S 2,i−S2, av ) ] >0
−0 . 5 ;ICQ∈ [−0 . 5,0. 5 ]
∑ ( S 1,i−S2, av )⋅( S2,i −S2,av )

(Equation 8)

The ICQ computes the sum of the product of concordant pixels (e.g., those that
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correlate), over the sum of all products of pixel pairs (e.g. those that correlation and those
that don't). In a sense, Li's ICQ is a binary correlation, and just as the other parameters
presented here, does not measure co-localization. The subtraction of 0.5 is to centre the
range about zero, with ICQ values less than zero representing segregation, and greater
than zero representing correlation, and thus co-localization. At present, Li's ICQ is only
implemented in FIJI.

4.3 Methods
Several parameters have been proposed to measure co-localization, the two most
common of which are Pearson's correlation coefficient (Table 1, Eq. 4,5) and Manders'
overlap coefficient (Table 1, Eq. 2,3) for quantitative fluorescence microscopy, as
determined by PubMed searches reporting co-localization. For reasons detailed below,
this review is focused on the PCC, and less common but potentially useful rank-based
parameters – SRC, Kendall's tau and Li's ICQ. In the interest of practising quantitative
co-localization, I recommend against using the overlap and Manders' coefficients (Table
1, Eq. 1-3). The overlap coefficient makes no attempt to normalize the channel
intensities, and is simply too sensitive to variations in noise, relative channel fluorescence
intensity, and channel mean to be of any practical use (32). Therefore it is equivalent to
creating a simple overlap, and the researcher is left to “measure by eye.” Similarly,
inspection of the Manders' overlap coefficient formulation, and experimental results from
Adler agree that it is best "to abandon the MOC and the related k1 and k2 pair of
coefficients" (32) in favour of Pearson's correlation and rank/sign-based correlations or
another of the parameters discussed herein. Their findings are also in agreement with the
findings of others (11, 33) and the authors' experience, with real and simulated data
showing poor performance with the MOC and complete insensitivity to the degree of
correlation. For these reasons, MOC will not be considered further here, in favour of
more robust parameters. The inclusion of Li's ICQ and the rank-based correlation
coefficients, SRC and Kendall's tau, are interesting but have not been considered
extensively in the literature. Li's ICQ (Eq. 8) was first introduced a decade ago, and
reduces the parameter to a binary comparison of pixel values. It has the potential to be as
robust as the PCC to noise, background and differences in relative channel intensity.
Similarly, the SRC and Kendall's tau are rank-based, and those may also offer similar
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advantages. These three parameters, along with the classic PCC and Costes' automated
threshold version of PCC (34) are compared in detail.

4.3.1 Image simulations and Co-localization Analysis
Simulated greyscale images were generated using a custom written script in the Python
programming language (Python Software Foundation. Python Language Reference,
version 3.2. http://www.python.org) using the Python Image Library (Pillow, version 2.5;
http://github.com/python-pillow/Pillow). Each image set contains a pair of pseudocoloured images to represent two fluorescence acquisition channels. All simulations
contained randomly located point objects, which were subsequently convolved with a
Gaussian kernel, to simulate the effect of point-spread function blurring of confocal
microscopy image formation. To control for the percent of object co-localization, both
simulated image channels shared a subset of the randomly generated objects for partial
co-localization, or the same set of objects for perfect co-localization. Objects with 0% colocalization (segregated objects), had unique sets of random object locations. To simulate
image noise, randomly generated Gaussian values were subsequently added to image
sets. The ratio of mean object intensity to mean background noise was held constant to
maintain signal-to-noise. For display purposes, the generated grey-scale images were then
pseudo-coloured, for display purposes. Simulations were performed for 1,000 repetitions,
and the calculated parameter values were averaged. Co-localization was measured using
the Coloc 2 plugin of the FIJI/ImageJ software package (http://fiji.sc/) (35), and verified
using a custom written Python script for selected co-localization statistics. Calculated
correlation values for co-localization were averaged over all simulations and are
presented as the mean value, and analyzed using the R software package (version 3.1;
http://www.r-project.org/).

4.3.2 Image Acquisition of Multifluorescent Beads and Chromatic
Aberration Calibration
Multi-fluorescent beads (Thermo-Fisher) 5.0 µm in diameter were imaged using a Zeiss
LSM 510 laser-scanning confocal microscopy under 60x objective magnification.
Microscopy was performed at the Biotron imaging facility at the University of Western
Ontario. Images were imported into FIJI for measurement of each colour channel's x- and
y-axial line profile. Overlay of red, green and blue line profiles show that the microscope
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is calibrated for lateral chromatic alignment, and no chromatic defect is observed.

4.4 Results
4.4.1 Chromatic calibration of the microscope
Before collecting any images for co-localization analysis, the confocal microscope must
be chromatically calibrated. Improper calibration leads to colour fringing artifacts and
will already degrade the detection ability of co-localization from a systematic bias, most
especially pronounced when trying to analyze punctate structures that correspond to
secretory granules (as is commonly done). The easiest method is to use multi-fluorescent
beads, which are both inexpensive and commercially available. (Core imaging facilities
may even have these beads readily available for this purpose.) The fluorescent coatings of
the beads are chosen to be compatible with the most common filter sets used in
immunofluorescence imaging, typically blue (e.g., DAPI), green (e.g., FITC,
AlexaFluor488), orange (e.g., Cy3, TRITC) and red (e.g., Cy5, AlexaFluor647). Using
the same light path that will be used for capturing immunofluorescence images, acquire a
few images of fluorescent beads in each channel that will be used for imaging. By
drawing a line profile through the beads for each of the x- and y-axes, and then
overlaying the profiles, any offset of the bead centre/edges can be measured, as in Figure
1. Ideally, this pinhole alignment need only be done once prior to beginning image
acquisition on sample specimens. If there is an offset (in any direction) and images have
already been acquired using the uncalibrated microscope, proper alignment can be
restored by digitally translating one channel with respect to another, restoring alignment
post-acquisition. In reality, there will always be some residual optical aberration left in
the system, but chromatic and optical alignment is necessary to properly detect colocalization.
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channel against the other channel. These graphs can be viewed during real-time
acquisition in some commercial packages (e.g., those offered by Zeiss or Leica) or postacquisition in many software packages (e.g., FIJI). In this scatter plot, each data point is
made up of spatially matched pixel intensity values, one from each image. Essentially, a
cytofluorogram represents a 2D histogram of pixel matched values across the image set,
with a variation of this to also show the intensity or height of each intensity pair as a heat
map. If the researcher uses Pearson's correlation coefficient, it is exactly equal to the
slope of the regression line through the cytofluorogram. Assessment of image data in this
graph is superior to examining a simple overlay, because the user can immediately see the
quality of image data, how much of the signal is not correlated or contains noise, and an
initial assessment of co-localization.
Let's consider three conditions of overlap in Figure 2. First, a set of simulated objects
that (by design) perfectly overlap and co-distribution (Figure 2A). Evaluating this
cytofluorogram of perfect co-localization (Figure 2A'), I expect every yellow pixel to
coincide with a magenta pixel, and their pixel intensity changes concordant with each
other. As expected, all calculated parameters of co-localization, shown in Table 2, agree
with the theoretical maximum value. Partial co-localization of simulated objects was
achieved by translating the objects in one image by 1 pixel in both the x- and y-directions
(Figure 2B). This results in a partial overlap of all objects, but should otherwise still be
considered co-localized. It is instructive to notice that this scenario is also representative
of uncorrected chromatic aberration, in which colour fringing effects will degrade
correlation values. The cytofluorogram (Figure 2B') still shows positive correlation,
indicating co-localization, albeit with added noise contributed by the non-overlapping
regions. The corresponding correlation parameters in Table 2 all show good agreement
with the perfect co-localization case, reflecting the notion of very good, but imperfect,
co-localization.
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Table 2. Performance of selected co-localization parameters under differing conditions of
true co-localization and segregation.
Condition
PCC
PCC (with SRC
Kendall's Li's ICQ
threshold)
tau
Theoretical range

[-1,+1]
*

[-1,+1]
*

[-1,+1]
*

[-1,+1]
*

[-0.5,+0.5]

Perfect colocalization

1

1

1

1

0.5*

Partial colocalization
(1 px shift)

0.88

0.85

0.93

0.88

0.46

Minor co-localization 0.61
(2 px shift)

0.52

0.85

0.76

0.42

Perfect segregation -5.0·10-2 -7.6·10-4
-0.23
-0.21
0.32
Note: These values correspond to images shown in Figure 2. Values are presented as the
mean over n=1,000 simulations. * values are presented as exact, and conform with their
respective theoretical maximum.

Lastly, I consider perfectly segregated objects (Figure 2C). The exact same distribution
of point objects have been horizontally translated so as to not overlap at all, and the
cytofluorogram shows all magenta and yellow objects clustered along the axes (Figure
2C'). The slope of the regression line is -0.05 (approximately equal to 0), indicating good
agreement with object segregation. With respect to the PCC, these values are
approximately equal to 0, though in both conditions of partial co-localization and
segregation, the un-thresholded Pearson's value over-estimates the degree of correlation.
Also some authors have misinterpreted the Pearson's formula concerning perfect
segregation as yielding a value of -1. However, the proper interpretation for no
association (perfect segregation) would be a value of 0, indicating no linear codependence, while a value of -1 represents perfectly negatively correlated data. It is very
rare for immunofluorescence images to contain truly negatively correlated labelled
molecules, and therefore negative Pearson's correlation values much below 0 should be
inspected more closely as it may be symptomatic of imaging artifacts (such as uneven
illumination). In real immunofluorescence images, the “lobes” that extend along the axes
of the cytofluorogram represent uncorrelated background signal (i.e., noise and autofluorescence). Lastly, Li's intensity correlation quotient (ICQ) (Table 1, Eq. 8) performed
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the poorest of these parameters to distinguish co-localized from segregated objects, given
its theoretical range is -0.5 to 0.5. While the intuition behind the ICQ is easy to
comprehend, using this parameter may result in inefficient detection of co-localization
differences, consistent with the findings of (32, 36). In the case of even less colocalization (Table 1), but not complete segregation, the values continue to trend toward
no association, with the rank-based methods (Spearman's, Kendall's tau) maintaining
power to detect co-localization from small offsets. Overall, the correlation parameters of
Pearson, Spearman and Kendall preserve much of their dynamic range for quantification
of co-localization.

4.4.3 Li's ICQ is insensitive to known co-localization
Previous attempts to estimate sensitivity of a co-localization parameter to various
“ground truth” degrees of co-localization fixed the percent of co-localized point objects
(23, 31). However, the observed effects are exaggerated when these tests are arranged as
a regular grid for MOC, SRC and PCC, because they are susceptible to slight changes on
a change of a few co-localized objects. To produce a more robust estimate when the set
of co-localized objects is fixed (“ground truth”), point objects were randomly generated
as in Figure 2, to remove any effect of objects arranged in a grid, while accounting for a
small amount of random overlap, representing spurious co-localization. For this set of
simulations, a fixed percentage of object co-localization was imposed, ranging from 0%
to 100% (Figure 3). Li's ICQ displays the least sensitivity to co-localization, and at 0%
object co-localization, yields a value slightly higher than reported in Table 1 (0.37 vs
0.32). This difference is not due to the number of objects (both have 200 random objects),
but is instead showing that when a group of objects is random dispersed in the same
image area (as in Figure 3), there may be minimal spurious overlapping, increasing the
parameter value, but when objects are segregated in the image, the parameter is a little
more sensitive to this separation.
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Figure 3. Effect of object overlap on the measured correlation coefficients without
background noise. 200 random point objects were generated, and Gaussian blurred to
simulate optical blurring by the microscope's point-spread function. A predefined
percentage of object overlap (from 0-100%) was imposed, such that "ground truth" object
co-localization was fixed. For each level of object co-localization, 1,000 simulations were
run, and the mean parameter values plotted. Connecting lines are shown as an aid for the
eye.

4.4.4 Background and noise
Image background is from the specimen caused by several factors, the most common of
which is auto-fluorescence (from cells or substrate coatings), mounting medium, the
choice of glass, and other sources that uniformly offset (or add to) pixel intensity. Prior to
the imaging session, the photomultiplier amplifier offset should be adjusted to a true
black value. Diffuse fluorescence signal arising from the specimen is not typically
considered valuable for co-localization, and should be accounted for in analysis by
setting an appropriately high threshold value for co-localization. On the other hand, noise
creates variance in the pixel intensity, and obscures the “real” value. Noise is caused by
electronic sources in the detector electronics, as well as fluorophore cross-talk and bleedthrough. Methods that specifically reduce Poisson noise (shot/detector noise) from
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electronic sources in confocal imaging were developed with good performance (37).
Another common noise removal technique is median filtering (low-pass filtering) (38),
which is scalable to 2D and 3D, but the tradeoff is a loss of resolution and only reduction,
not elimination, of noise. The concept of signal thresholds was quickly introduced with
co-localization measurements, and different methods exist. Coste's (34) proposed a
automated iterative method to select a threshold using orthogonal regression, iterating
through progressively lower threshold values for each axes of the cytofluorogram until
the PCC (below threshold) becomes negative (it is implemented in some software
packages, such as FIJI's Coloc 2 plugin). In most cases, researchers are interested in
positive correlations, and this auto-threshold algorithm is appropriate in that case. An
alternative approach (39) produces threshold by weighting the effect of each pixel to its
contribution to both MOC and PCC, and is also applicable in the case when negative
association is of interest. Thresholding methods are most effective for removing (constant
intensity) background and only partially reduce the effect of noise.

4.4.5 Higher order image structure in images may negatively
skew co-localization
For an ideal co-localization parameter, it would be beneficial if the value were linearly
proportional to the degree of co-localization. Over the entire range of percent colocalization, the SRC, Kendall's tau, and PCC (without threshold) have an approximately
linear response. The Pearson's using the Coste's auto-threshold shows some instability at
<5% of co-localization, and this is because an acceptable threshold value could not be
determined. This instability is possible (though not guaranteed) when the PCC has values
very close to its extremes (-1 or 1) (40). However, the PCC (with auto-threshold) is
stable and is the most sensitive across the majority of this range. Coincidentally, these
three parameters also estimate the percent of overlap, though there is no mathematical
basis for this in the general case because they are not guaranteed to have a linear
response, even in this ideal simulation. (Here, this approximation is because of a uniform
background level and equal object intensity.) While simulation results of Figures 3 and
Table 1 agree when there is partial or perfect co-localization, it reveals a negative bias in
the SRC and Kendall's tau for images that have regular, or higher ordered structures of
interest, resulting a lower reported parameter that the case where no co-localization is
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expected in overlapping regions of interest. In these cases, cross-correlation or autocorrelation methods (see Discussion) may offer an performance advantage. In biomedical
application, randomly oriented and localized sub-cellular structures would be expected to
have values closer to the 0% overlap values than the more negative extremes, arguing for
the need to have an appropriate negative co-localization control to define the lower limit
of the detection range for a particular biological system using a particular co-localization
parameter.

4.4.6 Effects of gain and bias
The PCC, and its derivatives, SRC and Li's ICQ, are all robust (or insensitive) to effects
of image gain and bias. This can be seen by substitution of the pixel value S 1,i =a⋅S1, i in
the case of gain, or S 1,i =S1,i +a in the case of bias, into the formula for Pearson's and
observing that the effect cancels out. Likewise, these substitutions do not change the
relative rank-order or sign-test, and therefore the SRC, Kendall's tau and Li's ICQ will
not be affected. This finding has not been reported with respect to co-localization
analysis. Therefore, the PCC, SRC Kendall's tau or ICQ are favourable to fluorescence
microscopy in which digital offset is usually adjusted in each imaging session to set the
black background level, and gain may need to be adjusted slightly for differences in
antibody staining between markers.

4.4.7 Effect of noise
An ideal co-localization should be robust to random background noise and still detect colocalization by correlation. To determine how these parameters performed, I varying the
type and amplitude of noise, and the signal-to-noise ratio when using point objects (as in
Figure 4), calculated by ratio of the mean noise level to the mean object intensity. For
confocal fluorescence images, having a minimum SNR of 20 is suggested for reliable
object detection and quantification. However, confocal images often suffer from less
SNR due to limiting the collected light of the pinhole. A high SNR image is produced in
direct relation to the effective resolution of objects within the image, as well as intensity
measurements, for which these correlation parameters rely on. To evaluate performance
using low SNR conditions, image sets were generated with either severe (SNR=2)
(Figure 4A) or moderate (SNR=5) (Figure 4B) degradation, in which it is either very
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difficult or minimally sufficient to discern objects within the image (41). Under three
scenarios of known object co-localization (0%, 50% and 100%), randomly generated
noise was added to the images prior to computing each co-localization parameter, and the
results are presented in Table 2. In the first, low SNR scenario (Figure 4A), random
Gaussian noise is added to represent noise, relative to the true mean signal (specified by
the coefficient of variation). When objects are randomly dispersed, and no co-localization
is expected, the PCC, SRC, Kendall's Tau and Li's ICQ correctly report no correlation. As
the degree of co-localization is increased to 100%, all parameters generally report
increased correlation or association, as expected. However, the dynamic range of
correlation as reported by SRC, Kendall's tau and Li's ICQ, under all noise conditions, is
far too small to accurately reflect any co-localization, and therefore all three are
susceptible to extremes of noise. With respect to PCC, it is similar susceptible to high
noise, yet detected co-localization given with less than 5% noise, though it under-reports
the degree of co-localization. When the Costes' auto-threshold is used for the PCC,
performance at low noise is substantially improved over non-thresholded PCC, but
quickly destabilizes at greater levels of noise. The cause of this instability is a result of
the auto-threshold algorithm over-fitting, and finding an unacceptably high threshold
value, and therefore removing “true” data, as seen in the case of 15% noise. Therefore,
these parameters all detect a lack of correlation/association even with unacceptably high
noise, yet the SNR determines overall co-localization sensitivity, with the PCC most
robust to this noise at low noise levels.

142
greatest response range, similar to that of the ideal case with no noise (Figure 3). The
instability of Costes' auto-threshold is apparent at low SNR and high noise conditions
(PCC (threshold) at SNR = 2, 15% noise, Figure 4A) compared to low SNR and low
noise (SNR=2 and 5% noise, Figure 4A), and is a result of over-fitting the orthogonal
regression to find a threshold value due to the noise. Greater noise and lower SNR causes
a general compression in the response range to different degrees of true co-localization.
Conversely, greater overall SNR improves parameter sensitivity, and with respect to the
PCC, is important for the stability of the auto-threshold stability. Overall, the PCC is the
most robust to noise conditions, and with high SNR image data, offers the greatest
response range to detect co-localization differences.

4.4.8 Effect of ROI selection
When co-localization analyses are conducted, it is considered good practice to draw
regions-of-interest around the whole cell area when individual cells are welldistinguished, if for nothing else but to remove excess background and noisy pixels.
Often times ROIs are drawn around sub-cellular compartments as defined by a
fluorescent marker. To determine the effect of ROI selection on the calculated statistics, I
simulated point objects that were generated with Gaussian noise (5% coefficient of
variation, mean of 100) in a situation where SNR was a not limiting factor, and with
known degrees of object co-localization (from 0% to 100%) (Figure 5). Gaussian noise
was chosen because of its symmetry, and would be expected to cancel out over a large
number of pixels. Objects were randomly distributed in the centre of the image (original
image dimensions were 512x512 pixel). When an ROI was selected around this centre
region (225x225 pixel image dimension), the noise was removed from calculation, and
the calculated statistics are consistent with the detection range reported in Figure 4 and
Table 1. However, not using an ROI let a large area of uncorrelated noise on the image
margins. The calculated parameters became inflated across all degrees of co-localization,
compressing the response range, as a direct result of the extra noise heavily weighting the
parameter calculations. Similar results were obtained with Poisson distributed noise to
mimic detector “shot” noise (results not shown).
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Figure 5. Regions of interest improve parameter performance by reducing the weighting
on background and noise pixels. Images were generated with Gaussian noise with
constant average background. Parameters were calculated for whole images (“no ROI”
group) and using the bounding area of point objects (“using ROI” group), with a fixed
degree of known object co-localization. The response range of parameters is expanded
when the ROI was used compared to not using an ROI.

4.4.9 Bench-marking common co-localization parameters using
open data sets
In order to evaluate these parameters in real fluorescence image sets, it would be
instructive to see how they perform using cells that are labelled for two structures that do
not co-localize, and in cells that display a wide variation in morphology. The
morphological variation is an important aspect because they will always be different,
even in clonal cell lines, and the argument could be made that the relative areas of the
two labels could have an influence on the calculated statistics. To this end, I used a freely
available image set in which the same cells, under experimental conditions, undergo
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extreme variation in their morphology, while stained for truly segregated markers. I used
image set BBBC020 from the Broad Bioimage Benchmark Collection (42), in which
murine bone-marrow derived macrophages were treated with a drug to investigate their
ability to spread. These cells were immunostained for CD11b/APC (a cell membrane
protein) and counter-stained with DAPI, and there is no real co-localization between
these two structures. All computed parameters for this data set are shown in Figure 6.
Even though these images were taken with a wide-field fluorescence microscope, it is
clear that the PCC and Li's ICQ parameters do not falsely identify co-localization. The
SRC and Kendall's tau perform relatively worse, with a broader distribution of values,
when when compared to simulated data, would suggest at least partial co-localization.
Also evident is that the Costes' auto-threshold appears to transform the Pearson
distribution by creating a heavy left (lower) tail. Here, I suggest that for biological data, a
negative value should be have the same interpretation as a zero value: the two labels are
not co-localized – in this case, a cell surface marker is definitely not in the nucleus.
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Figure 6. Performance of multiple co-localization parameters on open
immunofluorescence image sets. An open image set of wide-field immunofluorescence
images of bone marrow-derived macrophages (n=25), immunostained for cell membrane
protein, CD31b/APC, and counter-stained with DAPI, serving as a control for non-colocalizing labels. Images were collected during a time-lapse experiment to study
macrophage spreading, and the heterogeneity of cell morphology serves as a good colocalization false-positive benchmark. Details of the study can be found at (43) and image
set “BBBC020” was obtained from (42).

4.5 Discussion
The term co-localization is used to mean many different things, including the degree of
association between two proteins; a quantifiable measure of protein interaction; are two
proteins in the same place; and the more rudimentary meaning of visual overlap between
two fluorescent signals. I take co-localization to mean any two (or more) fluorescently
labelled objects that are highly correlated and co-distribute within immunofluorescence
images. Ultimately, the cell biologist wants to extract quantitative meaning from the
images they acquire. Even with perfect images, the biological question must be matched
to the quantitative techniques. Co-localization analysis is a routine method for
immunofluorescence microscopy, and cell biologists should strive to rigorously analyze
their images beyond the “eyeball” metrics. However, these methods all have their
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limitations. They cannot answer the question of what percentage of one protein interacts
with a second protein. Many examples of reliable proteins association can be found (e.g.,
secretory protein trafficking (10, 44)), but potential limitations arise from transient colocalization, or restricted localization within a sub-cellular compartment, or systematic
errors to labelling strategy (e.g., (45)). These parameters are useful to answer questions of
whether two (or more) fluorescence patterns are similar within the cell, as a measure of
the degree of statistical association (but not chemical interaction).
An immediate quality check of immunofluorescence images can be observed from the
cytofluorogram and PCC parameter. The section of the cytofluorogram that is correlated
and contains co-localized pixels is usually described as the upper-right quadrant (those
methods discussed here) or less commonly, by a radial arc centred along the diagonal of
perfect co-localization (46). These areas are then quantified (e.g., by linear correlation) to
determine the degree of co-localization and represents the biologically significant data.
The cytofluorogram gives a good idea of how many uncorrelated pixels exist in each
channel relative to what may contribute to correlated pixels. Since uncorrelated pixels
and noise cannot be avoided in even the most perfect immunofluorescence images, it is
critical to have a threshold value for each image channel. It is usually a good idea to
restrict the ROI for analysis to entire cell, or if the labelled molecules exist in one
structure (e.g., the nucleus), then drawing the ROI around the nucleus will improve the
quality of measurement. Of course, one must always compare to both a negative (known
segregated) and positive (known highly co-localized) biological control, to establish the
limits of detection within the particular biological and optical system.
There are several misconceptions regarding the use of correlation values as indications of
co-localization that should be addressed. Regarding the PCC, some believe that it is not
appropriate for immunofluorescence co-localization applications because the acquired
pixel data is rarely (if ever) normally distributed (32). Pearson's correlation coefficient
does not assume normality because it is defined based on the moments of the distribution,
and therefore only requires finite variance and co-variance for the joint distribution. Both
finite variance and finite co-variance are guaranteed since images are acquired with finite
spatial resolution (determined by the CCD and pixel dimensions) and finite pixel

147
dynamic range. In the condition where the joint probability distribution (of paired pixel
intensities) is bi-variate Normal then the PCC is an exhaustive parameter to describes any
linear dependence relationship. Second, the supposition that the PCC is not an acceptable
parameter for hypothesis testing (31) follows from the presumption that the normality
condition is not met. However, the PCC has a long pedigree of being resilient to even
severe departures from normality (47), and is considered a reasonable statistic for
hypothesis testing with specific application to co-localization analysis (33). While PCC is
by is by no means perfect in every application (e.g., (48)), it offers many advantages over
other correlation parameters discussed here with respect to less complex cases of
correlation. Li's ICQ was reported to be a better indication of co-localization (31), and it
does make the implicit assumption that pixel intensities be symmetrically distributed. The
parameter was chosen to simplify hypothesis testing by using the sign-test. However, this
is not a reasonable assumption especially when images contain noise. Secondly, the
choice of the underlying distribution of the sign-test for Li's ICQ is the Normal
approximation to the binomial distribution, but in all fluorescence microscopy
applications, pixels do not satisfy the binomial conditions of independence (between
pixels) and the probability of “success” (correlation), because pixels are more likely to be
similar to their immediate neighbours due to the blurring caused by the point-spread
function of the imaging system. This is a property of both the point spread function in
image formation (one pixel intensity is smoothed out over many), and because the
cellular location of a labelled molecule may be restricted to protein complexes,
membranes or compartments. The SRC and even more, the Kendall's tau are promising
statistics for co-localization analysis, and are currently implemented in FIJI.

4.5.1 Choice of appropriate controls
In terms of control experiments, it is first necessary to validate the probes that will be use
for co-localization experiments, and then prepare to take good quality images. A set of
slides should be sequentially imaged in all filter channels, where the slides are: 1) unlabelled, to assess autofluorescence of the sample, 2) labelled with only one of the set of
probes (one slide per probe) to determine the performance of each probe, and 3) if
necessary, slides in which primary antibodies are omitted to test specificity of the
secondary antibody labelling. Once validated, the optical system should be checked for
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proper chromatic calibration (e.g., using fluorescent beads), and optical alignment to
ensure the best quality image formation. If noise correction is anticipated, a replication
based noise correction calculation (37) is a method of reducing shot noise specifically
from confocal images, and requires a set of four images and two sequential scans to
produce a correction factor for co-lcoalization analysis. Other methods to consider to
reduce background and noise: software deconvolution, thresholding, sequential confocal
image acquisition using line scanning or frame averaging.
The issue of biological controls is more flexible, and must be considered based on the
particular system being examined. Negative controls should be collected in which two
proteins are known to not interact or associate (except possibly by random diffusion). For
example, if two proteins are expected to be restricted only to the nucleus, the choice
could be as simple as a nuclear-localized GFP and DAPI, to characterize random intensity
correlations within the ROI containing only the nucleus. On the other hand, if protein
trafficking is being monitored, one marker should be a stable marker of the
compartment(s) of interest (e.g., calnexin for the ER, or a BGALT1 for the TGN); the
second probe may be a protein that either does not traffic through the compartment but
has a similar sub-cellular distribution pattern (e.g., endosomal and vesicular
compartments), or does traffic through the compartment but does not interact within that
compartment with a protein of interest. If using soluble dyes or GFP-derived proteins of
acidic compartments, take precaution that they actually label the correct compartments
(see for example, (45)). Positive controls are meant to mimic the correlation of interest,
and serves as a maximum of the detectable co-localization. Such a control may be two
proteins that are known to interact within the compartment of interest, they may be
artificial interactions in the same compartment (e.g., adding high-affinity tags to
recombinant proteins). A positive control can also be done by simultaneously labelling
the same protein with limited amounts of two secondary antibodies, each labelled with a
different fluorophore. The latter method guarantees both correlated and co-distributed
labelling of a protein of interest, but could suffer from the loss of sub-cellular context,
and doesn't account for performance of a second labelled molecule. Having appropriate
biological controls is necessary to establish a dynamic range of independent and colocalized protein detection within the parameters of the imaging and biological systems,
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and can then be used for statistical comparison. Lacking credible evaluation of known
associated and independent proteins will be very difficult to interpret true from spurious
co-localization.

4.5.2 Hypothesis testing of correlation parameters
Once all the images have been collected, an the quantification techniques complete, the
cell biologist will next want to test their working hypothesis. Often the questions being
asked are related to “does this mutant protein affect protein trafficking?” or “does a drug
treatment alter protein localization?” or “does depletion or over-expression of one protein
affect the distribution of two other proteins?” These are all very fine questions to ask, and
with co-localization, they will be answered by hypothesis testing, usually turning to
Student's t-test or an ANOVA. Under the null hypothesis, none of these treatments will
have any measurable effect, and one must compute a test statistic (e.g., t-statistic, Fstatistic) that is conditioned on the null distribution to determine whether the observed
value is more extreme than is likely to have occurred by random chance within an
acceptable significance level (by convention, alpha is usually set to 5%).
The difficulty arises when considering what the joint probability distribution of two nonco-localizing images looks like, and consequently, the shape of the test-statistic under the
null hypothesis. This is not a trivial matter because if the null distribution deviates too far
from normal, a standard t-test could have a much higher false-positive rate, and would
lead the researcher to conclude a significant finding where none existed. Having a
significant finding first assumes that the underlying null distribution is accurate (or close
enough to accurate) and the finding was not likely to occur by chance. Conversely, failing
to find a significant result could mean that the finding was likely to occur by chance
given the null distribution, or that the null distribution is not accurate, and the conclusion
is irrelevant because it was predicated on an invalid statistic. Most of the quantitative colocalization studies neglect to address this specific point – what does a null distribution
look like for any two non-correlation and non-co-localized image set? Presumably it will
depend on a number of parameters, especially on the particular cell system, localization
of the proteins, fluorophore labelling and the optical system used for imaging. It is also
difficult, if not impossible, to predict this distribution in a general case a priori. How then
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can I expect the statistical conclusions being drawn to be valid?
There is still no answer to the question of what a general null distribution looks like, but
some researchers have made efforts in this way to find approximate distributions. Costes'
significance test proposes to work with two colour channels (34). Briefly, one image
channel is divided into discrete blocks, scrambling the image, and calculating the PCC
with the other, original image, and repeated (usually 1,000 times). The expectation is that
a scrambled PCC will be less correlated that the original image, and the resulting
scrambled PCC values form the null probability distribution due only to random
correlation, and the likelihood (p-value) can be computed. This scrambling technique, a
form of bootstrapping, is not specific to PCC, and can be applied to any of the pixel- or
voxel-based intensity correlation measures. A drawback of both this approach and its
improvements (49, 50) have been compared (33), finding the null distribution is too
broad and leading to false-positive rates greater than the acceptable significance
threshold. A stronger implementation of this randomization technique not considered by
McDonald was extended to multiple image labels, and is applicable to pixel-, voxel-,
object- and intensity-based correlation techniques, but only considered the case of MCC
(5). Through analysis of simulated and real image data (33), they find that the PCC is an
acceptable parameter to use for hypothesis testing when using a one- or two-sample t-test,
and expect similar performance for more complex experimental designs (e.,g requiring
ANOVA or regression). Therefore, for most cell biological application of quantitative colocalization, the standard statistical tests apply.
Another common pitfall is the issue of sample size, and often not reporting any power
analysis calculation to determine the minimum sample size. The process of calculating a
sample size is outside the scope of this paper (an excellent text on the subject can be
found by (27, 28)), the maximum anticipated effect size should be carefully considered
using a pilot experiment, and whether the researcher is interested in a one-tailed or twotailed hypothesis. For instance, many cell biological applications are interested in a onetailed hypothesis: the two labelled proteins are well segregated or they are co-localized
(to some degree). A two-tailed hypothesis would be the anticipate greater or lesser colocalization depending on the treatment. A well powered analysis requires consideration
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of how the proteins of interest are localized in the cell. In the case of proteins that traffic
together, more images will be needed for a well-powered study than if they are
segregated under some condition.

4.6

Conducting
Quantitative
suggested workflow

Co-localization:

A

I suggest a workflow for co-localization analysis of immunofluorescence images start
with ensuring that the microscope be optically calibrated, especially for chromatic
alignment, and samples labelled with spectrally distinct fluorophores to minimize crosstalk and bleed-through. While imaging, most software allow real-time monitoring of the
histogram which should be checked to ensure that the image pixels are within the
dynamic range of the camera and that no pixels are saturated from over-exposure, and at
a sufficient pixel dwell time to ensure an adequate signal-to-noise ratio. Antibodies
should be validated such that the labelling is specific to the protein of interest and
localized within the known sub-cellular compartment(s) from literature. Alternatively,
recombinant fluorescent proteins also need validation for immuno-detection and
biological validation demonstrating that the fluorescent protein tag does not interfere with
its usual function or sub-cellular trafficking. Following the characterization of the
imaging system, antibodies and fluorophores, the researcher must then choose of
appropriate biological controls, as discussed earlier. For 3D imaging, optical z-stack
images should be acquired for sufficient axial resolution of the sub-cellular structure
(e.g., 0.2 µm step size), and for each imaging channel, the pinhole diameter must be
matched for isometric resolution across each acquisition channel. Deconvolution for 3D
confocal image stacks is recommended for imaging intracellular trafficking in finestructure organelles. Deconvolution requires a z-stack acquisition of the PSF by imaging
single fluorescent beads that are much smaller than the optical resolution of the
microscope using the identical light path settings of the microscope. This PSF should be
used for deconvolution of microscope images. These steps are all important to ensure
equal resolution and good signal-to-noise ratios in collected images to produce good
quality image data. All image sets should also be saved in the microscope's native image
format to preserve the experimental meta-data (containing optical path information,
microscope settings, etc.), and when exported for analysis, should be saved in their native
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microscope software image format to preserve raw images, and exported to
uncompressed tagged-image file format (TIFF) images for analysis.
Next, images for the negative and positive controls should be acquired. If possible, the
live cytofluorogram at each stage of image acquisition should be viewed to monitor the
relative amount of background in each channel, and can alert you to image quality issues
during acquisition. Whether imaging individual or discrete clusters of cells, scan area
should be increased to maximize pixel resolution and results in scanning the laser over a
smaller sample area, reducing sample photobleaching and decreasing acquisition time.
Once control images have been acquired, analysis can be done off-line. It is best to draw
ROIs around single or distinct clusters of few cells for analysis, removing irrelevant
background pixels. (Depending on the software package used, calculating co-localization
coefficients can be performed using ROI selections, or these selections can be converted
to a binary mask.) To maximize efficiency several co-localization coefficients can be
calculated simultaneously, firstly the PCC with Costes' auto-threshold, and optionally the
SRC and Kendall's tau. By examining the measured degrees of segregation (negative
control) and association (positive control), the researcher now has a defined “dynamic
range” of the particular experimental system. The Costes' auto-threshold can also be
examined using the cytofluorogram to see if it is reasonable, in that a positive threshold
value is reported, and it should be less than the mean signal intensity for each channel. If
it is not reasonable, it may be symptomatic of poor image SNR, or not using an ROI and
the background pixels prevent a reasonable threshold from being detected. If the control
images look good and the co-localization parameters appear reasonable, images can be
acquired for experimental treatments using the same guidelines, and correlation
parameters calculated. If the co-localization results by PCC are not clear, then consider
the rank-correlation coefficients. If these results are still not clear, then the researcher
should explore using the more advanced cross-correlation functions (described below).

4.7 Advanced methods of 3D co-localization and
extensions to super-resolution imaging
The co-localization methods described above work in simple cases, and in two colours
only, making no assumptions about the underlying biological processes involved in
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protein co-localization. Further improvements to co-localization analysis have been
developed by including more information or using more sophisticated analysis
techniques. Ideally, the quantitative co-localization method should be sensitive to colocalization of one channel with another (and extended to multiple fluorophores),
insensitive to noise and background, and be able to detect non-linear interaction patterns,
such as protein complex assembly. Efforts made in this direction have been to propose
new co-localization parameters, and increasingly, moving toward super-resolution
imaging.
With careful collection of z-stacks in microscopy, it is possible to achieve even greater
resolution that the Rayleigh criteria by using optical deconvolution. Though more often
used for wide-field fluorescence, 3D deconvolution can also be performed on confocal
stacks, with the caveat that the volume be somewhat over-sampled (z-step of 0.2 µm) and
voxel sizes matched in each channel to achieve equal resolution in each channel.
Deconvolution is less often applied to confocal microscopy image sets, possibly because
resolution is deemed “good enough” for the proteins or structures of interest. A
comparison was performed using noise filtering and 3D confocal deconvolution
techniques for multi-channel imaging (51) in which the both filtering and deconvolution
improved co-localization parameter sensitivity. In their comparison, Pearson's correlation
and Li's ICQ performed best. However, when resolution becomes a limiting factor (often
by increased noise), noise removal techniques are necessary to simultaneously increase
the signal-to-noise ratio while possibly offering improved resolution, with resolution
approaching the diffraction limit (41). However, when noise reduction is applied,
confocal 3D deconvolution performs better than filtering methods in both simulated and
real image sets (38, 52–54), and deconvolution should be performed on confocal stacks
prior to co-localization analysis. Since 3D deconvolution is a computationally expensive
task, this was an impediment, especially a decade ago when computational power of
desktop computers was more limited. However, a recent computational technique uses
ImageJ and low-cost computer hardware to run a “blind” (Lucy-Richardson)
deconvolution in real-time, removing this barrier (55). Such “blind” deconvolution
methods are advantageous because they do not require any measurement of a pointspread function, but rather iteratively fit an ideal point-spread function to the images. To
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provide better quality data for co-localization analysis deconvolution should be applied to
improve image resolution and SNR.
Super-resolution techniques are now capable of dual-colour nanoscopic imaging
technique.

Fluorescence

techniques

using

photoactivable

fluorescent

proteins

(photoactivatable localization microscopy, PALM; and stochastic optical reconstruction
microscopy, STORM) use statistical reconstruction of time-resolved photoactivatable
fluorophores to create super-resolution images. These images often create fusion proteins
using photoactivatble or photoswitchable GFP (and derivatives thereof) to label specific
intra-cellular structures or molecules. However, GFP-derived fluorophore brightness is
known to be highly pH-sensitive, and a common problem of imaging within mature
granules (pH 5-5.5) is the partial or full quenching of fluorophore signal. Creating more
stable PALM/STORM fluorophores in acidic conditions is an active area of development
(56). Presently there are limited numbers of fluorophores with a pKa compatible for
imaging within acidic compartments, though it has received little attention for granule
imaging despite its apparent promise to imaging insulin secretory granules (57).
An alternative super-resolution approach called stimulated emission depletion (STED)
uses one laser to excitation a diffraction-limited spot, while simultaneously using a
second laser to force stimulated emission of fluorophores within a sub-region, switching
the fluorophores “off”, resulting in better lateral resolution (58). STED achieves lateral
resolution of about 15 nm in situ (59), and has the advantage of imaging live samples in
real-time with approximately 50 nm lateral resolution (60). STED systems are now
compatible with multi-colour imaging (61, 62), and can be combined with TIRF or multiphoton imaging. Recently, deconvolution techniques have also been considered for superresolution fluorescence imaging, as suggested by (60). Developing STED deconvolution
algorithms is still actively being investigated (63), providing near-real time deconvolution
speed (on the order of 1-10 seconds). The scaled-gradient-projection deconvolution
method is not just limited to STED, but any fluorescence microscopy method when the
point-spread function is supplied. This method not only increases STED image
resolution, but when applied to confocal images, brings the lateral resolution to ~90 nm,
below the diffraction limit. Since the lasers used in confocal and STED microscopy are

155
fundamentally diffraction-limited, STED imaging can still suffer from poor axial
resolution. Further improvements have been made using “compact” STED systems,
increasing the axial resolution to ~100 nm (62, 64, 65), bringing STED into the realm of
3D nanoscopic imaging. STED is now a viable nanoscopic imaging technique for
quantitative co-localization. For example, three-colour imaging can be used to determine
object-based co-localization (61) or using conventional PCC analysis to determine biased
interactions between hexokinase and distinct isoforms of mitochondrial voltagedependent anion channel (66). The natural increase in resolution lends itself to
developing more sophisticated object-based co-localization methods, especially for the
application to monitoring protein trafficking along the secretory pathway (e.g., within
secretory granules). These nanoscopic imaging techniques offer substantial increases in
spatial resolution, and although they still cannot directly answer whether proteins are
directly interacting, the increased resolution does offer greater insight to the dynamics of
the secretory pathway and greater certainty to image within individual granules.

4.7.1 Novel and advanced co-localization parameters
A novel rank-based correlation coefficient, a dual-channel rank-weighted correlation
coefficient (RWC), has the clear advantage of being sensitive to both spatial correlation
and intensity fluctuation (11). The intuition is similar to the PCC, in that a correlation is
measured, but every pixel value is also weighted by rank. The biological benchmark for
this parameter was to measure intracellular co-localization of the temperate-sensitive
VSV glycoprotein (tsO45-GFP), a model secretory cargo protein (67, 68). By using a
pulse-chase paradigm, a shift from the non-permissive incubation temperature 42°C to a
permissive 32°C releases a wave of protein from the ER, and by fixing cells at intervals
they measured co-localization from the ER to the trans-Golgi (11). Not only was this the
first quantitative analysis of co-localization for this cargo protein, their findings of
intracellular trafficking kinetics agree with biochemical kinetic measurements, and show
that the parameter performs well to detect small co-localization differences in a spatially
compact structure of the Golgi.
Novel co-localization parameters have been proposed to incorporate structural
information from 3D image stacks. Wang and colleagues (69) reported two parameters
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called the co-localization intensity and binary coefficients (CIC, CBC). This method has
similar intuition to the correlation parameters discussed above, weighting similarities of
pixel intensity from neighbouring focal planes to remove spurious cross-over that may
otherwise contribute to false positive co-localization. This method is more robust to
spurious co-localization in noisy image sets, as tested using a model of nerve myelantion.
An interesting aspect of their technique is that they specifically account for the axial
signal overlap across neighbouring focal planes, and have tested the method within the
limits of confocal axial resolution. It will be interesting to see how this method performs
with super-resolution techniques that can improve axial resolution by ~2-10-fold.
Currently no commercial software packages perform this calculation.
A powerful technique for taking advantage of 3D information from confocal stacks is
when sub-cellular compartments can be segmented and reconstructed into 3D volumes.
At present, commercial (Image Pro, Imaris) packages and non-commerical packages both
offer this ability. True “object-based” methods use these rendered volumes to detect colocalization by several means. First, compartments such as vesicles can be reconstructed
from image stacks based on an estimated size. Typically, object-based co-localization
occurs when the centroid of one object is near enough to another object's centroid, or it is
within the reconstructed volume of another object (see for example, (5, 48)). This
advanced method builds a model of point-based object detection for investigating
punctate objects (be it labelled proteins or vesicular compartments) with a bootstrapped
statistical framework for making inferences, and is easily extended to 3D and time-lapse
microscopy. This is still an area of active research to examine in such phenomena as virus
entry into cells (70), observing protein machinery maintaining cell polarity in S. pombe
using spherical geometry (71), and dynamic vesicle identification (3). In the case of
intracellular protein trafficking, I have previously validated object-based co-localization
of two secretory granule-targeted proteins, glucagon and a modified, dipolar GLP-2, to
introduce a granule-targeting sorting signal (Figure 7). The co-localization of these two
proteins were confirmed by PCC (72). The 3D renderings were reconstructed using each
protein, and a granule resident protein, chromogranin A, and the percentage of
overlapping objects agrees with the degree of co-localization as measured by PCC.
Object-based methods have the advantage of being able to exclude objects of
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colour image sets, and considers the effects of how the cross-correlation (both x- and yshifts of channel one with respect to channel two), and fitting a two-component Gaussian
decay curve to the cross-correlation peak. When a fast-decaying component is present,
this differentiates “true” co-localization from the slow-decaying curve that represents
auto-fluorescence. This technique also takes advantage of increased resolution of STED
microscopy, explaining its greater sensitivity to detecting co-localization. The idea of
cross-correlation has been extended to dynamic single-particle tracking of confocal image
stacks by comparing image cross-correlation with each particle's 3D trajectories to spatiotemporally match fluorescent probes (76). These cross-correlation and auto-correlation
functions are particularly suited to monitoring dynamic processes over time, when
intracellular trafficking or particle movement cannot be predicted a priori, but only after
re-alignment. They also have the advantage of being sensitive to repetitive structural
elements, something that may be useful when monitoring trafficking through tubular
structures or the Golgi cisternae.
Two novel methods take advantage of nearest-neighbour distance metrics and spatial
inhomegeneity to detect particle clustering as a marker of dynamic protein-protein
interactions. A recent approach (77, 78) whose method of co-localization is designed for
super-resolution images, termed spatial association/apposition analysis (SAA). Each
particle object is segmented and evaluated for co-clustering probability with other nearby
particles. First demonstrated to reveal receptor clustering on the cell surface (77), it has
now been applied to monitor inrtacellular trafficking by vesicular transport and is
extended to multiple interacting particles. The spatial inhomogeneity assumption is that,
if objects are not clustered, they should not exhibit a bias in nearest-neighbour distance or
radial clustering to other objects. This technique has been validated for GSD microscopy,
and should also be applicable to any single-particle super-resolution microscopy method.
A mathematically related technique was reported to observe individual RNA polymerase
II complexes, previously thought to exist as clusters of transcriptional factories within the
nucleus (79). The imaging technique is novel, adapting light-sheet and super-resolution
microscopy to achieve much higher SNR images than conventional confocal microscopy,
while spatio-temporal tracking of particles is used to detect spatial clustering as a
measure of protein co-localization. This technique can also be be extended to measure
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stoichiometric interactions within particle clusters. The combination of single particle
tracking methods using super resolution imaging techniques are advantageous for
delineating stoichiometric ratios of protein clusters, and profiling the dynamic spatiotemporal co-localization of proteins.
Lastly, a promising family of techniques that originate from the machine learning and
image segmentation literature are Bayesian approaches to co-localization. The
foundations of Bayesian analysis as applied to analysis of super-resolution images are
best explored for image feature extraction (for review see (80)), though these methods are
computationally more complex than many of the alternative method described here.
Some progress in this direction have been to use Bayesian post-processing techniques of
confocal and super-resolution images to localize proteins with similar precision to superresolution imaging alone (81,82). Recently super-resolution images were used for
Bayesian localization of proteins, to detect spatial clusters of fluorescently tagged
receptors in the cell membrane (83). This technique is promising to apply when
investigating multiple protein-protein interactions, such as the sorting events that occur in
the regulated secretory pathway, as receptors are localized to newly forming granules
with their cargo. As computational power increases, Bayesian analysis methods will be
very interesting to follow for co-localization studies.

4.8 Conclusion
Extracting quantitative information from optical microscopy requires care in the
preparation of the biological specimen but also knowledge of the image processing
techniques that are applied. Diffraction limited microscopy in particular suffers from
blurring due to the point-spread function and variable image SNR. These aspects can be
accounted for by appropriate image processing techniques, but it should be understood
that these alter the “raw” image data. Trade-offs involved in image processing and image
acquisition are illustrated by a discussion of quantitative immunofluoresence confocal
microscopy for co-localization analyses, which represent the most common quantitative
technique applied in confocal imaging. I suggest a workflow to acquiring 3D confocal
image stacks for co-localization analysis and consider the most commonly used
correlation parameters. As super-resolution and single particle imaging methods continue
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to be adopted, extracting quantitative information will require the development of novel
techniques. More sophisticated methods can also be applied to answer questions related
to stoichiometry of the interaction between labelled molecules. As the resolution limits
are pushed further down, the sheer amount of image data and associated analysis
techniques will become the limiting factors for quantitative microscopy, and these data
will continue to be mined to extract more quantitative spatial and temporal information.
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Chapter 5
5.1 Discussion and Future Directions
A central question in α- and L-cell biology is how proglucagon is sorted into granules in
order to undergo processing to its constituent hormones and be effectively concentrated
for later exocytosis. The mechanisms of differential processing by PC1/3 and PC2 are
well understood, but the specific location of where the convertase enzyme encounters its
substrate, proglucagon, is not yet resolved. It is recognized that many (pro)hormones and
neuropeptides contain sorting signals that are encountered and recognized by granuletargeted receptors as granules are formed. Here I have identified that proglucagon
contains several sorting signals, and interestingly, two are contained within the mature
hormone domains of glucagon and GLP-1 sequences. The molecular structure represents
a novel class of α-helical sorting signals: an electrically polarized (dipolar) α-helix with
discrete positively and negatively charged surfaces. This is distinct from the previously
identified amphipathic α-helices which rely on a large hydrophobic face. I have also
characterized some of the possible molecular interactions in both α- and L-cells that
could serve as receptor-mediated binding of proglucagon. I have documented that sorting
of proglucagon is cell-specific, requiring CPE, and is consistent with several reports that
characterize CPE as a receptor for multiple hormones. I also have preliminary evidence
for CgA serving a similar receptor role (in PC12 cells), binding to both the glucagon- and
GLP-1 sorting signals in a pH-sensitive manner. Therefore, I have identified distinct
sorting signals within proglucagon and propose two receptors for interaction such that αcells can efficiently and adequately sort proglucagon to granules for processing to mature
glucagon.
This work has raised new and unresolved questions concerning the biology of
proglucagon and the field of hormone biology. Since the identification of dipolar αhelices as sorting signals, this molecular motif may be represented and unrecognized in
other neuropeptides and hormones, proving that existing mechanisms for sorting are more
adaptive than previously thought, or supporting the existence of yet unidentified
receptors. On the basis of predicted protein secondary structure, dipolar helices may be
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functional signals within pro-adrenomedullin (ADML), pro-pituitary adenylate cyclaseactivating polypeptide (PACA), glucose-dependent insulinotropic polypeptide (GIP),
pancreatic polypeptide (PAHO) and peptide-YY (PYY). Additionally, reinterpretation of
the amphipathic α-helix data of pro-cocaine and amphetamine-related transcript
(1) would also support the notion of a dipolar α-helix. As a general mechanism for
dipolar α-helices, they are likely to undergo electrostatic association with charged granule
targeted proteins (e.g., granin association is calcium- and pH-dependent) or charged lipid
head groups of the granule membrane. A pH-dependent or cation-dependent interaction
would support this view as suggested by initial experiments with glucagon and GLP-1.
While no single universal mechanism for sorting prohormones exists, and there is a real
possibility that new classes of signals have yet to be identified. An interesting possibility
is that a β-sheet structure could be such a motif. The beta-sheet structure may form largescale aggregates, or target to granules by association with zwitterionic membrane lipids
(e.g., phosphatidylcholine) or by association with cholesterol. One example is found in
hepcidin, a key metabolic regulator of iron homeostasis. Both the pro-form and mature
hepcidin are small peptides (60 amino acids in the pro-form, and 20 or 25 in mature
form), and the mature hepcidin structure has been resolved (see Table 1). Then there is
the curious xenin-25, a regulated secretory protein found within granules of many
endocrine tissues. It is unique in that it is likely the shortest pro-peptide at 35 amino acids
in length, and is cleaved to mature xenin-25 (2). Since it constitutes the N-terminal
domain of coatomer sub-unit A, a cytosolic coat protein, it is unknown how pro-xenin
enters the regulated secretory pathway. Yet, xenin is still a secreted gut hormone (3) and
the beta sheet structure may constitute a novel sorting signal (Table 1). Further
characterization of how neuropeptides and hormones will likely reveal new classes of
motifs and interactions, and will contribute to the general understanding of sorting along
the regulated secretory pathway.
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Table 1. Hypothetical novel classes of sorting signals.
Putative
signal(s)

sorting Example
Protein 3D Structure
(Gene) name

Β-sheet or hairpin

Hepcidin (HEPC)

Protein Data Bank ID: 1M4E
B-sheet

Xenin-25 (COPA)

Results were generated by de novo
prediction.

Concerning new questions specifically related to the biology of proglucagon, there are
some major questions to resolve: 1) what is the location where proglucagon is both
initially sorted?; 2) where precisely is proglucagon initially cleaved into glicentin and
MPGF?; 3) what is the nature of the distribution of the processed PGDPs within the
granule population?; and 4) what is the nature of interaction between proglucagon and
CPE and CgA? It is well known that secretory granules are functionally
transported/diverted to distinct pools that are operationally distinguished based on
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whether they are docked at the plasma membrane or nearby, and whether they are
immediately releasable or if there is a lag prior to exocytosis. This difference is largely
explained by the type of effector proteins on the cytosolic leaflet of the granule (in
particular Rab3, Rab27 and SNARE proteins and SNARE accessory proteins) and the
particular secretory state of the cell. For example, young granules spatially segregate near
the membrane over older granules in bovine chromaffin cells, appearing docked at the
membrane, while older granules are more mobile (4, 5). A related and under-considered
question concerns the existence and identity of distinct sub-populations of newly formed
secretory granules. In other words, are (neuro)endocrine peptides further able to
differentially load cargo, thereby producing distinct subs-populations of granules? Many
reports, principally by immuno-electron microscopy, report natural variation the spatial
location and density of cargo proteins in the granule, distributed among the dense core
and the translucent halo. However, whether this process is a by-product either of natural
variations in granule biogenesis, or a result of divergent biogenesis mechanisms, remains
a mostly unexplored question (6). Immunoelectron studies of the distribution of GLP-1
and GLP-2; glicentin and MPGF; and glucagon and MPGF; are all suggestive that the
PGDPs are co-stored within the same granule, and thus enter the same population of
granules. However, this has not been definitively addressed, and the data at hand only
suggest a correlation. Recent evidence has been identified in GLUTag cells whereby the
classical techniques of labelling granules by means of GFP-tagged hormones (e.g., GH,
BDNF and NPY), were each shown to co-distribute to varying degrees with GLP-1 (7).
Though it was not the focus of that study, they found that GFP-tagged NPY and BDNF
strongly localized to GLP-1-containing granules, while GFP-tagged GH was completely
segregated from GLP-1. Super-resolution microscopy is an excellent method to examine
the distribution of GLP-1 and GLP-2, or glucagon and MPGF, within granules.
Evidence in support of distinct sub-populations of granules have only been reported for
pituitary-derived neuroendocrine cells. In AtT-20 cells (corticotrophs), exogenous
expression of syncollin enters granules containing ATCH, but not VAMP-2 (8), the
granule membrane v-SNARE required for exocytosis and in agreement with similar
findings of unequal cargo distributions in AtT-20 cells (9). A parallel observation was
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reported in multiple beta cell lines, in which the loading of CgB and insulin was
heterogeneously distributed, some granules containing only insulin, a mix of insulin and
CgB, or CgB alone (in a percent ratio of 66:27:7) (10). Though they demonstrated
different profiles of secretion through various types and doses of secretagogue
stimulation, the explanation could be due to truly distinct sub-populations of granules (as
the authors suggested), or a coincidental result of a single population of granules that is
being dynamically regulated for distinct kinetics of exocytosis, as has been welldocumented from PC12 and chromaffin cells (11–13). This remains a possible additional
layer of complexity to the granule biogenesis process and the functional significance of a
diverse granule population.
To understand when and where proglucagon is sorted and processed, advanced
visualization techniques and proteomics could be used to distinguish the subcompartments of the TGN from immature and mature SGs. This would necessarilyy add
temporal resolution to the examination of the dynamic sorting process. While the
specificity of antibodies to detect all species of PGDPs without cross-reactivity is major
challenge, both sensitive and specific detection methods are required for monitoring
proglucagon undergoing processing. LC-MS-based proteomic detection (14, 15) certainly
meets these requirements. However, proteomics methods destructively sample the
contents of cells, requiring pooling and a loss of temporal and spatial resolution. The
challenge is to not only distinguish proglucagon from the PGDPs (i.e., glucagon and
glicentin), but also to delineate the multiple compartments of the secretory pathway. The
latter is somewhat easier to accomplish by immuno-staining proteins that either reside in
ISGs but do not traffic to mature granules. Some examples include furin (16), mannose-6phosphate receptor (M6PR), syntaxin 6, clathrin (17), carboxypeptidase D (18),
synaptotagmin IV, VAMP4 (19), and Golgi-associated, γ-ear-containing, ADPribosylation factor-binding protein (GGA) (20), adding non-specific compartment
labelling. More specific labelling approaches have been proposed on the basis of using
fluorescent proteins as molecular timers.
A molecular timer is any molecule that can develop or change its fluorescence properties
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over time. Early uses of a fluorescent timer applied to intracellular trafficking used a pHsensitive GFP, pHluorin. As the pHluorin is exposed to increasingly acidic environments,
the GFP emission profile dims from physiologic pH and is quenched by the acidic
environment of mature granules (21). Applications to intracellular trafficking are
particularly convincing when using fluorescence TIRF imaging to monitor live granule
exocytosis, the fluorophore immediately recovering fluorescence as soon as the fusion
pore forms to neutralize the acidic granular pH. The disadvantage of this technique is the
progressive signal loss as granules mature, and no clear distinction of immature granules.
A related idea takes advantage of the slowly-maturing RFP variant that changes emission
from green to red, has been used to monitor chromaffin granule ageing and secretion
(4) when fused to a granule-targeted protein. One such protein, syncollin, is targeted to
granules of endocrine (22) and neuroendocrine cells (23), and unlike its natural inhibitory
action of granule exocytosis, does not affect exocytosis kinetics as a fusion (24). A major
draw back to this timer is that the transition time is ~ 16 h (4, 25), which would preclude
the temporal resolution of nascent and maturing granules, but is ideal to monitor agecoded mature granules. Therefore, a faster timer was engineered from th mKusabira-GO
fluorophore, undergoing a similar green to orange transition (5), which has a linear
transition over 1-10 hours, making it ideal for monitoring nascent and maturing granules.
An interesting third approach to timing makes use of a transgenic mouse expressing
recombinant SNAP-tagged insulin for monitoring young granules in beta cell (26). The
SNAP domain is derived from the human O6-methylguanine-DNA methyltransferase,
and when exposed to a benzylguanine-containing substrates, catalyzes a reaction that is
used to transfer a fluorescent dye (e.g., TMR-Star, BG-505) to the SNAP tag (27). As
used in the SOFIA mouse (26), the SNAP-tag approach offers the temporal resolution,
and was used in a pulse-chase paradigm to preferentially label older and younger
granules with different fluorescent dyes. While they showed preferential exocytosis of
“young” over “old” insulin granules, the technique is extensible to specific “gating” of
granules with defined age, and can be applied to specifically monitor immature granules.
To directly address the question of where the initial cleavage event of proglucagon
occurs, fluorescent tagging strategies could be leveraged to enrich a population of
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immature granules combined with downstream analysis by proteomics techniques. A
challenge to investigate proglucagon has always been the availability and performance of
antibodies against the multitude of PGDPs. To circumvent this issue, proteomics are
ideally suited for accurate quantitation and fingerprinting of proglucagon and PGDPs.
The approach described by (26) could be modified to only label the immature granules
(granules only 15-30 minutes old) by first “blocking” a granule-targeted SNAP protein
with the non-fluorescent BTP, followed by a short pulse of a rhodamine-derived TMRStar. Cell membranes can be gently lysed in hypotonic solution leaving in tact the granule
population, and subjected to fluorescent-activated organelle sorting (28). Doublelabelling approaches to specifically label the immature SGs, either by a a fluorescent
timer or specifically tagged ISG protein could be used as a positive control or for
increased specificity by dual-fluorescence-activated sorting. By preserving the labelled
immature granules, they can be enriched for LC-MS/MS proteomic analysis, or “printed”
onto a thin layer of mica for imaging by atomic force microscopy, electron microscopy or
optical imaging to ensure the quality and enrichment of immature granules. In this way,
the contents of ISGs will reveal the relative abundance of proglucagon to the PGDPs. If
this experiment is conducted in native cell lines, and compared with cells that either lack
PC1/3 and PC2 (e..g, PC12), or in native cell lines in which PC1/3 and PC2 have been
depleted or inhibited, this approach also answers whether initial cleavage occurs in the
TGN or ISG. If the initial cleavage occurs in both compartments, this technique can also
assign the degree of cleavage to each compartment. While more elaborate schemes can be
imagined, this approach is advantageous because it combines the sensitivity of MS
analysis with the specificity of granules that have been defined by their age. One could
also imagine a time course comparison to observe the changes in proteomic profile as
granules age to confirm the conversion of proglucagon to its constituent hormones.
From Chapter 2, I concluded that the initial processing of proglucagon was necessary to
enhance sorting, on the basis that a block in this event resulted less efficient sorting. I
refined this model in Chapter 3 by more closely examining the nature of the sorting
signals within the proglucagon-derived peptides. Based on the data at hand, I concluded
that the proglucagon cleavage event must occur after it is sorted to granules, on both the
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nature of the signals and the marked difference in trafficking between glicentin and
MPGF, where glicentin partially entered synaptic-like micro-vesicles. I developed and
validated a more rigorous approach to quantitative co-localization in Chapter 3, and
discuss how it compares to other common methods in Chapter 4, as well as considering
more innovative quantitative co-localization techniques. A more rigorous and quantifiable
technique to directly address proglucagon sorting can take advantage of one of the
advanced co-localization techniques described in Chapter 4, and complementary
proteomics-based approaches as previously described. Single-particle tracking analyses
can be used to visualize the spatial distribution of glicentin and MPGF when combined
with high-temporal resolution labelling techniques (such as fluorescent “timers” and
SNAP-tag labelling), bringing sufficient resolution to monitor sorting and processing
events in the secretory pathway.

5.2 References
1. Blanco, E. H., Lagos, C. F., Andrés, M. E., and Gysling, K. (2013) An amphipathic alpha-helix in the
prodomain of cocaine and amphetamine regulated transcript Peptide precursor serves as its sorting
signal to the regulated secretory pathway. PLoS One 8, e59695
2. Anlauf, M., Weihe, E., Hartschuh, W., Hamscher, G., and Feurle, G. E. (2000) Localization of xeninimmunoreactive cells in the duodenal mucosa of humans and various mammals. J. Histochem.
Cytochem. 48, 1617–26
3. Chowdhury, S., Reeds, D. N., Crimmins, D. L., Patterson, B. W., Laciny, E., Wang, S., Tran, H. D.,
Griest, T. a, Rometo, D. a, Dunai, J., Wallendorf, M. J., Ladenson, J. H., Polonsky, K. S., and Wice,
B. M. (2014) Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans
with and without type 2 diabetes. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G301–9
4. Duncan, R. R., Greaves, J., Wiegand, U. K., Matskevich, I., Bodammer, G., Apps, D. K., Shipston, M. J.,
and Chow, R. H. (2003) Functional and spatial segregation of secretory vesicle pools according to
vesicle age. Nature 422, 176–80
5. Tsuboi, T., Kitaguchi, T., Karasawa, S., Fukuda, M., and Miyawaki, A. (2010) Age-dependent
preferential dense-core vesicle exocytosis in neuroendocrine cells revealed by newly developed
monomeric fluorescent timer protein. Mol. Biol. Cell 21, 87–94
6. Laslop, A., Weiss, C., Savaria, D., Eiter, C., Tooze, S. A., Seidah, N. G., and Winkler, H. (1998)
Proteolytic processing of chromogranin B and secretogranin II by prohormone convertases. J.
Neurochem. 70, 374–83
7. Oya, M., Kitaguchi, T., Pais, R., Reimann, F., Gribble, F., and Tsuboi, T. (2013) The G protein-coupled
receptor family C group 6 subtype A (GPRC6A) receptor is involved in amino acid-induced
glucagon-like peptide-1 secretion from GLUTag cells. J. Biol. Chem. 288, 4513–21
8. Wäsle, B., Hays, L. B., Rhodes, C. J., and Edwardson, J. M. (2004) Syncollin inhibits regulated
corticotropin secretion from AtT-20 cells through a reduction in the secretory vesicle population.
Biochem. J. 380, 897–905
9. Sobota, J. A., Ferraro, F., Bäck, N., Eipper, B. A., and Mains, R. E. (2006) Not all secretory granules are
created equal: Partitioning of soluble content proteins. Mol. Biol. Cell 17, 5038–52
10. Giordano, T., Brigatti, C., Podini, P., Bonifacio, E., Meldolesi, J., and Malosio, M. L. (2008) Beta cell
chromogranin B is partially segregated in distinct granules and can be released separately from

172
insulin in response to stimulation. Diabetologia 51, 997–1007
11. Sombers, L. a, Maxson, M. M., and Ewing, a G. (2005) Loaded dopamine is preferentially stored in the
halo portion of PC12 cell dense core vesicles. J. Neurochem. 93, 1122–31
12. Grabner, C. P., Price, S. D., Lysakowski, A., and Fox, A. P. (2005) Mouse chromaffin cells have two
populations of dense core vesicles. J. Neurophysiol. 94, 2093–104
13. Dong, Y., Ning, G., Ewing, A. G., and Heien, M. L. (2014) Pituitary adenylate cyclase activating
polypeptide modulates catecholamine storage and exocytosis in PC12 cells. PLoS One 9, e91132
14. Taylor, S. W., Nikoulina, S. E., Andon, N. L., and Lowe, C. (2013) Peptidomic profiling of secreted
products from pancreatic islet culture results in a higher yield of full-length peptide hormones than
found using cell lysis procedures. J. Proteome Res. 12, 3610–9
15. Lapko, V. N., Miller, P. S., Brown, G. P., Islam, R., Peters, S. K., Sukovaty, R. L., Ruhn, P. F., and
Kafonek, C. J. (2013) Sensitive glucagon quantification by immunochemical and LC-MS/MS
methods. Bioanalysis 5, 2957–72
16. Dittié, A. S., Thomas, L., Thomas, G., and Tooze, S. A. (1997) Interaction of furin in immature
secretory granules from neuroendocrine cells with the AP-1 adaptor complex is modulated by
casein kinase II phosphorylation. EMBO J. 16, 4859–70
17. Klumperman, J., Kuliawat, R., Griffith, J. M., Geuze, H. J., and Arvan, P. (1998) Mannose 6-phosphate
receptors are sorted from immature secretory granules via adaptor protein AP-1, clathrin, and
syntaxin 6-positive vesicles. J. Cell Biol. 141, 359–71
18. Varlamov, O., Eng, F. J., Novikova, E. G., and Fricker, L. D. (1999) Localization of
metallocarboxypeptidase D in AtT-20 cells. Potential role in prohormone processing. J. Biol. Chem.
274, 14759–67
19. Eaton, B. a, Haugwitz, M., Lau, D., and Moore, H. P. (2000) Biogenesis of regulated exocytotic carriers
in neuroendocrine cells. J. Neurosci. 20, 7334–44
20. Kakhlon, O., Sakya, P., Larijani, B., Watson, R., and Tooze, S. a (2006) GGA function is required for
maturation of neuroendocrine secretory granules. EMBO J. 25, 1590–602
21. Miesenböck, G., De Angelis, D. A., and Rothman, J. E. (1998) Visualizing secretion and synaptic
transmission with pH-sensitive green fluorescent proteins. Nature 394, 192–5
22. Ma, L., Bindokas, V. P., Kuznetsov, A., Rhodes, C., Hays, L., Edwardson, J. M., Ueda, K., Steiner, D.
F., and Philipson, L. H. (2004) Direct imaging shows that insulin granule exocytosis occurs by
complete vesicle fusion. Proc. Natl. Acad. Sci. U. S. A. 101, 9266–71
23. Hodel, A., and Edwardson, J. M. (2000) Targeting of the zymogen-granule protein syncollin in AR42J
and AtT-20 cells. Biochem. J. 350 Pt 3, 637–43
24. Hays, L. B., Wicksteed, B., Wang, Y., McCuaig, J. F., Philipson, L. H., Edwardson, J. M., and Rhodes,
C. J. (2005) Intragranular targeting of syncollin, but not a syncollinGFP chimera, inhibits regulated
insulin exocytosis in pancreatic beta-cells. J. Endocrinol. 185, 57–67
25. Kebede, M. a, Oler, A. T., Gregg, T., Balloon, A. J., Johnson, A., Mitok, K., Rabaglia, M., Schueler, K.,
Stapleton, D., Thorstenson, C., Wrighton, L., Floyd, B. J., Richards, O., Raines, S., Eliceiri, K.,
Seidah, N. G., Rhodes, C., Keller, M. P., Coon, J. L., Audhya, A., and Attie, A. D. (2014) SORCS1
is necessary for normal insulin secretory granule biogenesis in metabolically stressed β-cells. J.
Clin. Invest., 20–23
26. Ivanova, A., Kalaidzidis, Y., Dirkx, R., Sarov, M., Gerlach, M., Schroth-Diez, B., Müller, A., Liu, Y.,
Andree, C., Mulligan, B., Münster, C., Kurth, T., Bickle, M., Speier, S., Anastassiadis, K., and
Solimena, M. (2013) Age-dependent labeling and imaging of insulin secretory granules. Diabetes
62, 3687–96
27. Keppler, A., Pick, H., Arrivoli, C., Vogel, H., and Johnsson, K. (2004) Labeling of fusion proteins with
synthetic fluorophores in live cells. Proc. Natl. Acad. Sci. U. S. A. 101, 9955–9
28. Gauthier, D. J., Sobota, J. a, Ferraro, F., Mains, R. E., and Lazure, C. (2008) Flow cytometry-assisted
purification and proteomic analysis of the corticotropes dense-core secretory granules. Proteomics
8, 3848–61

173

Appendix
Appendix 1. Code contributions to the FIJI/ImageJ project
In order to explore the computational application of co-localization, I sought a software
package that both implemented Pearson's correlation coefficient and was intended for
scientific applications. Several commercial and non-commercial software packages
incorporate Pearson's correlation coefficient and multiple other co-localization algorithms.
Among them, I chose to use FIJI/ImageJ, because of its popularity in biological sciences; it is
free (in cost and license); open-source; has a responsive developer community; and runs on
platforms. Within FIJI, the Colocalization analysis plug-in (called “Coloc 2”) measures colocalization either on whole images, masked images or selected regions-of-interest (ROIs). I
first tested the validity of the calculation by using “toy” image sets, such that the Pearson's
correlation coefficient could be independently verified by manual and Excel spreadsheet
calculations. From these tests, it became apparent that the Pearson's correlation coefficient
calculations were numerically flawed, and resulted (at times) in substantially under- or overinflated correlation values on test image sets. Obviously, this was problematic, and in
reaching out the core FIJI developers, I discovered that this bug had not yet been reported.
Therefore, it is possible that had Coloc 2 been used for co-localization, incorrect correlation
values may have been reported in scientific literature. At the same time as fixing this bug, I
had also added another algorithm to compute Spearman's rank correlation coefficient. The
Spearman's rank correlation might be useful for future co-localization studies using FIJI.

Bug fixes for the FIJI Colocalization analysis plug-in
The existing bugs inside of the Colocalization analysis plug-in could be divided into two
categories: a numerical error, and a logical error. The latter, logical error, failed to properly
handle ROI selections. In theory, any selected ROI would have its co-localization parameters
calculated for only those pixels within the ROI. In this bug, a selected ROI correctly returned
the pixels contained therein, yet the image statistics of each channel mean intensity and sum
of squared differences were computed from the entire image, ignoring the selected ROI,
causing the parameter to be miscalculated. Second, the numerical error was the use of
incorrect arithmetic in translating the mathematical equation for Pearson's correlation into
computer arithmetic, resulting again in miscalculation. A by-product of this numerical error
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was that there was a mismatch between the software calculation of an integer and a floatingpoint value, that results in rounding error. This code was sent to the developer mailing list
and was incorporated in the code base by the core developers (at approximately the same
time as the Spearman rank correlation coefficient below).

Addition of the Spearman's Rank Correlation Coefficient Algorithm
to FIJI
The Spearman's rank correlation coefficient is the rank-ordered equivalent of the Pearson's
correlation coefficient. Specifically, when both continuous variables used for Pearson's
correlation are converted to their rank-order, the Pearson's ρ is equivalent to the Spearman's
ρ. An additional component of this correlation value is that ties in rank must be resolved
according to the average of their positions. For a sample of i values (e.g., a pair of images
each with i pixels), the Spearman's ρ is calculated as follows:

where subscript i is the rank of each pixel, x and y represent each image channel, and
overbars represent mean pixel rank. Similar to Pearson's ρ, Spearman's ρ is also continuous
on the domain [-1,1].
An attractive feature of using this technique is that Spearman's ρ is more sensitive to nonlinear statistical co-relationships. Despite similar advantages to Pearson's correlation,
Spearman's rank correlation has the potential to discriminate sub-cellular compartments by
nature of its rank-ordered computation. However, this has not yet been critically applied to
fluorescence microscopy for the purposes of protein co-localization in real image sets.
The revision history for the Spearman's rank correlation coefficient is publicly available from
GitHub (commit# 5e134f48; found online at
http://github.com/fiji/fiji/commit/5e134f487709fc37e5afd7e72b0f8d92605b4168). The
substantive algorithm code has been re-produced below, from the
SpearmanRankCorrelation.java source file:
public static <T extends RealType<T>> double
calculateSpearmanRank(TwinCursor<T> cursor) {
5

// Step 0: Count the pixels first.
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int n = 0;
while (cursor.hasNext()) {
n++;
cursor.fwd();
}
cursor.reset();
data = new double[n][2];
ch1raw = new double[n];
ch2raw = new double[n];
ch1ranks = new double[n];
ch2ranks = new double[n];
for (int i = 0; i < n; i++) {
cursor.fwd();
T type1 = cursor.getChannel1();
T type2 = cursor.getChannel2();
data[i][0] = type1.getRealDouble();
data[i][1] = type2.getRealDouble();
ch1raw[i] = data[i][0];
ch2raw[i] = data[i][1];
}
/**
* Here's the concept. Rank-transform the data, then run
* the Pearson correlation on the transformed data.
*
* 1) We will sort the dataset by one column, extract the
*
column values and rank them, and replace the data by
*
the ranks.
* 2) Repeat the process now with the remaining column.
* 3) Calculate the coefficient from the individual rank
*
columns, the t-statistic and the df's of the test.
*/
// Step 1: Sort the raw data, by column #2 (arbitrary choice).
Arrays.sort(data, new Comparator<double[]>() {
public int compare(double[] row1, double[] row2) {
return Double.compare(row1[1], row2[1]);
}
});
for (int i = 0; i < n; i++) {
ch2raw[i] = data[i][1];
}
// Rank the data then replace them into the dataset.
ch2ranks = rankValues(ch2raw);
for (int i = 0; i < n; i++) {
data[i][1] = ch2ranks[i];
}
// Step 2: Repeat step 1 with the other data column.
Arrays.sort(data, new Comparator<double[]>() {
public int compare(double[] row1, double[] row2) {
return Double.compare(row1[0], row2[0]);
}
});
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for (int i = 0; i < n; i++) {
ch1raw[i] = data[i][0];
}
ch1ranks = rankValues(ch1raw);
for (int i = 0; i < n; i++) {
data[i][0] = ch1ranks[i];
ch2ranks[i] = data[i][1];
}
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// Step 3: Compute statistics.
rhoValue = calculateRho(ch1ranks, ch2ranks);
tStatisticSpearman = getTStatistic(rhoValue, n);
dfSpearman = getSpearmanDF(n);
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}
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return rhoValue;

public static double getTStatistic(double rho, int n) {
double rho_squared = rhoValue * rhoValue;
return ( rhoValue * Math.sqrt((n - 2) / (1 - rho_squared)) );
}
public static double[] rankValues(double[] sortedVals) {
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int len = sortedVals.length;
int start = 0;
int end = 0;
double[] newranks = new double[len];
double avg = 0, ranksum = 0;
boolean ties_found = false;

100

// first assign ranks, ascending from 1
for (int i=0; i<len; i++) {
newranks[i] = i+1;
}

105

// check for tied values
for (int i=0; i<len; i++) {
start = i;
end = i;

110

// Advance values while you haven't exceeded the final value in the
ranked data,
// and until we break a tie in values.
while ((++end < len) && (sortedVals[start] == sortedVals[end])) {
ties_found = true;
}
// Check if we advanced our end position
if ((end-start != 1) && (ties_found)) {
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// Compute arithmetic average of rank according to Spearman's
method:
120

// average = sum of ranks / number of ranks
avg = 0;
ranksum = 0;
for (int j=start; j<end; j++) {
ranksum += newranks[j];
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}
avg = ranksum / (end-start);

130

// Assign averages to the tied ranks
for (int x=start; x<end; x++) {
newranks[x] = avg;
}
ties_found = false;
}
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//reset i
i=end-1;
}
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}

public static double calculateRho(double[] x, double[] y) {
// Define some variables.
double rho;
int len = x.length; // the lengths should be the same for each array
double mean_x = 0.0, mean_y = 0.0;
double sum_x = 0.0, sum_y = 0.0;
double sd_x = 0.0, sd_y = 0.0, sd_xy = 0.0;
double ssd_x = 0.0, ssd_y = 0.0;
double denominator = 0.0;
int i = 0;
// Calculate the mean of each rank set
for (i = 0; i < len; i++) {
sum_x += x[i];
sum_y += y[i];
}
mean_x = sum_x / len;
mean_y = sum_y / len;

155

160

for (i = 0; i < len; i++) {
// Calculate the Sum of Differences (numerator)
sd_x = x[i] - mean_x;
sd_y = y[i] - mean_y;
sd_xy += sd_x * sd_y;
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}

175

180

return newranks;

}

// Calculate the Sum of Squared Difference
ssd_x += (x[i] - mean_x) * (x[i] - mean_x);
ssd_y += (y[i] - mean_y) * (y[i] - mean_y);

/** Calculate rho
* We calculate it this way rather than the alternative in the case
* (1 - [ (6 sum d^2) / (n(n^2 - 1)) ] which is a simplification when
* there are no ties in rank transformed data.
*/
denominator = Math.sqrt(ssd_x * ssd_y);
rho = sd_xy / denominator;
return rho;
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